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Operations on the sympathetic chain have had a long and colourful history and were often 
considered for a disparate group of medical conditions. Currently recognised indications for 
sympathectomy are hyperhidrosis and Chronic Regional Pain Syndrome (CRPS). The role of 
sympathectomy for non-reconstructible peripheral vascular disease PVD) and Raynaud's 
disease not responding to medical treatment is controversial. Presently, the perceived benefits 
and wide availability of thorascoscopic sympathectomy has resulted in large numbers of this 
procedure being undertaken. 
A greater understanding of the anatomy relevant to upper limb sympathectomy is appropriate 
given the confusing and complex arrangement of the proximal sympathetic chain. Instances 
of unsuccessful sympathectomy have often been attributed to the anatomical arrangement of 
the sympathetic chain. 
The pathogenesis of conditions treated by sympathectomy is unknown; the possible aetiology 
of these conditions may be gleaned from the histopathological changes occurring in ganglia 
from patients treated successfully. 
Aims 
This study has 3 components 
1. Clinical
• a review of the clinical experience, including a comparison of the supraclavicular and
thoracoscopic approaches and evaluating the extent of sympathetic ganglionectomy.
• anaesthetic considerations, evaluating the role of a single-lumen endotracheal tube.
• defining the role and timing of sympathectomy for CRPS
2. Anatomical
• to define the surgical anatomy appropriate to a safe and effective upper limb
sym pathectomy
• to evaluate a modified anterior approach for stellate ganglion blockade (SGB)
3. Pathological





In 498 patients, a total of 939 sympathectomies were undertaken for hyperhidrosis (n=884), 
CRPS (n=43), Raynaud's disease (n=9) and non-reconstructable peripheral vascular disease 
(n= 3). When compared to the supra-clavicular approach, the thoracoscopic approach was 
shown to be superior in terms of safety, technical demand and cost. 
A limited 2 nd thoracic ganglionectomy was effective for palmar hyperhidrosis (100% and in 
associated axillary hyperhidrosis [8 1.2%] and plantar hyperhidrosis [53%]). A compensatory 
hyperhidrosis rate of 12 .6% was noted. The single lumen endotracheal tube was found to be 
as effective but safer than the double lumen endotracheal tube. When undertaken early 
(within 3 months), the outcome to sympathectomy for CRPS was excellent 
2. Anatomical
A total of 4 1  proximal sympathetic chains were evaluated. 
Three categories of alternate neural pathways to the upper limb were defined (total incidence 
90.5%). When correlated with the clinical outcome to a limited 2 nd thoracic ganglionectomy, 
it is suggested that these alternate neural pathways are of no clinical significance. 
The modified anterior SGB was always effective in blockade of the clinically significant 2 nd 
thoracic ganglion. 
3. Pathological
There is strong evidence for an autoimmune hypothesis in both primary hyperhidrosis as well 
as CRPS. The mechanisms responsible for the development of the symptoms in these 
conditions appear to be different. 
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PREFACE 
It is 110 years since the first operation on the sympathetic chain was undertaken (Alexander, 
1890). The evolution of this practice has been associated with the search for the appropriate 
indications and a rational and safe surgical technique. The anatomy - varied and confusing at 
best - has long been held responsible for instances of unsuccessful sympathectomy; however, 
current techniques for sympathectomy are consistently successful. A re-appraisal of the 
relevant anatomy and the pathology of conditions successfully treated by sympathectomy is 
therefore timeous. 
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The history of the sympathetic nervous system - its understanding and application in 
surgical practice - has been a long and colourful one. Not unlike many facets of surgical 
development it has also suffered from misrepresentation and denial but benefited from 
serendipity and dogged perseverance. Indeed, the history of surgery in general is littered by 
acts of sheer inspiration and foresight that have transformed standard surgical procedures. 
Equally and sadly so, enterprising endeavours have been under-appreciated and cast aside, 
only to be belatedly appreciated decades later. The history of the sympathetic nervous 
system illustrates this with respect to its anatomical and surgical status. In formulating the 
current status of the sympathetic nervous system, particularly with respect to the upper 
limb, it is imperative to appreciate the varied contributions of our intrepid predecessors, 
often aided by the absence of ethical restraint. 
From being originally wholly misrepresented anatomically at around the beginning of the 
last millennium, the sympathetic chain progressed to being accurately depicted and credited 
for important physiological functions (at around the mid 19th century). However, in view 
of the multiplicity and mutual inter-dependence of the factors which control the function of 
the end organ (whether blood vasculature or glandular), pin-pointing the actual cause of a 
specific disorder ( eg. vascular disorders, causalgia or hyperhidrosis) has remained elusive. 
Thus the physiological, pathological and biochemical basis underlying such disorders are 
still in many respects far from clear; furthermore, therapeutic treatment by autonomic nerve 
surgery has not always been satisfactory. The turn of the 20th century saw some operations 
on the sympathetic nervous system being undertaken for an often disparate group of 
conditions. The invariably sporadic success to sympathectomy led to the unpopularity of 
this approach. Genuine indications for sympathectomy were thereby relegated. However, 
it is equally true that symapthectomy has freed many patients from the agonizing pain of 
"causalgia"; it has saved in many instances, patients from ulceration or complete gangrene 
and amputation and it has cured many patients from the embarrassment of having a hand or 
foot dripping constantly with sweat. However, the greater appreciation of physiology 
coupled with advances in vascular surgery and pharmacotherapy, particularly from the third 
decade of the 20th century onwards, gradually relegated the status of sympathectomy in 
surgical practice. 
Many patients have benefited in the past from surgery of the autonomic nervous system 
despite the lack of clarity in the scientific background just as patients suffering from cancer 
or peptic ulcers have been helped by surgery despite our ignorance about the basic causes 
of these diseases (Pick, 1970). With increasing numbers of sympathectomies being 
undertaken, afforded by the relative ease of thoracic sympathectomy, a re-evaluation of the 
role of sympathectomy may be timeous. The increasing experience of thoracic 
sympathectomy affords the opportunity to evaluate the indications for sympathectomy in 
current surgical practice; furthermore aspects of surgical technique (as extent of 
ganglionectomy, role of open sympathectomy, aspects of anaesthetic technique and timing 
of sympathectomy for Chronic Regional Pain Syndrome (CRPS) may also be evaluated and 
modified. 
The anatomy of the sympathetic nervous system, though nicely diagrammed in standard 
texts, remains in part a veritable Pandora's Box; many questions still remain unanswered 
and many traditional views are unchallenged. For decades the role of alternate sympathetic 
outflow to the upper limb dominated as a cause of persistent (or recurrent) activity 
following sympathectomy. Thus the Nerve of Kuntz (described in 1927) has been 
constantly stated to be an important cause of persistent sympathetic activity. In the current 
experience (that avoids a stellate ganglionectomy), persistent sympathetic activity does not 
appear to be an issue; this prompts a re-evaluation of the role of alternate sympathetic 
pathways. In our practice, the open approach of sympathectomy is undertaken by the 
supraclavicular route, effectively confining the understanding of the anatomy of the 
sympathetic nervous system to this approach. The increasing popularity of the 
thoracoscopic route prompts an evaluation of the sympathetic chain as noted on 
thoracoscopy. Furthermore, the pitfalls of the thoracoscopic approach also merit evaluation 
as does the problem of persistent and recurrent sympathetic activity following a seemingly 
successful sympathectomy. With a more precise anatomical background, together with a 
finer understanding of the function and role of the sympathetic nervous system, successful 
surgery on this component of the nervous system may become the rule in selected patients. 
An investigation into the pathogenesis of diseases that are successfully treated by 
sympathectomy has not been previously undertaken. The role of the sympathetic nervous 
system with respect to the upper limb is largely considered to promote symptoms such as 
sweating (in primary hyperhidrosis and CRPS) and vasomotor changes (in CRPS and 
Raynaud's Disease); its role in potentiating and maintaining pain in CRPS has not been 
investigated. Similarly, neither has the pathogenesis nor the potentiating factor in primary 
hyperhidrosis been evaluated. An investigation of the pathological mechanism for 
conditions successfully treated by sympathetic ganglionectomy is therefore merited. 
This thesis has three components viz. clinical, anatomical and histopathological: 
a) Clinical
1. The role of sympathectomy for upper limb in current surgical practice. The efficiency,
complication and durability of the outcome will be considered. Given the global
standpoint on sympathectomy for classic vascular diseases (vasospastic and vaso­
occlusive) primary hyperhidrosis and CRPS will be considered in greater detail.
2. The most appropriate surgical approach will be defined with aspects of technique that
will expedite technical ease and minimize complications, failures and enhance patient
satisfaction and clinical outcome. This will include the extent of the sympathetic
ganglionectomy and the most user friendly and effective surgical technique.
Mechanisms responsible for an unsuccessful sympathectomy will be evaluated.
b) Anatomical
I. To define alternate sympathetic pathways applicable to the upper limb; these have long
been considered as possible causes for failure of upper limb sympathectomy.
2. The arrangement of the inferior cervical, Tl and T2 ganglia in relation to the 2nd rib -
considered as a key landmark for an accurate and complete upper limb sympathectomy
will be evaluated.
3. Because the so-called Stellate Ganglion Block is held as pivotal in diagnosing those
patients with CRPS who will benefit from sympathectomy, the anatomical basis for an
accurate Stellate Ganglion Block will be defined.
6 
c) Histopathological
I. To define the histopathologic baseline with respect to the spectrum of changes seen in
hyperhidrosis and CRPS. Preliminary appraisal of ganglia from hyperhidrotic and
CRPS patients has demonstrated a variable number of lymphocytes, mast cells and
lymphoid aggregates with germinal centers.
2. To investigate the immunophenotype of the lymphocyte infiltrate, the intensity of this
infiltration and its pathological significance.
CHAPTER2 
LITERATURE REVIEW 
2.1 HISTORICAL PERSPECTIVES 
"if the science of surgery is not to be lowered to the rank of a mere technical exercise, it must pre­
occupy itself with its history" 
Emile Littre 
(11h C French Surgeon) 
2.1.1 ANATOMICAL PERSPECTIVE 
As in many facets of medicine, an appreciation of the contributions of our predecessors 
is often the key to innovation and advances in surgery. The sympathetic nervous system 
was a totally under-appreciated structure until Galen of Pergamon ( 130-199 AD) drew 
attention to it. Unfortunately his descriptions of a common vago-sympathetic trunk 
arising from the brainstem remained unchallenged for centuries, a reflection of the 
standing and reverence of Galen's work. This anatomical misconception was 
perpetuated by Versalius, a renowned anatomist at Padua, at around the midway of the 
2
nd 
millennium (Figure I). Versalius, however, established the principle of anatomical 
dissection that led to Eustachius demonstrating that the vagus and sympathetic trunk 
were separate neural entities (Versalius, 1555; Russel, l 979; Royle, 1999). 
---o 
s 
Figure 1: Earliest drawing of the sympathetic trunk, rami communicantes 
and peripheral autonomic nerves; the vagus and adjacent lower cranial 
nerves are also shown (Adapted from Huart and Jmbault-Huar, 1980 
9 
10 
Winslow (1749) is credited as having named the sympathetic nerve as such (in 1732). It 
was suggested that nerves arising from the ganglionated trunks extending along the 
ventro-lateral aspects of the vertebral column supply both the intestine and the heart. 
By reason of the numerous connections of these trunks it was assumed that through 
these connections one part of the body extended influence on other parts of the body. In 
accordance with the then existent teaching, it was presumed that the sympathies of the 
body were orchestrated by these nerves. Winslow therefore called them the great 
sympathetics. Because he believed that the vagus and nervus intermedius subserved a 
similar function, he called these nerves respectively the medium and small sympathetics 
(Winslow, 1749; Royle, 1999). 
By the end of the I 8
th 
century the anatomy of the sympathetic nervous system was fairly 
well defined. Greater anatomical refinements were produced by Gaskell ( 1886-1889) 
who named the chain of ganglia along each side of the spine the "vertebral or lateral 
ganglionic chain"; he also documented three great separate outflows of small 
medullated connector fibres from the central nervous system viz. a bulbar, a 
thoracolumbar and a sacral, forming together with the sympathetic fibres, the 
"involuntary nervous system." Langley and Dickinson ( 1889) greatly contributed to the 
spinal outflow and anatomical mapping of the sympathetic ganglia, elaborating upon an 
earlier observation of the paralysing effect of nicotine on papillay dilatation by 
pinpointing the action of this drug at the sympathetic ganglion cells of the superior 
cervical ganglion. This discovery gave Langley a tool to localise the cell station, which 
issued their fibres to the specific effector cells in various regions, and to map out the 
areas of distribution of "preganglionic to postganglionic" neurons (Pick, 1970). He 
classified the cervical, thoracolumbar and sacral outflows as the "autonomic nervous 
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system," a term he coined in 1898. In 1905, Langley observed that pilocarpine and 
other drugs stimulate the cranial and sacral outflows, which he then called the 
parasympathetic nervous system. Thus, Langley and Dickinson ( 1889) established the 
anatomical distributions of the autonomic nervous system by separating them into two 
great divisions (Langley and Dickinson, 1889; Pick, 1970). 
The spinal origins of the sympathetic nervous system in the intermediolateral column 
with a localised thoracolumbar outflow was widely accepted, as was the arrangement 
and concept of preganglionic and postganglionic sympathetic fibres. Impetus for an 
even finer appreciation of sympathetic neuroanatomy came as surgical procedures were 
undertaken on the sympathetic nervous system. In the absence of restraining ethical 
committees, these pioneering and intrepid surgeons, by performing an array of 
procedures on the sympathetic nervous system, indirectly contributed to an even greater 
understanding of the sympathetic nervous system. Similarly, an understanding of the 
physiology of the sympathetic nervous system was often procured by serendipity. 
The beginning of our understanding of the sympathetic nervous system physiology was 
in March 1852, when Claude Bernard and Brown Sequard serendipitously discovered 
the role of the sympathetic nervous system in the human circulation. Having transected 
the cervical sympathetic trunk at "about the middle of the neck" Bernard anticipated a 
fall in temperature; however, he noted "in the whole of the corresponding side of the 
rabbit's head a striking hyperactivity in the circulation, accompanied by increase in 
warmth" This observation, a reversal of Bernard's hypothesis, inadvertently prompted 
operations on the sympathetic nervous system for the management of vasculopathies 
some four decades later (Bernard, 1852; Pick, 1970). 
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TABLE 1: THE SYMPATHETIC NERVOUS SYSTEM- HISTORICAL LANDMARKS 































original anatomic dissection and documentation of a vago­
sympathetic trunk ( part of 6
th 
cranial nerve) described 
superior,inferior cervical,semi-lunar ganglion and rami 
communicantes 
did not challenge Galen's "6
th 
nerve·' 
considered vagus and sympathetic as different 
described sympathetic trunk as "intercostal" with an intracranial 
origin 
demonstrated cervical ganglia and rami communicantes 
suggested "intercostal" nerves originate below cranium ie the 
spinal origin of the sympathetics 
described 3 "sympathetic nerves·• viz '·small .. (facial nerve) 
"middle" (vagus), "large" (sympathetic) 
regarded ganglia as stations wherein nerve bundles are sorted prior 
to dispersal to terminations. 
regarded ganglia as "little brains" 
described sympathetic trunk as "chain of little brains", noting 
some rami to be white, others grey 
ganglia connected with cervical and sacral nerves by grey rami 
only 
described vasoconstrictor function of the sympathetics 
cooling of skin and diminution of blood flow on stimulation of 
the sympathetics 
comprehensive account of the histology of sympathetic ganglia. 
Observed that preganglionic, white rami contained only 
myelinated fibers and postganglionic, grey rami contained 
myelinated and unmyelinated fibers 
described the sympatheic innervation of upper limb vessels 
ventral spinal roots contain efferent sympathetic fibers to the 
gastro-intestinal tract, iris, bladder, salivary glands and blood 
vessels. Visceral efferents mediate reflexes over the spinal cord 
sympathetic communicates to spinal cord exclusively via white 
rami. Spinal origin of sympathetic from cells in lateral horn. 
Efferent fibres to trunk (by white rarni) only in thoraco- lumbar 
region 
cranial, thoracolumbar and sacral outflow comprises the auto­
nomic nervous system. Saw a functional antagonism between 
sympathetics and parasympathetics. Described pre- and post­
ganglionic neurons, using the paralyzing effect of nicotine on 
s m athctic an lia 




1942 Hyndman & Wolkin 
1946 Pick & Sheehan 
1953 Mitchell 
1959 Wrete 




1987 Groen et al. 
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sympathetic fibres do not reach periphery along main vessels but 
run with sensory nerves to join arteries at successive levels 
demonstration of an intrathoracic ramus that was considered to be 
an alternate neural pathway to the upper limb 
preganglionic fibres to upper limb emerge below the I 51 thoracic 
segment of the spinal cord 
division of trunk between 2nd and 3
rd thoracic ganglion produced 
denervation of vascular structures of the upper limb 
2
nd 
thoracic ganglion pivotal to upper limb sympathetic supply
ganglia designated according to the number of the vertebrae 
lateral gray column of spinal cord provides origin of preganglionic 
fibers 
numbered ganglia according to intercostal space 
reported 11 ganglia in 71 % of cases; 12 ganglia in 23% of cases; 
IO ganglia in 4% of cases and 13 ganglia in 20% of cases 
reported that ganglia ranged in numbers between 9 and 13 
described only 11 thoracic ganglia 
ganglia either para-vertebral (along ventrolateral aspect of spinal 
column) or pre-vertebral (close to median plane of body) 
ganglia ranged between 8- 10 in number 
Because the nuances of the physiology of the sympathetic nervous system as we 
currently appreciate were lacking, indications for surgery on the sympathetic nervous 
system, not surprisingly, were discordant. This, coupled with a less than clear 
appreciation of the anatomy, the absence of a censorial surgical milieu and willing 
patients, led to operations on the sympathetic nervous system being undertaken for a 
disparate group of conditions. Thus, desperately, sympathectomy was undertaken to 
alleviate a variety of conditions for which there was no efficient treatment at the time. 
The first surgeon to operate on the sympathetic nervous system was Alexander of 
Liverpool; he performed a cervical sympathectomy for epilepsy in 1889. Jonnesco of 
Bucharest (1896) undertook sympathectomy for exophthalmic goitre; as reported by 
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Drott (1994), sympathectomy was also undertaken by Abadie (1899) for glaucoma, 
Pappalado ( 1902) for trigeminal neuralgia and Ball (1905) for optic nerve atrophy. Not 
surprisingly, the outcome to sympathectomy for these conditions was invariably 
unsatisfactory. 
Perhaps of prescient significance was the endeavour by Jaboulay in 1899. He, mindful 
of Bernard's observations some four decades earlier, undertook peri-arterial 
sympathectomy for the so-called spastic vascular disorders. This procedure did not gain 
prominence until his protege , Rene Leriche ( 1913), gave it greater publicity. Peri­
arterial sympathectomy did not prove to be an enduring surgical option. An anatomical 
basis for failure after peri-arterial sympathectomy was presented by Kramer and Todd 
( 1914) who demonstrated that the sympathetic fibres do not reach the periphery along 
the main vessels, but run with the sensory nerves to join arteries at successive levels. 
The endeavours of Jaboulay and Leriche, notwithstanding the enormous contributions to 
the understanding and clinical applications of surgery on the sympathetic nervous 
system, represented a timely departure from the developing trend of cervical 
ganglionectomy (including superior and middle ganglionectomy). 
Bruning ( 1923) was one of the few to have used peri-arterial sympathectomy 
extensively for the treatment of Raynaud 's phenomenon and scleroderma. He therefore 
suggested extirpation of the stellate ganglion in order to interrupt all the sympathetic 
fibers before they join the spinal nerves. He subsequently reported excellent immediate 
results in several cases of Raynaud's phenomenon and scleroderma. Within the next few 
years various authors (Royle, I 924; Adson and Brown, 1929; Davis et al., 1926) 
started to employ ganglionectomy for the treatment of Raynaud's phenomenon. 
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The years of invariably inappropriate surgical endeavours finally ended when Kotzareff 
(1920) performed a cervical ganglionectomy (he excised two cervical ganglia under 
local anaesthesia) in a patient with primary hyperhidrosis of the face and upper limbs. 
The operation was a success despite the Homer's syndrome. The ensuing years saw the 
further refining of the indications for sympathectomy and, with this, an appreciation of 
the anatomy in order to obtain a complete sympathectomy. In addition to primary 
hyperhidrosis, vasospastic disorders were also considered then to be a valid indication 
for sympathectomy. The treatment of causalgia was added to these, when, in 1930, 
Spurling reported the successful treatment of this condition by cervico-dorsal 
sym pathectomy. 
The rapid emergence of peripheral and cardiovascular surgery and its wide availability 
together with the development of new pharmacological agents during the 1940s and 
onwards saw the gradual decline of sympathectomy as a relevant surgical technique. 
However, the pharmacological treatment of palmar hypcrhidrosis and, on occasions, 
CRPS (previously called causalgia) have been shown to be unimpressive. Furthermore, 
the effect of relegating sympathectomy saw the avoidance of the critical evaluation of 
this operation. Lack of clinical interest also impacted negatively on the further 
anatomical evaluation of the sympathetic nervous system; thus the contributions to its 
understanding over the past fifty years have largely not matched those up to the 1940s. 
2.1.1.1 Spinal Sympathetic Outflow To The Upper Limb 
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The exact preganglionic sympathetic outflow from the spinal cord in humans was 
determined physiologically by recording the electrical activity of peripheral nerves 
during stimulation of the ventral roots of the spinal cord and recording changes in skin 
resistance (Geohegan and Aidar, 1942). The lateral grey column of the thoracic 
segment of the spinal cord provides the origin of the sympathetic nerves cells 
responsible for the sympathetic preganglionic fibers (Mitchell, 1953). The precise 
extent of the spinal preganglionic outflow is a vexed issue; Telford (1935) and 
Smithwick (1936) demonstrated that the preganglionic fibers for the upper limb 
emerged in white rami communicantes below the level of the I st thoracic segment of the
spinal cord. White and Smithwick (1952) suggested that "it is not necessary to divide 
the I st thoracic white ramus; it does not carry vaso-or sudomotor fibres of importance to
man." Simmons and Sheehan (1939), Goetz and Marr (1944), Palumbo (1956) and 
Barcroft and Swan (l 953) re-affirmed this view, finding no sympathetic activity in man 
when the outflow from the I st thoracic segment is not divided.
The distal limit of the outflow of preganglionic sympathetic fibres to the upper limb is 
largely inconclusive (Hoffinan, 1957). The view that all preganglionic fibers to the 
upper limb traversed the nerve roots distal to the thoracic ganglion was supported by 
Gask (1934 ), Foerster (1939), Sheehan and Marrazzi ( 1941) and Geohegan and Aidar 
(1942). Smithwick (1940), White et al. (1952) suggested that the upper spinal origin of 
the upper limb sympathetic outflow was at the level of the 2nd thoracic spinal root. The 
spectrum of the spinal origin of the upper limb sympathetic supply as suggested by 
various authors is demonstrated (Figure 2); Ray (1943, 1953) demonstrated that the 
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spinal outflow may be higher, including the I st thoracic or even the 8
th 
cervical spinal
root. Bridges and Yahr (1955) and Hoffinan (1957) suggested that the upper limit for 
preganglionic outflow may b as high as the 8
th 
cervical segment. Similarly the lower 















Figure 2: Schematic distribution of sympathetic 
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2nd thoracic ganglion 
Stellate ganglion 
Postganglionic fiber to upper limb 
18 
The failure to precisely define the extent of the spinal origin of upper limb 
sympathectomy outflow impacted on the extent of sympathectomy to effect upper limb 
sympathetic denervation. Emphasis on the spinal segments or the spinal root rather than 
the level of the ganglionectomy in effecting sympathetic outflow, may have contributed 
to this dilemma. Thus, Foerster (1939) on the basis of stimulation of ventral nerve roots 
and plethysmographic studies concluded that the 3rd to 7th thoracic preganglionic fibres 
were concerned with the sympathetic innervation of the upper limb; he suggested that 
the division of the sympathetic chain between the 2nd and 3rd thoracic ganglia produced 
denervation of the vascular structures of the upper limb. In contrast, Hyndman and 
Wolk in ( 1942) advocated removal of the 2nd thoracic ganglion alone. Atlas ( 1941 ), 
Richards (1946) and White et al. (1952) reported that some sympathetic activity 
persisted in the hand following removal of the sympathetic chain below the 2nd thoracic 
ganglion. The reports of Ray (1943), Lazorthes (1949), Thompson (I 950) and Haxton 
( 194 7) and Pick ( 1970), who all found evidence that vasomotor fibres to the upper limb 
emerged in the I st thoracic nerve root, ensured that the issue remained a controversial 
one. Indeed, Foerster (1936), Smithwick (1936), Telford (1935) and Hyndman and 
Wolkin ( 1942) argued that the I st thoracic spinal nerve did not contain sympathetic 
fibres to the upper limb. 
The increasing success with limited sympathectomies (2nd thoracic ganglionectomies) 
for upper limb sympathectomy has essentially resolved this issue (O'Riodian, 1993); it 
is clear, regardless of the spinal origin of the sympathetic outflow, that the 2
nd 
thoracic 
ganglion is pivotal for upper limb sympathetic innervation. Large clinical series of 2
nd 
thoracic ganglionectomy have shown that this approach is adequate for upper limb 
sympathetic denervation, reinforcing the view of Hyndman and Wolkin (1942). The role 
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of alternate neural pathways, originally described by Kuntz and long considered an 
important cause of an unsuccessful operation, merits a re-evaluation in the light of the 
large numbers of syrnpathectomies presently undertaken. 
2.1.2 SURGICAL PERSPECTIVE 
The pioneering surgical endeavours of the sympathetic nervous system were associated 
with an unpredictable outcome. Although often associated with an inappropriate 
indication; the increasing surgical endeavours on the proximal sympathetic chain 
prompted further re-appraisal of the anatomy of this component of the sympathetic 
chain. Table 2 chronicles the evolution of indications and techniques for upper limb 
syrnpathectomy until the 1990s. 
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TABLE 2: EVOLUTION OF INDICATIONS AND TECHNIQUES FOR SYMPATHECTOMY 
(UP TO 1993) 
,E\R \l r
!
IOR PIH)( EDl RE (0\DIJIO'\ 
1889 Alexander Superior cervical ganglionectomy Epilepsy 
1892 Jacksch Reserted vertebral plexus : divided trunk Epilepsy 
between mid and inferior ganglion 
1896 Jonnesco Divided trunk above and below mid izangJion 
1899 Jaboulay Peri-arterial sympathectomy Trophic vascular 
disorders 
1899 Abadie Superior cervical ganglionectomv Glaucoma 
1902 Paooalado Suoerior cervical ganglionectomv Trigeminal neuralgia 
1905 Ball Sunerior cervical ganglionectomv Ootic nerve atrophy 
1913 Leriche Peri-arterial sympathectomy Raynaud's Disease 
1917 Leriche Peri-arterial svmpathectomv 'Causalgia' 
1920 Kotzareff Superior and mid ganglionectomv Hyperhidrosis 
1921 Jonnesco Mid and inferior ganglionectomv Angina 
1924 Royle Stellatectomy Raynaud's Disease 
1930 Spurling Cervico-dorsal svmoathectomv 'Causalgia' 
1924 Henry Stellatectomv (oost approach) Angina 
1929 Adson Stellatectomy and upper dorsal Raynaud's Disease 
svmoathectomv 
1935 Telford 2nd and 3rd ramusectomy; trunk transected Raynaud's Disease 
below 3'd ganglion 
1936 Smithwick Preganglionectomy and transection of trunk Ravnaud's Disease 
1942 Hughes Endoscopic stellatectomy Raynaud's Disease and 
Causalgia 
1942 Hyndman and 
Wolkin 
2nd thoracic ganglionectomy Raynaud's migraine 
1944 Goetz and Marr Transthoracic and endoscopic 2na thoracic Raynaud's Disease 
gang! ionectomy 
1954 Kux Various endoscopic operations on the 
'vegetative' nervous system i.e. sympathetic 
and parasympathetic (vasotomv) fGerrnan] 
1969 Cloward Dorsal midline approach for bilateral Hyperhidrosis 
svmpathectomv 
1971 Roos Transaxillary, extrapleural with I'' rib 
resected 
1978 Kux Endoscopic 2nd to 61" thoracic Hyperh idrosis 
gang! ionectomv 
1990 Byrne et al. Endoscopic 2"0 to 41" ganglionectomv Hvuerhidrosis 
1991 Claes and Endoscopic sympathectomy Hyperhidrosis 
Gothberg 
1993 O'Riordan 2"0 thoracic ganglionectomy {Telford Hyperhidrosis 
annroach) 
1993 Chandler VA TS; 2"0 and 3rd thoracic ganglionectomy 'Causalgia' 
1993 Krasna Video assisted thorascopic sympathectomy Hyperhidrosis 
(VA TS); I'' to 3rd thoracic ganglionectomv 
1998 Lin et al. Thoracoscopic cl inning of svmoathetic chain Hyperhidrosis 
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Of significance was Kuntz's demonstration (1927) of a nerve by-passing the 2
nd or 3
rd 
thoracic ganglion to the brachia! plexus. In the context of obviating a failed 
sympathectomy, this nerve - then reported to be present in up to I 0% of humans - was 
considered to be of crucial importance. Additional sympathetic nerves that reached the 
brachia! plexus via the sinu-vertebral nerve (van Buskirk, 1941) or the vertebral plexus 
were also described. The latter originates from a large branch of the stellate ganglion ; 
rami communicantes from this plexus may join the ventral rami of the upper five or six 
cervical spinal nerves (Williams et al., 1995). With continual clinical experience it also 
became apparent that effective upper limb sympathectomy could be undertaken without 
cervical (including the stellate ganglion) ganglionectomy and that ganglionectomy at 
the level of the 2
nd 
thoracic ganglion (and cephalad) was effective. (Hyndman and 
Wolk.in, 1942; Atlas, 1941; Goetz and Marr, 1944). 
Despite these refinements in the understanding of the upper limb sympathetic supply, 
the surgical approach remained a vexed issue. Several surgical techniques were 
described during the late I 920's and early I 930's. These techniques not only employed 
different approaches (anterior cervical, anterior thoracic or posterior extra-pleural), but 
also different forms of handling of the sympathetic chain ranging from resection of the 
stellate ganglion with or without segments of the upper thoracic sympathetic chain. 
Leriche ( 1926) was the first to use an anterior approach for the resection of the stellate 
ganglion. Royle ( 1932) performed stellectomy through a 5cm skin incision across the 
insertion of the sternocleidomastoid muscle. Gask ( 1934) modified these approaches, 
using a collar incision to undertake the bilateral resection of the stellate ganglion and 
the 2
nd 
thoracic ganglion. Telford (1935) used essentially the same technique as Gask; 
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however, the stellate ganglion was left intact, the white rami of the 2
nd and 3rd thoracic
nerves were divided and the sympathetic chain crushed below the 3
rd 
thoracic ganglion. 
The posterior extra-pleural approach by rib resection was first introduced by Henry 
( 1924) for the unilateral removal of the stellate ganglion. Ad son and Brown ( 1929) and 
Adson ( I 93 I) described an operation for the bilateral resection of the stellate ganglion 
and upper thoracic sympathetic ganglia. Smithwick ( 1936) advocated a pre-ganglionic 
sympathectomy- rather than ganglionectomy- for optimal sympathetic denervation. The 
premise for this was based on the observation that recurrent sympathetic activity was 
approximately three times greater than following a pre-ganglionic section (Ascroft, 
I 937). It became apparent that the sympathetic nerves had great ability to regenerate 
following transection or resection, leading to recurrent sympathetic activity. To this end 
Smithwick (I 936, 1949) devised a preganglionic section of the sympathetic chain. The 




thoracic ganglia together with their respective 
intercostal nerves were transected; the sympathetic chain was transected below the 3
rd 
ganglion and sutured to muscles. The effectiveness of this approach was not reported. 
If anything, this elaborate approach depicts the challenges posed to our innovative, 
pioneering surgical forefathers. Indeed, procuring an effective and reproducible 
operation to effect upper limb sympathectomy long remained a holy grail to the 
surgeon; to this end a variety of approaches evolved since sympathectomy had become 
a viable and essential operation (Table 3, Figure 3). 
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TABLE 3: THE SPECTRUM OF APPROACHES FOR UPPER LIMB SYMPATHECTOMY 
n l'E 01- \Pl'RO \( U \l I IIOR 
Anterior Supraclavicular Telford (1935) 
Bogokowsky et al. (1983) 
Keaveny et al. (1977) 
Posterior Paravertebral Golueke et al. ( 1988) 
Posterior Midline Cloward ( 1969) 
Anterior transthoracic Goetz and Marr ( I 944) 
Palumbo ( 1956) 
Axillary transthoracic Atkins ( 1954) 
Axillary transthoracic with I st rib resection Roos (1971) 
Minimally invasive sympathectomy 
Endoscopic Hughes ( I 942) 
Goetz and Marr ( I 944) 
Kux (I 954) 
Video-Assisted Chandler (1993) 
Chao et al ( 1993) 
• 
Figure 3: Surgical options for sympathectomy 
1-Gany(l949), 2-Palumbo (1956), 3- Lougheed(l965), 4-Cloward (1969), 5- Roos (1971)
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From South Africa, Goetz and Marr (1944) described the trans-thoracic approach via an 
incision over the I st or 2
nd intercostal space about 4 inches in length, commencing at the 
margin of the sternum; in the same communication the authors drew attention to the 
possibility of the thoracoscopic approach. Atkins (1954) modified this to an axillary 
trans-thoracic approach. Palumbo ( 1956) re-appraised the anterior trans-thoracic route 
in 1966, advocating access to the sympathetic chain via the 3rd or 4
th intercostal space. 
Although providing the best exposure, the trans-thoracic approach evokes the morbidity 
and sometimes the mortality of a thoracotomy. 
Cloward (1969) described the dorsal midline approach which gives access to both sides. 
This approach has been particularly popular among neurosurgeons. Roos (I 971 ), in 
modifying the Atkin's axillary trans-thoracic approach, described an extra-pleural 
approach after trans-axillary resection of the l st rib. This approach gained popularity 
among vascular surgeons. 
Regardless of the open technique favoured, these are invariably technically demanding 
procedures which, apart from leaving sizeable scars, often require several days of 
recovery in hospital and weeks or months delay in resuming normal activity. The 
variety of surgical approaches to affect upper limb sympathectomy attest to the failure 
by surgeons to find a safe, user friendly and universally reproducible surgical approach. 
The supraclavicular approach popularised by Telford ( I 935) is arguably the most 
widely used of the available "open" surgical approach. This is probably reflective of 
the tradition that defines "cervical sympathectomy" as primarily a vascular procedure; 
vascular surgeons are facile with this approach which also affords ready access to the 
thoracic outlet 
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Notwithstanding this, the choice of the surgical approach has largely been a subjective 
one : no comparative trial has been undertaken to justify the suitability of a particular 
approach. This is of particular importance given the popularity of the thoracoscopic 
approach. Since Jacobeus (1922) first passed a cystoscope into the pleural space for 
diagnostic purposes and Hughes ( 1942) initial report of a sympathectomy undertaken at 
thoracoscopy, this approach had often fallen into obscurity. This, despite the enormous 
experience of Kux - widely regarded as the father of thoracoscopic surgery - who 
reported his experience of over 1400 sympathectomies (and vagotomies) in 1954. His 
thoracoscopic technique was largely confined to the German speaking countries during 
the following decades (Kux, 1954). 
The endoscopic approach was however reported sporadically, the most impressive of 
these being by Byrne ( 1990). Employing standard equipment, Byrne emphasized the 
ease of this approach; this was at the dawn of the minimal access surgery era. The 
subsequent advances in optics, video-technology and illumination proved to be a major 
boost for the thoracoscopic technique. The wide availability of necessary 
instrumentation coupled with the refinements of basic minimal access surgical skills has 
rapidly installed the thoracoscopic approach as an invaluable technique to effect upper 
limb sympathectomy. 
Refinements in the thoracoscopic technique have continued with the description of two 
millimeter ports that have provided even better cosmesis without the loss of technical 
benefit (Yim, 2000; Kao, 200 I). 
In order to diminish the troublesome problem of compensatory hyperhidrosis following 
the excision or cautery of the sympathetic ganglion, clipping of the sympathetic chain 
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without the transection of the ganglion or its branches has been advocated. This 
technique, it is suggested, interrupts the sympathetic outflow and has the appeal of 
restoring the original sweating distribution on removal of the clips if unpleasant effects 
follow the original clipping procedure (Lin, 1998). 
2.2 CLINCAL PERSPECTIVES 
2.2.1 INDICATIONS 
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A greater appreciation of the anatomy and physiology of the sympathetic nervous 
system coupled with the clinical experience with sympathectomy harnessed during the 
course of the previous century has helped crystallize the indications for upper limb 
sympathectomy. The primary indications are primary hyperhidrosis and, increasingly, 
CRPS. The advances in reconstructive vascular surgery and pharmacotherapy had 
made sympathectomy an adjunctive in therapeutic option for occlusive vascular disease 
and vasospastic disorders. 
2.2.1.J PRIMARY HYPERHIDROSIS 
Sweating is a natural phenomenon necessary for the regulation of an individual's body 
temperature. The secretion of sweat is mediated by a portion of the vegetative nervous 
system (the sympathetic nervous system). In some people (approximately I% of the 
population), this system is working at a very high activity level, far higher than needed 
to keep a constant temperature. The incidence is generally higher amongst infants, 
teenagers and young adults; this is probably reflective of the social implications of 
hyperhidrosis. Although both sexes are equally affected, females may find this 
condition less acceptable. 
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CLASSIFICATION AND CAUSES 
Causes 
• Primary or essential ( idiopathic)
This is a far more frequent condition than secondary hyperhidrosis and appears, 
generally, to be localized in one or several locations of the body (most often 
hands, feet, axillae or a combination of them). It usually starts during childhood 
or adolescence and persists throughout life. It has been suggested that 
nervousness and anxiety can elicit or aggravate sweating, but psychological or 
psychiatric disturbances are only rarely causes of the disorder. 
• Secondary (as part of an underlying condition)
Some conditions can promote excessive sweating, as a rule, involving the whole 
body. Listed are some of the predisposing conditions: 
- physiological emotional factors, hot environment, 
over-clothing, exercise 
- febrile illness
- endocrine and metabolic disorders : thyrotoxicosis, diabetes 
mellitus, hypoglycaemia, acromegaly, phaeochromocytoma 
- drugs and substance abuse : acetaminephen, aspirin, insulin, anti­
emetics, morphine, bethanecol, pilocarpine, mercury poisoning and
narcotic withdrawal
- cardiovascular disorders: myocardial infarction, congestive cardiac
failure
- respiratory failure
Although neither a life nor limb threatening condition, primary palmar hyperhidrosis 
may have acute social implications. This is underscored by Charles Dickens (ever the 
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diagnostician with an unerring eye for detail) description of palmar hyperhidrosis in the 
fictional character, Uriah Heep, the conniving clerk with cold clammy hands in his 
classic, "David Copperfield". Uriah Heep arguably developed as one of the most 
celebrated scoundrels in English literature. His most distinctive physical features were 
cold, sweaty palms and lank hands, "like a fish". Uriah was portrayed as an obsequious, 
hypocritical and manipulative character. 
" ... As I came back, I saw Uriah Heep shutting up the office, and feeling.friendly 
towards everybody, went in and spoke to him, and at parting, gave him my hand. But 
oh! What a clammy hand his was! As ghostly to touch as to the sight! I rubbed mine 
afterwards, to warm it, and to rub his off It was such an uncomfortable hand that, 
when I went to my room, it was still cold and wet upon my memory ... " 
" ... ! found Uriah reading a great/at book, with such demonstrative allention, that 
his lank forefinger followed up every line as he read and many clammy tracks along the 
page (or so I jiilly believed) like a snail ... " 
" . . .  He frequently ground his palms against each other as if to squee=e them dry 
and warm, besides often wiping them, in a stealthy way, on his pocket handkerchief. .. "
-David Copperfield, chapter I/, by Charles Dickens
The repulsive nature of the Uriah character probably impacts on the sufferers of primary 
hyperhidrosis leading to embarrassment, psycho-social trauma and physical discomfort 
(Carter, 1994). 
The aetiology of primary hyperhidrosis is unclear. Issues such as ethnicity, geographic 
factors (eg altitude, humidity, coastal location) have not been seriously considered. It 
has been suggested that up to 40% of sibling or other first or second degree family 
members have a similar condition. Though presently unproven, genetic factors may play 
a role in primary hyperhidrosis (Mares, 1996). The condition is universally distributed. 
Large series have been reported from South East Asia, Israel and Europe (Table 4 ). In 
South Africa primary hyperhidrosis has been known to be fairly common in the Durban 
region. To date, there has been no audit on the presentation and management of 
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hyperhidrosis from a South African centre. Significantly, there has been no reports on 
the incidence and management ofhyperhidrosis from elsewhere in Africa. 
TABLE 4: PALMAR HYPERHIDROSIS: WORLD WIDE SERIES 
1.0( \ 110'\ P\llt'\r OPER \ 110'\ PUUOI> 01· \llllOR 
'\l ,,urns s I l In 
p ( ) 
Boras (Sweden) 602 Thoracoscopic 1987-1992 Goth berg ( I 994) 
London (UK) 50 Thoracoscopic I 986-1991 Edmondson et al. (1992) 
Taiwan 150 Thoracoscopic I 991-1992 Chih (1993) 
Cork, Ireland 94 Open 1978-1990 O'Riordain (1993) 
Vienna 323 Thoracoscopic 1965-1992 Herbst (1994) 
Taipei, Taiwan 450 Thoracoscopic 1991-1994 Kao (I 994) 
Tainan, Taiwan 719 Thoracoscopic 1989-1992 Lee (1994) 
Vienna 63 Thoracoscopic 1974-1976 Kux (1978) 
Durban, RSA 103 Thoracoscopic 1992-1994 Singh et al. (1996) 
Dublin, Ireland 112 Thoracoscopic 1980-1990 Byrne (1990) 
Haifa, Israel 85 Open 1975-1990 Hashmonai (1992) 
MANIFESTATIONS OF PRIMARY HYPERIIlDROSIS 
Pa/mar hyperhidrosis: This is by far the most distressing location since hands are more 
exposed in social and professional activities than any other part of the body. 
Axillary l1yperhidrosis: This may cause embarrassing wet marks to the clothing as well 
as some discomfort; however it is less distressing than palmar hyperhidrosis 
Plantar hyperhidrosis : Though less distressing than palmar hyperhidrosis, plantar 
hyperhidrosis leads to bromhidrosis, blisters, infections and rotting of socks and shoes 
Facial hyperhidrosis : Sweat pouring down from the forehead in conditions of stress 
can be very distressful, inducing the patient to think that others may consider him or her 
to be insecure. 
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Individuals invariably present with a combination of the above categories; not 
surprisingly it is the palmar component of this condition that drives the patient to seek 
help. Sweating presents spontaneously without provocation. It is seldom continuous. 
TREATMENT 
Primary hyperhidrosis may be managed by a variety of techniques directed specifically 
at reducing the sweating to an acceptable level or abolishing it altogether. Non­
operative approaches include local measures such as the application of topical agents 
(aluminium chloride, glutaraldehyde and tannic acid), iontophoresis, systemic anti­
cholinergic medication and psychotherapy. Operative treatment includes excision of 
axillary sweat glands, suction assisted lipolysis and sympathectomy (Moran and Brady, 
1991 ). 
Local Measures : Patients with plantar hyperhidrosis should apply an absorbent foot 
powder; leather shoes and cotton or woollen socks should be worn, avoiding rubber and 
synthetic materials (Moran and Brady, 1991) 
Topical agents: Aluminium chloride (20-25%) in 70-90% alcohol is the most widely 
used. Varying success rates for the treatment of hyperhidrosis has been reported 
(Scholes, 1978; Perdikis, 1988). It may work by obstructing the sweat gland pore or 
causing atrophy of the secretory cells. Treatment is limited by some degree of axillary 
irritation. Tanning agents, gluaraldehyde and tannic acid may also be effective but are 
associated with brown staining that preclude their use (White, 1986). 
lontophoresis: This procedure, which coagulates eccrine sweat glands electrically, can 
be used to treat palmar and plantar hyperhidrosis. A direct current of 15-30 mA supplied 
by a galvanic generator is applied to the palms and soles immersed in an electrolyte 
solution. The initial treatment lasts for twenty minutes and treatment may be repeated 
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for three to six times weekly until the desired results are obtained. Maintenance 
treatment can be performed as frequently as necessary (Shrivastava and Singh, 1977; 
Reinauer et al., 1993). 
Drugs : Systemic anti-cholinergics may be effective but unpleasant side-effects such as 
blurred vision, dry mouth and urinary retention preclude their use (Moran and Brady, 
1991 ). 
Psychotherapy: This has a very limited effect in the majority of patients. Psychological 
problems are in most cases a consequence of hyperhidrosis and not the cause 
(Greenhalgh, 1971 ). 
Botulin um toxin: Treatment of hyperhidrosis by intracutaneous Botulin um toxin is a 
recent non-surgical option. Botulinum is a potent neurotoxin that blocks cholinergic 
nerve terminals (Ambache, 1951 ). Several studies have shown its effectiveness in 
reducing palmar hyperhidrosis in the short term. A multicentre trial of Botulin um toxin 
showed this therapy to be effective and safe. Several (strictly) intracutaneous injections 
are necessary at one sitting after the identification of the hyperhidrotic areas by the 
minor iodine starch test . The treatment has to be repeated within 4-6 weeks of the 
initial therapy. Furthermore, mild transient muscle weakness of the hand may occur. 
Relapses and non-response to further botulinum therapy may occur, due to the 
development of neutralising antibiotics (that may develop with deeper injection of the 
botulinum injection) (Kessier, 1999). Whilst seemingly effective in the short term, 
further studies are needed to define the optimal dose and frequency of injections and 
thereby establish the role of this treatment in the management of hyperhidrosis 
(Karamfilov et al., 2000). 
The spectrum of non-operative options attests to the failure of anyone of these being 
consistently successful. Surgical options include excision of the axillary sweat glands 
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and sympathectomy. Patients with axillary hyperhidrosis who are unresponsive to 
medical therapy can be effectively treated by excision of the axillary sweat glands. The 
area of greatest concentration of eccrine sweat glands corresponds to the hairy portion 
of the axilla and can be accurately identified by starch iodine test. The simplest method 
involves excision of this outlined area (Hurley and Shelley, 1963). Excision of the 
axillary sweat glands may prove to be unattractive option because repeated and more 
extensive excisions may be necessary resulting in the formation of hypertrophic and/or 
constrictive scars (Stenquist, 1985). Presently, sympathectomy is the treatment for 
palmar hyperhidrosis; a definitive cure rate of nearly I 00% is widely reported. This 
outcome is also noted to be enduring. Furthermore, associated axillary hyperhidrosis 
may also be successfully treated by sympathectomy. Whilst sympathectomy may be 
undertaken by a variety of techniques the thoracoscopic approach is widely considered 
to be a safe, easy and successful option (Kao, 1994; Lin, 1990; Singh, 1996). 
Employing basic minimal access surgical techniques, complications are minimal. The 
chief concern with sympathectomy for the treatment of hyperhidrosis is the issue of 
compensatory hyperhidrosis which may occur in up to 64 % of patients (Byrne, 1990). 
The cause of compensatory hyperhidrosis is obscure. Guttman ( 1940) suggested it to be 
a compensatory response associated with heat response ; Monro (1960) attributed it to a 
special supraspinal reflex whilst Shelley and Florence (1960) suggested that 
compensatory hyperhidrosis served a thermoregulatory function. Regardless of its 
aetiology, compensatory hyperhidrosis may be a devastating effect of sympathectomy 
with some patients regretting the procedure. The impact of a limited (2
nd) 




ganglionectomy) is unclear. The
effect of a limited 2
nd 
thoracic ganglionectomy on associated plantar and axillary
hyperhidrosis merits evaluation as some patients obtain relief of plantar and axillary 
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hyperhidrosis following this surgical approach; mechanisms for these beneficial effects 
remain unclear at present. 
Whereas the other indications for upper limb sympathectomy are atbest equivocal, 
primary hyperhidrosis is the one solid and universally acceptable indication for 
sympathectomy. With the large number of sympathectomies currently being undertaken 
for palmar hyperhidrosis and the greater public and clinical awareness of its treatment 
by minimal access surgery, an opportunity is presented to reappraise the role of the 
sympathetic nervous system in surgical practice. 
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2.2.1.2 CHRONIC REGIONAL PAIN SYNDROME (CRPS) 
In 1854 Weir Mitchell first described the syndrome of causalgia during the American 
Civil War. Since then the tenn causalgia has been redefined several times. The tenn 
Complex Regional Pain Syndrome (CRPS) is currently used to describe the 
constellation of symptoms previously described as Causalgia, Reflex Sympathetic 
Dystrophy, Sudeck's Atrophy or, mimo-causalgia, amongst others. 
The lntemational Association for the Study of Pain (IASP) classification of the chronic 
regional pain syndromes (CRPS Types 1 and fl) affords the early clinical recognition of 
this condition, and provides clearer definitions. The 4 diagnostic criteria (3 of which 
must be present to confirm the diagnosis) for CRPS Type I (previously Reflex 
Sympathetic Dystrophy) are: (Stanton-Hicks et al., 1995, Boas 1996). 
I. the presence of an initiating noxious event or a cause of immobilization
2. continuous pain (disproportionate to an inciting event), allodynia or hyperalgesia
3. oedema, changes in skin blood flow or sudomotor activity in the region of pain
4. exclusion of conditions that would otherwise account for the degree of pain
CRPS type II has a peripheral nerve injury as the initiating factor together with criteria 2 
- 4 as described for CRPS Type I.
The traditional therapeutic approach to CRPS is a conservative one. With respect to the 
upper limb, surgical intervention by cervical sympathectomy is usually indicated when 
the condition becomes refractory to medical treatment, and is responsive to sympathetic 
blockade. 
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The pathogenesis of CRPS is poorly understood. Several theories have been proposed. 
Lewis ( 1942) suggested that pain-producing vasodilatory substances are released at the 
site of injury. Doupe et al (1944) proposed that cross-linkage occurred between 
sympathetic efferents and sensory afferents. Leriche (1913) felt that the pain was 
secondary to vasospasm. That no consensus exists with respect to the pathogenesis is 
reflected in the current therapy of CRPS. Interpretations of the mechanistic aspects and 
the therapeutic modalities have long been varied and contentious. Primary treatment is 
invariably effected by neurologists, anesthetists, physicians and belatedly by surgeons. 
Lnitial treatment is conservative, employing tricyclic anti-depressants (Prothiden®), 
membrane-stabilisers (Tegretol®, carbamazepine) or Gabapectin, a selective voltage 
gated Ca
2+ 
channel blocker and non-steroidal anti-inflammatory drugs. This therapeutic
schedule (which is subscribed to by the Pain Clinic at Addington Hospital, Durban) is 
conventionally administered for up to 2 months; patients undergo intensive 
physiotherapy during this period. Stellate ganglion blocks (SGB) are performed if there 
is no clinical improvement. SGB may even prove to be curative in itself when the pain 
relief extends beyond the durations of the block. The guidelines for repeated SGB, 
when pain is not adequately controlled, are unclear. It has been recommended that if 
relief from repeated SGB becomes less effective or static, and if the initial response is 
dramatic but of a short duration, surgical sympathectomy should be undertaken 
(Mockus, 1987). 
Two issues merit consideration. Firstly, successful SGB does require a measure of 
expertise. If an accurate block is to be obtained, the 1st thoracic ganglion component of 
the stellate ganglion- which subserves the upper limb- needs to be blocked. 
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Secondly, repeated SGBs may predispose to inflammation and scarring in the region of 
the stellate ganglion and the proximal sympathetic chain. This may make technically 
difficult any future procedure undertaken in this region. 
The role of sympathectomy in the management of CRPS is not without criticism. It is 
argued that reports advocating sympathectomy are largely subjective and descriptive. 
There are no controlled randomized studies that have supported the use of sympathetic 
block or sympathectomy over placebo controls or pharmacological measures. 
Furthermore, the overall sympathetic outflow to the skin of the patient with CRPS, 
although often thought to be hyperactive, is normal when assessed by 
microneurography. Indeed sympathetic hypofunction is suggested by the low venous 
plasma concentrations of nor-adrenaline and its intra-neuronal metabolite 3,4 
dihydroxyphenylethyleneglycol, from the painful area (Schott, 1995). Yet sympathetic 
denervation has been reported to be effective. 
The rationale for sympathetic ganglionectomy, the timing of this approach and the 
accuracy of SGB in the management of CRPS merits review. 
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2.2.1.3 RA YNAUD'S DISEASE 
This condition rarely progresses to severe finger ischaemia or gangrene. The natural 
history is characterized by periods of symptoms interspersed with periods of 
improvement, even remission. Sympathectomy was commonly performed in the past to 
treat patients with Raynaud's disease. Given the often transient relief obtained by 
sympathectomy, the availability of effective pharmaco-therapy and the tendency of even 
severe manifestations to resolve spontaneously, it is not surprising that in current 
practice sympathectomy is not widely recommended. 
2.2.1.4 PERIPHERAL VASCULAR DISEASE 
In the context of vascular disorders, sympathectomy largely holds an adjunctive status; 
it is therefore often suggested as salvage therapy. This is not surprising given the non­
enduring effect of sympathectomy on the vasculature and the current status of 
reconstructive vascular surgery. It has been suggested that sympathectomy may be a 
useful adjunct in cases of critical ischaemia that need by-pass surgery. Advocates of 
this propose that minimal dilatation of the distal run-off vessels should at least in theory, 
exert a positive influence on both graft patency and overall limb perfusion. However, it 
is difficult to access the relative contributions played by by-pass surgery and 
sympathectomy. 
In those patients with Buerger's Disease, the complete and permanent avoidance of 
tobacco in any form forms the cornerstone of treatment of this condition. Vasodilatory 
drugs may be used during exacerbation of the disease. It has been suggested that 
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sympathectomy may afford a more enduring effect, increasing the flow of blood to the 
skin of involved extremities to prevent development of ischaemic lesions and expedite 
healing of ulcerative and gangrenous lesions if present. 
2.2.2 ISSUES IN TECHNIQUE 
2.2.2.1 OPEN SYMPATHECTOMY VERSUS THORACOSCOPIC 
SYPA THECTOMY 
The apparent ease of patient recovery, sometimes technical ease and smaller 
cosmetically acceptable incisions has firmly ensconced the practice of minimal access 
surgery. 
Although initially creating a major impact on abdominal operations, the improvements 
in video technology, illumination and fibre-optics- has prompted a major resuscitation 
of the thoracoscopic approach. Yet, despite its current status, the value of the 
thoracoscopic approach has not been compared against the traditional "open" approach. 
The thoracoscopic approach is widely perceived as most appropriate, on account of its 
apparent technical ease, reproducibility, patient acceptance and safety. Paradoxically, a 
randomized trial comparing thoracoscopic surgery versus the open supraclavicular 
approach (Hashmonai, 1994) reported the open supraclavicular approach to be superior. 
This issue clearly merits a review. 
In the light of the innumerable favourable reports that attest to the vaunted status of 
thoracoscopic sympathectomy, it would be impossible to obtain permission to undertake 
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a prospective randomized trial comparing open sympathectomy to thoracoscopic 
sympathectomy. In the light of justifiable ethical restraint a case controlled study 
evaluating thoracoscopic sympathectomy with the most recently performed open 
sympathectomy was undertaken. 
2.2.2.2 ANAESTHESTIC CONSIDERATIONS : SINGLE LUMEN 
ENDOTRACHEAL INTUBATION VERSUS DOUBLE LUMEN 
ENDOBROCHIAL INTUBATION FOR THPORACOSCOPIC 
SYMPATHECTOMY 
In current surgical practice the technique for thoracoscopic sympathectomy for upper 
limb sympathectomy, its safety and ease has made this operation a popular one for 
conditions such as palmar hyperhidrosis. The often unsatisfactory conservative 
therapeutic options has led to even more patients than ever before presenting for 
thoracoscopic sympathectomy. The ease of the surgical technique has been alluded to; 
to make the procedure universally applicable, it is imperative that the anaesthetic 
technique is equally safe, effective and reproducible in the hands of an anaesthetist with 
standard training and ability. In this regard, in addition to the choice of induction and 
anaesthetic maintenance agents, the choice of endotracheal vs endobronchial intubation 
is crucial. 
The traditional approach has been to perform the surgery (under anaesthesia) using a 
DLEBT (Double Lumen Endobrochial Tube) and then selectively collapsing the lung on 
the side being operated upon (Jedeikin, 1992; Hartrey, 1994). The placement of the 
expensive DLEBT requires anesthetic expertise which is not often available; DLEBTs 
are also expensive ( costing up to $80 US). The benefit of a total lung collapse afforded 
by DLEBT has to be weighted against these drawbacks. Also warranting consideration 
is the fact that the operating surgeon requires no more than 5cm apical pneumothorax to 
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undertake the procedure; a total lung collapse is therefore unnecessary. With partial 
lung collapse attained with a SLET (Single Lumen Endotracheal Tube), thoracoscopic 
sympathectomy can be safely undertaken (Lee et al., 1994). Benefits associated with 
SLET use include ease of placement and a substantial cost saving (SLET costs $8 US!). 
To date a randomized evaluation of DLEBT vs SLET has not been undertaken. 
2.2.2.3 EXTENT OF GANGLIONECTOMY FOR UPPER LIMB 
SYMPATHETIC DENERVATION 
Currently thoracoscopic sympathectomy is universally recognized as affording the most 
effective option in obtaining an enduring treatment of palmar hyperhidrosis (Moran and 
Brady, 1991; Byrne et al., 1990). The extent of the sympathectomy undertaken for 
upper limb hyperhidrosis is controversial and ranges from an isolated resection of the 
2nd thoracic ganglion (Hederman, 1994) (T2 ganglionectomy) to an excision of the 
sympathetic chain from the 2nd to 4th thoracic ganglion (Kux, I 978; Weale 1980). The
most devastating and unpleasant side-effect of a thoracic sympathectomy undertaken for 
Primary Hyperhidrosis is compensatory hyperhidrosis. This side effect is largely 
unpredictable but is more likely to follow an extensive sympathectomy (Shelley and 
Florence, 1960; O'Riordain et al., I 993). The debility imparted by compensatory 
hyperhidrosis may be so severe that patients are known to regret the procedure and with 
hindsight, would have accepted the original condition. Thus Lin (I 998) has described 
the technique of clipping the sympathetic chain (without transection of the chain or its 
branches); if unpleasant compensatory hyperhidrosis is reported post-operatively, the 
clips are removed. In 5 patients undergoing removal of clips (within 5 weeks of the 
procedure), the original hyperhidrotic state (without compensatory hyperhidrosis) was 
noted to return within 6 weeks of clip removal. This approach awaits further evaluation. 
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Tn this study the efficacy of a limited thoracic ganglionectomy undertaken for palmar 
and axillary hyperhidrosis and the incidence of compensatory hyperhidrosis following 
this limited ganglionectomy was prospectively evaluated. 
2.2.2.4 OUTCOME OF THORACOSCOPIC SYMPATHECTOMY: 
MECHANISMS FOR FAILURE 
In the minimal access surgery era the procedure to effect upper limb sympathectomy is 
safe, easy and widely reproducible (Byrne 1990 ; Lin, 1990). This has led, universally, 
to an increase in the numbers of upper limb sympathectomies being undertaken (Lee, 
1994). Whilst the outcome to sympathectomy in current practice is invariably 
successful, persistent (pSA) or recurrent (rSA) sympathetic activity, after a seemingly 
successful procedure, has refocused on the causes of this phenomenon. Explanations 
have been varied and often tenuous; these include the possibility of an incomplete 
operation, failure to appreciate an alternate neural pathway (ANP) e.g. the nerve of 
Kuntz, sympathetic regeneration and the misidentification of the sympathetic chain at 
surgery [Kuntz, 1927 ; Singh et al., 1998] . 
Experience with early and late sympathetic failure following an apparently successful 
sympathectomy was evaluated with a view to establishing the mechanisms that result in 
failure. 
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2.3 ANATOMICAL CONSIDERATIONS 
"the sympathetic nervous system, though nicely diagrammed in the anatomical texts, has often been found 
by the surgeon to be apparently anoma/011s beyond all understanding in its devious origins and 
ramifications. This has been the case partic11/arly with the 11pper extremities." 
Ray et al. (1943) 
2.3.1 ALTERNATE NEURAL PATHWAYS 
The gross anatomy of the upper limb sympathetic outflow has been a consistent issue of 
anatomical interest, fuelled largely by its clinical relevance. It has been suggested that 




thoracic spinal segments. The evidence for this is based on histological staining. 
Tenuous, however, are the definitions of the neural networks of the sympathetic upper 
limb outflow. Thus, the mapping of sympathetic neural outflow from the spinal cord is 
structured on clinical extrapolation, surgical hindsight and complications to surgical 
endeavour (eg. the development of a Homer's Syndrome following stellate 
ganglionectomy). Whereas there have been advances in the understanding of the 
physiology of the sympathetic nervous system and the indications for sympathectomy, 
the anatomy of the sympathetic nervous system and its teachings has remained as 
outlined as at the turn of the last century (Figure 4). 
....... dr 
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Figure 4: Schematic diagram of the autonomic nervous system . 
••••••••. 
cranial and sacral outflow (parasympathetic)
thoraco-lumbar outflow (sympathetic) 
(Adapted.from Kuntz, 1934) 
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Current clinical experience suggests that the 2
nd 
thoracic ganglion is pivotal to the upper 
limb sympathetic outflow. It is therefore appropriate that the gross anatomy and neural 
pathways pertinent to the 2
nd 
thoracic ganglion be fully appreciated. Anatomical 
variations in the sympathetic nervous system were traditionally credited for instances of 
operative failure following attempts at upper limb sympathectomy. 
Sympathectomy as a valid surgical procedure was incorporated into surgical practice 
during the 1920s to 1930s. The standard surgical approach was a stellate (fused inferior 
cervical and Tl ganglia) ganglionectomy. Whilst this approach produced an upper limb 
sympathectomy effect consistently, it also left the patient with a Homer's Syndrome. 
This complication may have been an acceptable complication during that era and was 
sometimes addressed by performing a contra-lateral stellatectomy to make the effect 
more acceptable. Recurrent or persistent sympathetic activity following stellate 
ganglionectomy was a vexed issue and was attributed to nerve regeneration or alternate 
neural pathways, for example, the nerve of Kuntz. Notwithstanding its outcome, stellate 
ganglionectomy did contribute to formulating our understanding of the sympathetic 
outflow of the proximal sympathetic chain. 
Given that the highest spinal outflow to the sympathetic chain is to the I SI thoracic 
ganglion; the following may be extrapolated 
i. the origin of the sympathetic supply to the eyelid has to be via the 1 st 
thoracic root, the source of the highest sympathetic spinal outflow (Figure 2)
ii. effective upper limb sympathectomy by 2
nd 
thoracic ganglionectomy would
suggest that the 1 SI thoracic and inferior cervical ganglia are not pivotal to
upper limb sympathetic supply; these ganglia (2nd thoracic)
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may represent either a post-ganglionic (to the 2
nd 
thoracic ganglion)
component or a more downstream component of the pre-ganglionic 
sympathetic outflow to the upper limb. With the successful outcoooe to the 
2nd thoracic ganglionectomy (and minimal sequalae) it is a mo-Ot point 
whether defining this as a pre- or post ganglionic section is necessary or 
worthy of investigation. 
During the era of stellate ganglionectomy anatomists focussed on the varia..1ions of 
sympathetic neural outflow to define the causes of persistent or recurrent syrripathetic 
activity. Up to then anatomical research focussed on the spinal origins of the 
sympathetic nervous system, an approach hamstrung by inappropriate staining 
technique, inadequate magnification and little clinical experience. The clinical despair 
prompted by persistent sympathetic activity following stellate ganglionectomy led to the 
performance of more extensive ganglionectomies; thus surgery either included or 
excluded the stellate ganglion in addition to removing various segments of the 
sympathetic chain (2nd to 5th thoracic ganglia). 
Albert Kuntz, a renowned neuroanatomist of St Louis University School of �edicine 
(USA), drew attention in 1927 to a variable intrathoracic ramus (ITR) betwee111 the 2nd 
intercostal nerve and the ventral ram us of the I 
s
t thoracic nerve, proximal to the 
pointwhere the latter gave a large branch to the brachial plexus (Figure 5). This 4ramus' 
was located in front of the neck of the 2
nd 
rib in the thorax. This nerve, called toe nerve 
of Kuntz, was reported by Kuntz himself to be present in up to 53% of cadaveric 
dissections. 
Middle cervical ganglion 
Ste/JaJe ganglion 
4"' cervical nerve 
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Nerve of K11ntz 
2"" thoracic nerve 
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Figure 5: Drawing from the cadaver to illustrate the inconsistent intrathoracic 
ramus from the 2nd to the F1 thoracic nerve and the communicating rami joining 
the brachia/ plexus (Adapted from Kuntz, 1934) 
The clinical significance of the nerve of Kuntz resides in the supposition that following 
a stellate ganglionectomy sympathetic outflow from the spinal cord may pass to the 2
nd 
thoracic root and then , via the nerve of Kuntz , to the periphery via the I st thoracic
nerve root (Figure 6). 
TIICN 
T2G 
Figure 6: The neural pathway to the brachia/ plexus is not interrupted by 
ste/late ganglionectomy when an alternate neural pathway is present 
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1 st rib
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Further descriptions of the nerve of Kuntz were noted (Table 5, Figure 7) : a grey 
ramus from T2 ganglion or the sympathetic trunk was traced directly into the ramus 




thoracic nerves. In other cases, a ram us from the SG was
traced into the ramus described above (Kuntz, 1927; Jit and Mukerjee, 1960). Jit and 
Mukerjee (1960) noted an incidence of 30% of a ramus between the SG and the 2nd
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intercostal nerve, irrespective of whether the nerve of Kuntz was present or not. These 
descriptions kindled an interest in defining other neural pathways, not only in relation 
to the I 
st 




intercostal nerves as well. 
In subsequent studies by Kirgis (1941 ), Kirgis and Kuntz (1942) and Kuntz (1946), a 
similar 'ram us' joined the 2nd and 3 rd intercostal nerves in front of the 3
rd rib. Kirgis
and Kuntz (1942) recorded an incidence of 54.5% of this ram us in their series of 88 
dissections. This ramus can divide into two branches to join the 2nd intercostal nerve at 
more than one place. Communicating rami were also reported from the 3 rd intercostal 
nerve to the 2nd thoracic ganglion and to the sympathetic trunk just below the 2nd 
thoracic ganglion. Jit and Mukerjee (1960) recorded the presence of a 3
rd 
communication between the 3
rd 
and 4
th intercostal nerves. 
Kirgis (1941) depicted a recurrent ram us from the 3
rd 
intercostal nerve which joined 
either the 2nd thoracic ganglion or the sympathetic trunk just inferior to it. This 
recurrent ramus arose either from the grey communicating ramus of the 3 rd intercostal 
nerve or from the nerve just distal to the point at which it was joined by the grey ramus. 
The recurrent ramus also joined the 2nd intercostal nerve or its grey communicating 
ramus. This ramus constitutes an alternate neural pathway through which fibres 
emerging from the sympathetic trunk via the grey ram us of the 3 rd intercostal nerve may 
reach the 2nd intercostal nerve, from which they enter the brachia! plexus via the JTR 
between the 2nd intercostal nerve and the ventral ram us of the 1
st
• To date, none of these 
variants have been classified in terms of their anatomical or clinical relevance. This lack 
of clarity with respect to the spectrum of variations merits a re-consideration given the 
vast increase of sympathectomies undertaken at present. 
. . ... .,. 
. . . .
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TABLE 5: INCIDENCE OF NERVE OF KUNTZ 
REFERENCE SAMPLE SIZE INCIDEl\CE ('¼,) 
--------- ------ -------
Kuntz (1927) 96 51(53.1) 
Kirgis (1941) 25 18 (72) 
Kirgis and Kuntz (1942) 88 66 (75) 
Jit & Mukerjee ( 1960) 100 38 (38) 










8th ce!Vical; I st thoracic 
ventral rami 
2"d,3,d,4th thoracic ganglion
I '1, 2nd, 3rd, 4th intercostal nerves 
Figure 7: Alternate neural connections described by Kuntz (1927) and Kirgis and Kuntz (1942) 
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These variations were collectively and perhaps inappropriately also described as the 
nerve of Kuntz. The clinical implications of the distal alternate neural pathways on 
upper limb sympathetic supply are essentially negligible and therefore have not 
engendered anatomical interest. For practical purposes it is the variations located in the 
2
nd 
intercostal space - between the I st and 2
nd 
thoracic roots that are of surgical
significance with respect to upper limb sympathetic supply. 
The current practice of an isolated 2nd thoracic ganglionectomy - a procedure that does 
not attempt to define the nerve of Kuntz - is consistently associated with a successful 
upper limb sympathectomy. Given the long held view that alternate neural pathways 
such as the nerve of Kuntz may serve as conduits for upper limb sympathetic supply, 
the significance of alternate neural pathways in current surgical practice merits review. 
The proximity of alternate neural pathways to the sympathetic chain also merits 
evaluation; whilst the isolated 2nd thoracic ganglionectomy is predictably successful, it 
may be conceivable that alternate neural pathways are transacted inadvertently during 
this technique. This would be possible when the alternate neural pathways are closely 
adjacent to the sympathetic chain. A truly isolated 2
nd 
thoracic ganglionectomy will 
then relegate the significance of alternate neural pathways. 
Since the 2
nd thoracic ganglion is pivotal to upper limb sympathectomy, it is crucial that 
it is correctly identified i.e not misinterpreted as is conceivable when the 2
nd 
ganglion is 
fused to the I st thoracic or stellate ganglia. Misinterpretation of the 2nd thoracic 
ganglion may also result when the stellate ganglion is not fused and the lower 
component (the thoracic component) extends over the neck of the 2nd rib to beyond its 
lower border. Appreciation of the location of the 2nd thoracic and stellate ganglia will 
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therefore be of surgical relevance. In this context, acquaintance with the shape and 
dimensions of the stellate ganglion may be valuable; likewise knowledge of the location 
of the 2
nd 
thoracic ganglion in the 2
nd 
intercostal space and the spectrum of rami 
communicantes associated with it will be of value to the operating surgeon. 
2.3.2 STELLATE GANGLION BLOCK: AN ANATOMICAL 
RE-APPRAISAL 
The role of the so-called Stellate Ganglion Block (SGB) in the diagnosis, determination 
of prognosis and management of Chronic Regional Pain Syndrome (CRPS) has been 
shown in the clinical component of this study, to be unpredictable. The SGB has long 
been considered pivotal in defining those patients who may benefit from a 
sympathectomy; thus, an inaccurate SGB will mislead the clinician and may deny a 
patient a potentially beneficial procedure. A successful (or positive) SGB in the context 
of CRPS is defined in our practice as the development of a transient IJorner's Syndrome 
[with even minor, evanescent eye signs] with the alleviation of the upper limb pain of 
CRPS. This latter effect is described as being reflective of Sympathetic Maintained 
Pain (SMP); in such a situation a sympathectomy would be invaluable in the 
management of CRPS. 
The accuracy of SGB in effecting an isolated upper limb sympathetic block (and 
thereby diagnosing SMP) is unknown. Furthermore, blockade of the sympathetic 
ganglia /and chain in the cervical and upper thoracic region is incorrectly referred to as 
SGB. The location, shape and extent of the proximal sympathetic chain and ganglia are 
known to be varied ; the stellate ganglion itself is present in up to 80% of the population 
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(Jit and Mukerjee, 1960). To effect a complete upper limb sympathetic blockade, it is 
clear, from current surgical experience that this may occur without the development of 
a Homer's Syndrome; this is reflected in the surgical outcome to a 2nd thoracic 
ganglionectomy. Thus, a more accurate description is either a lower cervical 
sympathetic block or upper thoracic sympathetic block (cervico-thoracic sympathetic 
trunk block) (Elias, 2000a,b). 
An accurate definition of upper limb SMP mandates the isolated blockade of the upper 
limb sympathetic pathway. In practical terms this presently may not be possible. 
Multiple approaches have been used to localize the lower cervical sympathetic ganglia 
and the stellate ganglion. This, in itself, represents a failure to appreciate that the 
sympathetic pathway to the upper limb is effectively independent of the stellate 
ganglion. In our practice, the traditional approach to effect an upper limb sympathetic 
blockade is a 'blind' technique i.e not using ultrasound, MRI or fluoroscopy for the 
localization of the sympathetic chain. 
Several 'blind' techniques have been described. These include the paratracheal 
approach (Moore, 1954), the anterior approach, the lateral approach, the posterior 
approach and the tissue displacement method (Atkinson, 1982). Arguably, the most 
widely used of these is the paratracheal approach; it is the technique favoured in our 
Pain Clinic. The precise point of the injection in this technique varies between the C6 
and C7 vertebral level; classically, the needle is recommended to be perpendicular to 
the skin surface at the chosen landmark. In an anatomical study using the anterior 
"standard" technique, the injectate was noted to spread onto the posterior mediastinum 
and over the pleura; there was no spread onto the thoracic sympathetic chain 
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(Guntamukkala and Hardy, I 99 I). Hogan (1992) reported the spread of the local 
anaesthetic to be anterior to the position of the stellate/cervical sympathetic ganglia. It is 
suggested that it is the unpredictable nature of the local anaesthetic extravasation that 
may account for the unreliable predictive value of the so-called SGB. In order to obtain 
a predictable blockade of the stellate/cervical sympathetic ganglia and the proximal 
thoracic chain, a modified anterior technique was evaluated. 
2.4 PA THO LOGICAL CONSIDERATIONS 
A limited excision of the 2
nd 
thoracic ganglionectomy for primary palmar hyperhidrosis 
is well established as the prime indication for sympathectomy. The role of this 
procedure in other conditions is controversial (eg. vascular disorders). Sympathectomy 
is, however, gaining acceptance as valid therapy for Chronic Regional Pain Syndrome 
(CRPS) and cases of Raynaud's phenomenon not responding to medical therapy. 
Notwithstanding the invariably excellent outcome to sympathetic ganglionectomy for 
primary palrnar hyperhidrosis and, on occasions, for CRPS, the role of the sympathetic 
nervous system in the pathogenesis of these conditions has not been evaluated. The 
reasons for this are principally 2 fold: 
i) in many surgical practices the sympathetic ganglia are coagulated and
thereby not presented for histological evaluation.
ii) the rationale for the histological evaluation of excised ganglia is invariably to
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confirm a sympathectomy, particularly when technical difficulty was 
encountered during surgery. The histo-pathologist particularly seeks the 
presence of sympathetic ganglia rather than subtle pathological changes. 
Our experience with routine histological (Haematoxcylin and Eosin staining) 
evaluation of sympathetic ganglia excised from patients with hyperhidrosis and CRPS 
have demonstrated an infiltration of inflammatory cells with occasional fibrosis. The 
normal histological profile of sympathetic ganglia shows an absence of cellular 
infiltrations. The significance of the described cellular infiltrate in the pathogenesis of 
hyperhidrosis and CRPS has not been previously considered. In addition, evaluation of 
the sympathetic ganglia has not been pursued as these are thought to interrupt the 
pathological process rather than to mediate it, as proposed by currently accepted 
postulates. 
a) Primary Hyperhidrosis
There are 2 types of sweats glands, eccrine and apocrine. The human skin contains 
approximately 2 million eccrine sweat glands (Bisbal et al, 1987). The production of 
sweat depends on the functional innervation of eccrine sweat glands by intact non­
myelinated C fibres of sympathetic nerves. Glands deprived of their post-ganglionic 
nerve supply cease to respond to any stimuli, even though they remain histologically 
normal. The eccrine glands are present over the entire body surface, but are most 
numerous on the palms, soles and, to a lesser extent, on the back and chest (Cunliffe et 
al., 1976) Apocrine glands are confined to the axilla, the areola of the nipple, the 
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anogenital area and the external auditory meatus. The sweat produced by these glands 
is usually in small quantities and has little role to play in hyperhidrosis. Apocrine 
glands also have no direct secretory innervation, although local stimulation with 
epinephrine will result in sweat production (Leung et al., 1999). 
Whereas there has been considerable research into the pathogenesis of CRPS this is not 
so for primary hyperhidrosis. The cause of hyperhidrosis remains obscure; indeed the 
cause is considered to be of no clinical significance since there is no known association 
of primary hyperhidrosis with any medical condition. This contrasts with the situation 
wherein hyperhidrosis may be associated with thyrotoxicosis and phaechromocytoma, 
conditions that prompt wide investigations, treatment and follow-up because of their 
formidable physiologic and clinical impact. Since there is considerable knowledge of 
the sweat gland distribution and its innervation it is not surprising that hitherto interest 
has focused on the sweat gland morphology. In primary hyperhidrosis, the sweat 
glands of the palms and soles are normal in histology and numbers. The sympathetic 
nerve supply to these areas is also normal (Ellis, 1975 and Leung, 1999). 
b) Chr-onic Regional Pain Syndrome
That various mechanisms have been suggested for the evolution and progression of 
CRPS underscores the current failure to crystallize the pathogenesis of this condition. 
The hard evidence for these mechanisms are invariably lacking. An evaluation of the 
injured nerve- the provocative factor for the condition - is invariably not feasible; 
likewise the evaluation of the affected skin or muscle is neither practical nor ethical. 
There is, however, strong clinical evidence for an underlying sympathetic over activity 
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viz altered skin colour, hyperhidrosis, temperature change, piloerection and swelling 
(Hannington-Kiff, 1994). Furthermore a favourable outcome to sympathectomy has 
been reported in patients with CRPS (Abu-Rahma, 1994; Mockus, 1987; Olcott et al., 
1991 ). Clinicians have long observed that patients suffering from CRPS may have the 
pain associated with these conditions as dependant on activity in the sympathetic 
nervous system; this is often referred to as "sympathetically maintained pain". It has 
been demonstrated that an abnormal contact develops between the sympathetic nervous 
system and the sensory nervous system following peripheral nerve injury, prompting an 
enhanced sensitivity to catecholamines (Janig et al, 1996). 
Several sites of coupling between sensory and sympathetic nervous system have 
been proposed and tested in animal models (Perl et al, 1992, Levine et al, 1994 and 
Blumberg 1982). The possibility of direct coupling between the sympathetic and 
sensory nervous systems in the dorsal root ganglion (DRG) has received much 
attention with numerous studies demonstrating that peripheral nerve injury leads to 
sympathetic axons sprouting into the DRG has been described following the 
experimental ligation of the sciatic nerve (McLachlan et al., 1993). 
The mechanisms for the onset of the sympathetic sprouting are unclear. It is likely that 
neurotrophic factors and cytokines may be crucial to the process. The cytokine 
Leukaemia Inhibitory Factor (LIF) has been demonstrated to stimulate sympathetic 
sprouting (Thomson et al., 1998). The neurotrophin Nerve Growth Factor (NGF) has 
also been demonstrated to induce sympathetic sprouting in the DRG (Isaacson et al, 
1992 and Jones et al, 1999). The terminals of the sprouted neurons have been shown to 
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form functional synapse-like structures with the cell bodies (McLachlan et al., 1993). 
These structures could be involved in the formation and maintenance of abnormal 
excitation arising from DRG, a hypothesis supported by electrophysiological studies in 
which sympathetic stimulation increased sensory ectopic discharge from the DRG 
(Devor et al, 1994). The time scale of sprouting corresponds to the onset of allodynia 
and hyperalgesia, the hallmarks of sympathetic maintained pain. Whilst the 
information regarding changes has been substantiated in other studies, what prompts 
this development remains obscure. There is evidence that pain is mediated peripherally 
as well as centrally by cytokines; hence the common failure of peripherally acting 
analgesics to control pain. The retrieve of the cellular infiltrate, particularly the 
lymphocytic infiltrate, in the sympathetic ganglia from patients with CRPS may 
provide further insight into the possible pathological process of this conditions. The 
role of the sympathetic nervous system - either in concert or sequential to the DRG 
pathology has not been previously considered. The precise role of the immunological 
system vis-a-vis the sympathetic ganglia in the pathophysiology of CRPS has not been 
evaluated. 
In the light of foregoing information, an investigation into the nature of the 
inflammatory infiltrate in the ganglia of excised from patients with Primary 
hyperhidrosis and CRPS is appropriate. The definition of these lymphocyte 
populations being B-type or T-type (helper or suppressor) may provide insight into 
the pathogenesis of these conditions. 
CHAPTER3 
MATERIALS AND METHODS 
GENERAL 
3.1 CLINICAL COMPONENT 
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A prospective evaluation of all patients referred for and under-going upper limb 
syrnpathectomy for 
1. Primary hyperhidrosis
11. Chronic Regional Pain Syndrome
m. Raynaud' s Disease
1v. Peripheral Vascular Disease
SETTING 
The three academic hospitals that serve as referral centres with catchment areas 
geographically and socio-economically distributed throughout the Durban Function Region 
[in the province of Kwa-Zulu Natal, South Africa]. In addition to these academic hospitals 
(King Edward VIII, R.K. Khan and Addington Hospitals), two private hospitals (City and 
Chatsmed Garden Hospitals) with comparable surgical services also served as a setting for 
the study. 




3.1.1 PRIMARY HYPERHIDROSIS 
Patients presenting with debilitating palmar hyper
hidrosis- sweating in amounts that is
greater than that required for insensible loss or physiological needs- were considered. The 
degree of hyperhidrosis was considered to be debilitating when it had affected schoolwork 
(smudging of writing, slipping of computer keyboard), was socially embarrassing (leading 
to social withdrawal or low self esteem) or if it affected vocation ( switchboard or computer 
operator, use of fine hand instruments). 
Exclusion Criteria : 
• Patients were excluded if there was an underlying cause for the hyperhidrosis.
• If the hyperhidrosis was considered to be generalized (rather than isolated to the palms
with associated axilla or plantar sweating).
• Patients with isolated plantar or axillary hyperhidrosis.
The severity of the hyperhidrosis as well as the outcome to surgery was scored on a linear 
analogue scale (LAS) from 0-10. The score of zero represented complete anhidrosis or 
complete satisfaction; the score of 10 represented dripping hyperhidrosis or total 
dissatisfaction with the outcome. The spectrum of the presenting hyperhidrosis was further 
categorized as being mild (1-3), moderate (4-6) or severe (7-10). Likewise the outcome to 
operation was quantified as being excellent (1-3), satisfactory ( 4-6) or poor (7-10). 
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The biographic data collected included the age, onset and duration of symptoms, sex and 
race. 
The distribution pattern of the hyperhidrosis was documented i.e palmar and/or axillary 
and/or plantar hyperhidrosis. If excessive sweating was present in more than one region, 
patients would be asked to prioritize the most debilitating of these regions. 
The possible side effects of upper limb sympathectomy to treat hyperhidrosis were fully 
explained to the patients. In particular, the possibility of excessive sweating developing 
along the trunks, back and thighs (compensatory hyperhidrosis) was emphasized. Other 
effects (such as Homer's Syndrome) though remote, were also mentioned. 
Thoracoscopic sympathectomy was the favoured approach for the upper limb 
sympathectomy. In patients suspected of having pleural adhesions (following previous 
thoracotomy, lung trauma or chronic lung disease eg. pulmonary tuberculosis, 
thoracoscopic approach would be attempted, notwithstanding the difficulty of attaining an 
adequate lung collapse to undertake an adequate thoracoscopy. If pleural adhesions were 
suspected pre-operatively, the patients would be given the option of undergoing the 'open' 
operation. The 'open' procedure undertaken will be the supraclavicular (described by 
Telford, 1935). 
• Following surgery, patients were reviewed at one week and then at one month
following the procedure. The effectiveness of the sympathectomy on palmar
hyperhidrosis was evaluated. In a subset of patients presenting with palmar
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hyperhidrosis, the effect on associated axillary and plantar hyperhidrosis was 
evaluated. Subsequent review at three month intervals would be undertaken by 
telephonic interviews. 
3.1.2 CHRONIC REGIONAL PAIN SYNDROME 
Patients were assessed at the Pain Clinic at Addington Hospital; anesthetists, psychologists, 
physiotherapists and occupational therapists were involved in the evaluation and initial 
therapy. Only patients with CRPS (Type II) were evaluated. Details of the precipitating 
injury were documented. The duration of the pain (in months), details of therapy used until 
referral for sympathectomy were noted. The number of stellate ganglion blocks performed, 
and the outcome for these were noted. The pre-operative degree of pain was evaluated by a 
visual Linear Analogue Scale from 0 to 10, 10 being the worst degree and 0, no pain. 
Criteria for inclusion 
1. Adequate and complete treatment of the precipitating mJury [debride event,
fracture mobilization, repair of associated soft tissue injury (including nerve
injury) and treatment of any infection].
11. Syndrome follows a nerve injury.
m. Spontaneous pain, allodymia, hyperalgesia, not necessarily limited to the
territory of the injured nerve.
1v. There is or has been evidence of edema, skin blood flow abnormality or
abnormal sudomotor activity in the region of the pain since the inciting event.
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Criteria for exclusion 
1. Excluded by the existence of conditions that would otherwise account for the
degree of pain and dysfunction.
11. The inability to localize the underlying nerve injury.
The initial assessment was undertaken at the Pain Clinic at Addington Hospital. The 
diagnosis was made entirely on clinical assessment. Standard biographic data (age and sex) 
was collected. 
Initial treatment was pharmacological and included 
- Tricyclic anti-depressant (Prothiaden®)




- Non-steroidal anti-inflammatory agent
With the pharmacotherapy, regular active physiotherapy was instituted. 
Unsatisfactory clinical progress on the outlined therapeutic schedule prompted the use of a 
Stellate Ganglion Block (SGB). The SGB was performed by a specialist anesthetist under 
local anesthesia via the supraclavicular paratracheal approach. With the patient supine and 
the neck extended to the contralateral side, the stellate ganglion was localized along the 
medial aspect of the stemocleidomastoid muscle at the level of the cricoid cartilage. The 
needle is advanced posteriorly between the carotid and internal jugular sheaths, aiming for 
the lateral bony mass of the C7 and T l  vertebrae. 10ml of local anesthetic (0.25% 
65 
Bupivacaine solution) was then injected. Classically, development of a Homer's Syndrome 
with warming and drying of the hand and relief of pain indicated a successful SGB. 
When symptoms recurred after an initially satisfactory response to SGB, the block was 
repeated. Patients were offered sympathectomy when the clinical progress was 
unsatisfactory, notwithstanding repeated SGB. Prior to sympathectomy, the number of 
SGBs performed was documented. The duration of symptoms until performance of 
sympathectomy was noted. The degree of pain was independently assessed by using a 
Linear Analogue Scale (LAS); using a 1 cm graduated line; patients were asked to quantify 
their pain from O (no pain) to 10 (worst, most unbearable pain). Following sympathectomy, 
outcome to surgery were also assessed on a LAS, independently. The patients progress 
were monitored at the one week and one month review (at the Outpatient's Department). 
Longer review, if necessary, was effected telephonically. 
3.2 ISSUES IN TECHNIQUE 
THORACOSCOPIC SYMPATHECTOMY 
Informed consent was obtained in patients evaluated as being suitable for upper limb 
sympathectomy. The thorascopic approach was always attempted. When the thorascopic 
route was not feasible (because of technical or anatomical factors such as pleural adhesions 
or pleural thickening) in patients with CRPS an open sympathectomy was undertaken under 
the same anaesthetic. This surgical attitude is reflective of the progressively debilitating 
effect of CRPS. 
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By contrast, if thorascopic sympathectomy was not feasible in patients with hyperhidrosis 
recourse to the open approach was dependant on the options given to the patient pre­
operatively. Anatomical factors that precluded the thorascopic approach because of pleural 
adhesions was suspected in patients with previously treated chronic lung disease, previous 
thoracotomy or lung trauma. 
Surgeons performing thorascopic sympathectomy were technically proficient and had 
participated in a basic minimal access surgical skills course. A thorough understanding of 
the anatomy of the sympathetic chain, its variations, landmarks and relation to adjacent 
structures was mandatory. When procedures were performed by surgical trainees, these 
procedures were overseen by an experienced surgeon facile with the procedure. Because 
there are no universally accepted criteria for what constitutes a surgeon experienced in 
thorascopic surgery; it was considered that the performance of at least 30 procedures 
satisfied this requirement. 
Surgeons performing thorascopic surgery were familiar with the open sympathectomy 
approach since this maybe necessary to effect sympathectomy. 
Pre-operative Assessment 
All patients had an evaluation of their full blood count, urea and electrolytes and blood 
glucose to ascertain their fitness for a general anaesthetic; however, in younger patients(less 
than 18 years) only the haemoglobin was evaluated. 
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Ifthere was co-existent cardio-pulmonary disease, a chest x-ray and electrocardiograph was 
done. 
Technique 
I. Thoracoscopic sympathectomy: Because it is the preferred approach it is described in
detail. Depending on their accessibility to the hospital, patients were admitted on the 
morning of the procedure, having being fasted from 18:00hrs the previous evening. 
The procedure was performed under a standardized general anesthetic. Intra-operative 
analgesia was provided by Sufenta® and Marcaine® with infiltration to the proposed port 
sites. A single lumen endotracheal tube was routinely used, apart from a group in whom 
the double lumen endotracheal tube was evaluated. A non-steroid anti-inflammatory 
suppository was inserted following induction of the anesthetic. 
Intra-operative monitoring included continuous measurement of arterial blood pressure, 
pulse oximetry, end tidal carbon dioxide concentration, electro-cardiography and peak 
airway pressure. 
The patients are placed in the supine position and in 30 degree reverse Trendelenberg 
position. A small pillow is located between the scapulae to throw the chest into profile. 
The drapes are placed from the clavicles to the xiphoid, as well as amply exposing the 
axilla. Depending on the prospect of converting to the open procedure, the supraclavicular 
region was also prepared for this possibility .. 
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Mechanical ventilation was stopped, facilitating partial collapse of the lung. 
Simultaneously the ipsilateral pleural space was insufllated with carbon dioxide delivered 
via a Veress needle; the Veress needle was placed posterior to the lateral aspect of the 
pectoralis major muscle at the level of the sternal angle (Plate 1 ). The carbon dioxide 
insufllation was continued only if the lung apex obscured the dissecting field , to no more 
than an intra-pleural pressure of 7crns water. The patient's ventilation was maintained by 
intermittent shallow manual ventilation. 
Plate 1 : Port placement 
Dissection port (5mm) - [A] along the 3
rd 
intercostal space posterior to pectoral fold
Camera port (5mm) - [BJ along the anterior axillary line, 5
1h 
intercostal space 
A 5mm port was then introduced along the 5th intercostal space in the anterior axillary line. 
Care was taken to ensure that the trocar is placed accurately, without impinging on the 
over-or underlying rib. Through this port a 5mm telescope (either O degrees or 30 degrees) 
connected to a video monitor was passed into the pleural space. Thoracoscopic evaluation 
of the pleural apex was conducted. Total lung collapse is unnecessary, an apical 
pneumothorax no more than 8crns being adequate to identify the relevant section of the 
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sympathetic chain. Continued pleural insufflation is not necessary. The telescope could be 
used to inferiorly displace lung obscuring adequate visualization of the chain; the telescope 
was also used to take down soft adhesion by blunt dissection. 
At the site of the Veress needle a second 5mm point was placed. This port served as the 
access for the dissecting instrument. Accurate intercostal placement of the trocar - taking 
precaution to avoid bruising of the ribs - was essential (to obviate post-operative intercostal 
neuralgia). 
A right angled hooked diathermy probe was used to identify the sympathetic chain which 
typically courses over the neck of the ribs. The important landmark is the 2nd rib; this was 
readily recognized as the most superiorly visible rib. The 1 st rib, over the neck of which 
lies the stellate ganglion, is usually not seen. The stellate ganglion (mainly the inferior 
component) is not directly evident as it is covered by a characteristic yellow fat pad. 
If the sympathetic chain was not readily seen overlying the neck of the 2nd rib, it was 
palpated by stroking the diathermy probe over the neck of the rib. 
The pleural overlying the chain was then stripped from the inferior aspect of the 2nd rib 
upto the midportion of the 3 rd rib. This was facilitated by initially creating a pleural 
window adjacent to the chain by using diathermy. The hook was then used to strip the 
pleura to expose the sympathetic chain up to the superior border of the 3 rd rib .. 
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The interganglionic component of sympathetic chain , between the stellate ganglion and the 
2nd thoracic ganglion , was mobilized. It was usually free of neural connection. Thereafter, 
the interganlionic segment between the 2nd and 3 rd thoracic ganglion was similarly 
mobilized. Bowstringing these two interganglionic segments brought the 2nd thoracic 
ganglion into profile. Gentle traction on this ganglion revealed its connections (white and 
grey rami communicantes) to the underlying intercostal nerve. 
The connections were hooked and individually transected by cautery. Cautery (unipolar) 
was not used on the ganglion or its interganglionic connections; being unipolar it may 
inflict coagulative necrosis on the chain in an unpredictable manner. Injury to the 
intercostal artery which passes between the rarni communicantes is easily avoided when the 
ganglion is mobilized in the manner outlined (Plates 2-8). 
Plate 2 : View at right thoracoscopic sympathectomy 
BCV Brachiocephalic vein SIA - Superior intercostal artery 
PN Phrenic nerve SC - Sympathetic chain 
TIVR- TI ventral ram us SIV Supreme intercostal vein 
SFP - Stellate fat pad FLC- Fascia over longus col Ii muscle 
CCT- Costocervical trunk 
Plate 3 : Left thoracoscopic sympathectomy: If the sympathetic chain (SC) is not readily seen it is 
easily palpable as a cord-like structure coursing over the neck of the 2nd rib 
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Plate 4 (a,b): The pleura overlying the right sympathetic chain is mobilized (after creating a 
pleural window using cautery) 
Plate 5 (a,b) : The pleura overlying the right sympathetic chain is mobilized (after creating a 
pleural window using cautery) 
T2G 
T3G 
Second thoracic ganglion 
Third thoracic ganglion 
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Plate 6 : Right thoracoscopic sympathectomy : the pleural stripping has extended proximally to 
demonstrate the inferior component of the stellate ganglion (SG). Rami to the second thoracic 
ganglion (I'2G) [__.] and to SG [ ►} are demonstrated 
Plate 7 : Right thoracoscopic sympathectomy : the sympathetic chain is transected proximally initially 
Plate 8 : Left thoracoscopic sympathectomy : second thoracic ganglion (I'2G) has been transected 
proximally and distally 
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Troublesome bleeding from the posterior intercostal veins was controlled by the judicious 
use of cautery. These veins are variable in their arrangement, coursing both anterior and 
posterior to the sympathetic chain. They pose more of a problem in dissecting the right 
chain; here the 1 st posterior intercostal vein tends to enter the operative field as it courses 
towards the superior vena cava. In contrast, on the left side, the 1 st posterior intercostal 
vein is invariably lateral to the field of dissection, draining into the left subclavian or left 
brachiocephalic veins. The lower intercostal vein (2nd, 3rd or 4
th
) only become significant 
when more extensive ganglionectornies (3 rd and 4th) are undertaken.. The technical 
exercise is aided by their pre-emptive cautery. The sympathetic chain, now mobilized from 
the 2nd to the 3 rd rib, is transected above and below the 2nd thoracic ganglion. During the 
early period of the study, a more extensive ganglionectomy - up to the 3 rd thoracic ganglion 
- was routinely undertaken. Currently, a limited (2nd thoracic) ganglionectomy is routine
practice. The excised 2nd thoracic ganglion is retrieved for histological evaluation. 
With homeostasis accomplished, the area of dissection was infiltrated with a local 
anaesthetic agent (Macaine®). The surgeon ensured that the CO2 insufllation is stopped 
off : gentle suction is applied through the dissecting port.. A saline washout of the 
dissection site is only undertaken if pooled blood or a clot is noted. In concert with the 
suction gentle positive end expiratory pressure is applied by the anesthetist. The cannula 
with the telescope is steadily retracted in the face of the re-expanding lung. Prior to 
removing the cannula the lung should be seen to be herniating through the intercostal 
musculature as the camera cannula is withdrawn (Plate 9). 
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Plate 9 : Herniation of expanded lung through port site facilitated by application of positive end 
expiratory pressure and aspiration of pneumothorax 
Closure of the port site is with absorbable sub-cuticular suture. Post-operatively patients 
are nursed in the general recovery bay. Blood pressure, pulse and oxygen saturation levels 
were routinely monitored. Analgesia was provided by Panado® and continuation of the 
non-steroidal anti-inflammatory suppository. Omnopon® was only administered if pain 
could not be controlled by these measures. 
Intercostal chest drains were not routinely placed. Furthermore, post-operative chest 
radio graphs were not routinely undertaken, being reserved for those instances of respiratory 
distress, progressive desaturation (SP 02 < 95%) or unremitting or progressive surgical 
emphysema. 
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Following full recovery from the anesthesia, the patients are transferred to the general 
ward; by the evening of the procedure (usually 8-9 hours following the procedure), the 
patients were discharged home. Patients were only kept overnight if there was clinical 
concern ( eg. developing pneumothorax or haemothorax) or patient lived in an area remote 
from the medical facility. 
If the patient required bilateral sympathectomy, the procedure was repeated on the 
contralateral side under the same anesthetic. The post-operative care was not different from 
those undergoing a unilateral procedure. 
OPEN SYMPATHECTOMY 
The preferred approach for open sympathectomy is the Telford supraclavicular approach 
(Telford, 1935) (Figure 8). In patients with CRPS, skin positioning, preparation and 
draping should be arranged in anticipation of a conversion to the open approach. The 
necessary instrumentation must be readily available. The sympathetic chain is dissected 
and transected as in the thoracoscopic procedure. Diathermy is used with caution. The 
excised 2nd thoracic ganglion is sent for histology. 
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2"� rib 
Figure 8: Supraclavicular approach to the 2
nd 













TI ventral ramus 
Scalenus anterior muscle 
Recourse to the open approach should always be anticipated in those patients in whom lung 
collapse - crucial to an adequate thoracopscopy - cannot be procured. This includes 
patients with a history of chronic lung disease eg. pulmonary tuberculosis, history of lung 
trawna or previous thoracotomy. This prepares the scrub nurse for the prospect of an 
operation (therefore positioning and preparing the appropriate site for open surgery and 
having the relevant instruments available). The surgeon is also prepared for the potentially 
more challenging open procedure. 
3.2.1 OPEN VERSUS THORACOSCOPIC SYMPATHECTOMY 
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Patients undergoing endoscopic transthoracic cervical sympathectomy for pnmary 
hyperhidrosis were prospectively recruited for evaluation (Group I). These were 
compared to a retrospectively collected age-matched group of the most recently 
undertaken open cervical sympathectomy for palmar hyperhidrosis (Group II). This 
investigation was conducted at the RK Khan and King Edward VIII Hospitals, Durban. 
The procedures were undertaken by experienced surgeons competent in both the 
thoracoscopic and the open approach. The inclusion and exclusion criteria have been 
described. 
Factors evaluated were: 
1. operating time in minutes
11. hospital stay in days
m. opioid usage
iv. return to normal activity
v. cost analysis comparing open vs thoracoscopic sympathectomy
Group I patients underwent thoracoscopic sympathectomy under general anaesthetic with 
single lumen endotracheal intubation. The thoracoscopic technique was standard and has 
been described. 
Group II patients underwent the standard Telford procedure undertaken via the 
supraclavicular approach. 
Statistical analyses was performed using the Student T Test and the Fischer Exact Test. 
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In both groups of patients the procedures were undertaken bilaterally during the same 
anaesthetic. Both procedures entailed excision of the 2nd thoracic ganglion that was sent 
for histopathological assessment. 
3.2.2 ANESTHETIC CONSIDERATIONS : SINGLE LUMEN ENDO-TRACHEAL 
INTUBATION VERSUS DOUBLE LUMEN ENDOBRONCHIAL 
INTUBATION FOR THORACOSCOPJC SYMPATHECTOMY 
With ethical approval and informed consent, 20 patients between the ages of 15 - 30 years 
undergoing thoracoscopic sympathectomy for palmar hyperhidrosis were prospectively 
randomized after a standard general anesthetic to have either a single lumen or double 
lumen intubation. This investigation was undertaken at the King Edward VIII Hospital. 
The anesthetic in both groups was administered by a senior anesthetist. Diprivan® 
(2mg/kg) was used for induction of anaesthesia; intra-operative analgesia was provided by 
Sufenta® (0.5mg/kg) and infiltration of the port sites with Macaine®. A non-depolarizing 
short acting muscle relaxant, (Nocuran® 0. l mg/kg) was used. 
Routine monitoring used included electro-cardiography, non-invasive blood pressure, 
oxygen saturation, end-tidal CO2 concentration, ventilator disconnect and low inspired 02
concentration alarm. 
In both groups the patients were placed in a 30° reverse Trendelenberg position with the
arms widely abducted. 
Patients in Group I had a double lumen endobronchial tube passed to allow selective 
deflation of the ipsilateral lung. This involved clamping the bronchial catheter mount and 
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opening the tube lumen to atmosphere. A Veress needle was then introduced through the 
axilla via a small incision in the 3rd intercostal space. Carbon dioxide insufllation was 
effected to attain an intra-pleural pressure of 7cm H20. Contralateral lung ventilation was 
maintained mechanically to maintain oxygen saturation to at least above 97-98%. 
Patients in Group II were intubated with a single lumen endotracheal tube. The patients 
were slightly hyperventilated by keeping the end-tidal carbon dioxide concentration at 30-
35mm/kg. The patients were then kept apnoeic and the lung partial y collapsed by 
disconnecting the anesthetic circuit before the Veress needle was introduced into the 3
rd
intercostal space. This step was necessary to avoid iatrogenic injury to the lung. Carbon 
dioxide insufllation to the inpsilateral pleural space was continued to a preset value of 7cm 
The patients were maintained on shallow, manual ventilation. Visualization of the proximal 
sympathetic chain was further expedited by the surgeon depressing the apex of the lung 
caudally with the telescope. Anesthesia was maintained with I 00% oxygen and a hypnotic 
agent (Isoflurane®). 
In both groups, at the completion of the ganglionectomy, the area of dissection was 
infiltrated with Macaine®. Lung re-expansion was facilitated by the application of positive 
end expiratory pressure by the anesthetist and by the concomitant aspiration of the pleural 
space (by gentle suction) undertaken by the surgeon. Intercostal chest drains were not 
routinely placed. 
In addition to the demographic data, the following were evaluated 
• episodes of desaturation (Sp02<95%)
• hypotension (systolic BP< 90 mmHg)
• post-operative pain score evaluated on a Visual Linear Analogue Scale
• the need for supplementary analgesia
• incidence of complications were noted.
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Post-operatively patients were administered Panado® and a non-steriodal anti­
inflammatory agent. Opiate analgesics were administered when pain was persistent. 
Statistics were performed using the Fisher's Exact Test. 
3.2.3 LIMITED GANGLIONECTOMY : A PROSPECTIVE EVALUA Tl ON 
This evaluation was conducted at the King Edward VIII Hospital, Durban. All patients 
presenting with socially or functionally incapacitating Primary Hyperhidrosis during a 14-
month period (February 1997 - March 1998) were prospectively evaluated. At the initial 
assessment the patients demographics (age and sex) and distribution of the hyperhidrosis 
were noted. The severity of the hyperhidrosis as well as the outcome was scored on a 
linear analogue scale (LAS) from O to 10. The score of zero represented complete 
anhidrosis or complete satisfaction; the score of 10 represented dripping hyperhidrosis or 
total dissatisfaction with the outcome. 
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The spectrum of the presenting hyperhidrosis was further categorized as being mild (1-3), 
moderate ( 4-6) or severe (7-10). Likewise, the outcome following surgery was quantified 
as excellent (1-3), satisfactory ( 4-6) or poor (1-3). 
The pre-operative evaluation of these patients has been outlined. The operative technique, 
which was consistently used, has also been detailed. 
All patients were reviewed at one week and then at 3 monthly intervals until the end of the 
study period. At this time an independent assessor evaluated patients for outcome and side­
effects, specifically compensatory hyperhidrosis. The extent of the compensatory 
hyperhidrosis was assessed using a LAS (see above). 
Statistical analysis was performed by the paired Students t test. 
3.2.4 OUTCOME TO THORACOSCOPIC SYMPATHECTOMY 
MECHANISMS FOR FAILURE 
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All patients who were subjected to thoracoscopic sympathectomy for debilitating primary 
hyperhidrosis between 1992-2001 were evaluated for early and late sympathetic failure. 
Patients who had sympathectomy undertaken for other indications ( eg. chronic regional 
pain syndrome and Raynaud's phenomenon) were not enrolled, owing to the unpredictable 
outcome to sympathectomy in these conditions. 
The thoracoscopic approach was the preferred method to effect upper limb sympathetic 
denervation. There was a standard technique for thoracoscopic sympathectomy ; this 
technique has been detailed. The excised 2nd ganglion was routinely sent for histology. 
Outcome to thoracoscopic sympathectomy was quantified on a linear analogue scale (J ,AS) 
from zero to ten. The score of zero represented complete anhidrosis or complete 
satisfaction; the score of ten represented dripping hyperhidrosis or total dissatisfaction with 
the outcome. 
Patients were evaluated at 1 week and then at 3 monthly intervals for a year. Patients were 
advised to return if they suspected or developed recurrence of the hyperhidrotic state. 
3.3 ANATOMICAL CONSIDERATIONS 
3.3.1 ALTERNATE NEURAL PATHWAYS 
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An anatomical evaluation of the cervico-dorsal sympathetic chain (its variations and 
connections) appropriate to upper limb sympathetic supply using standard dissection 
techniques was undertaken. 
Location of Study 
The adult human specimens used in this study, were obtained using cadaveric material (in 
accordance with the Human Tissue Amendment Act, 51 of 1989) from the Department of 
Anatomy, School of Basic and Applied Medical Sciences, University of Durban-Westville 
and Department of Anatomy, Nelson R Mandela School of Medicine, University of Natal, 
and the Department of Human Biology, Technikon Natal. Ethical permission to undertake 
this study was obtained from the Research and Ethics Committee, University of Natal. 
Participants 
Dissections were conducted in adult human cadavers. Cadavers displaying cervical trauma, 
evidence of previous surgical exploration or macroscopic pathology were excluded. 
Technique 
A midline incision was made from the lower border of the mandible to the sternal angle. 
The skin, together with the platysma muscle was reflected and all superficial muscles 
(stemocleidomastoid, pectoralis major, pectoralis minor, omohyoid, stemohyoid and 
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stemothyoid muscles) were excised. The rib cage was removed after incision of the ribs 
along their mid axillary line. The clavicle was removed after both the acromio-clavicular 
and stemoclavcular joints were cut. The brachial plexus was dissected as far medially as 
their roots and laterally to the cords after removal of scalenus anterior muscle. 
The thoracic and abdominal cavities were eviscerated to expose their posterior walls. 
Parietal pleura was gently stripped bilaterally to reveal the sympathetic chain. All neural 
connections between the sympathetic chain (from ganglia and interganglionic segments) 
and intercostal nerves were micro-dissected from the stellate ganglion superiorly to the 3 rd
thoracic ganglion distally to display the location and configuration of these and 
intermediate ganglia. Dissections were undertaken to display all neural connections from 
the sympathetic chain (including ganglionic and interganglionic segments) to adjacent 
ventral rarni. Neural connections i.e alternate neural pathways between the adjacent rarni 
were be identified; their precise course and distance from the sympathetic chain (in 
millimeters) were recorded on a schematic representation of the sympathetic chain. 
The precise location of the stellate ganglion and its incidence were documented. The 
incidence of ganglionic fusion i.e stellate to 2nd thoracic, 1 st to 2nd thoracic, 2nd to 3 rd
thoracic ganglionic fusion were recorded. 
3.3.2 STELLA TE GANGLION BLOCK : AN ANA TOMI CAL RE-APPRAISAL 
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The study was conducted at the Department of Anatomy, University of Durban-Westville. 
Permission to undertake the study was obtained from the University's Ethics Committee. 
The sympathetic block technique was a modification of the blind paratracheal approach. 
Technique : The procedure was performed by an anesthetist accomplished in performing 
sympathetic blockade of the upper limb and the anesthetist standing behind the cadaver. 
With the neck fully extended, the surface landmark for the transverse process of the 6th 
cervical vertebra was defined. The accuracy of this location was confirmed by the palpation 
of the Chassaignac Tubercle, the bony landmark for the 6th cervical transverse process. The 
sternocleidomastoid muscle and the carotid sheath are retracted downwards and laterally. A 
23 gauge needle is inserted perpendicularly into the skin at the described landmark; the 
needle is then advanced infcro-medially until the tip impinges upon the antero-lateral aspect 
of the body of the 7th cervical vertebra. The needle is then withdrawn approximately 5mm 
such that its tip now overlies the underlying longus colli muscle. Ten lOmls of Toludine 
Blue Solution was then slowly injected (over 2 minutes) (Figure 9). 
Cadavers who had surgery, trauma or gross pathology in the supra-clavicular region were 
excluded from the study. 
Thirty minutes following the delivery of the injectate a median sternotomy was perfomed. 
The lungs were gently displaced antero-medially; great care was undertaken to ensure that 
the pleura, particularly the apical and mediastinal pleura, was not disturbed. The extent of 
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the spread of the Toludine Blue Solution- medial, lateral, superior and distal- and the 














2nd thoracic ganglion 
th cervical; l st thoracic vertebrae 
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3.4 PATHOLOGICAL CONSIDERATIONS 
Patients successfully undergoing surgery for primary hyperhidrosis and CRPS Type II at 
King Edward VIII Hospital, Durban during the period spanning January 1999 to 
December 2000 were enrolled into this study. All patients had an excision of the 2nd 
thoracic ganglion either at thoracoscopy or at open surgery. At surgery, there was 
minimal manipulation, traction or cautery applied to the sympathetic chain. Following 
its excision, the ganglion specimen was placed in formalin solution. 
The ganglion specimens were harvested from 
• Ten consecutive patients who had the 2nd thoracic ganglia excised for primary
hyperhidrosis
• Ten consecutive patients who had a 2nd thoracic ganglion excised for CRPS
and,
• Five specimens were retrieved from fresh cadavers from the forensic mortuary
at Pinetown, Durban.
All specimens taken from patients were with informed consent. Cadaver specimens were 
taken after securing ethical approval in accordance with the Human Tissues Act 51 of 
1989 of South Africa. 
All ganglia were subjected to histological examination to confinn that the tissue was of 
ganglionic origin. The standard and immunopathological examinations of the ganglia 
were undertaken at the Department of Anatomical Pathology, University of Natal. 
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Biopsied tissue was fixed in l 0% formol saline and underwent processing in an 
automated tissue processor for approximately 15 hours. Biopsied tissue samples that 
have been embedded in molten paraffin wax and cast into a block a solidified wax were 
used for the further section and slides. 
The cell surface markers evaluated (using the immunoperoxide microwave staining 
technique) were: 
• CD 3 - thymocyte cell receptor
• CD 4 - T helper cell marker
• CD 8 - T cytotoxic cell marker
• CD 20 - mature B cell marker
• CD 68 - macrophage marker
• LCA - CD 45 - Leucocyte Common Antigen
Technique for evaluating the cell surface markers 
Block specimens were then cut into 2µm sections and mounted on poly-L-lysine coated 
slides (Sigma Diagnostics Inc.). The slides were then heat fixed at 60° C for 
approximately 15 minutes. The sections were then deparaffinized and rehydrated with 
water. 
Slides were then placed in antigen retrieval solution (0.01 M trisodium citrate buffer, pH 
6.00) for IO minutes at 85° C in a  microwave. 
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The sections were cooled to room temperature and this usually took between 5 to I 0 
minutes. The slides were then washed well under water. 
Thereafter, the slides were placed in 3% H202 for 5 minutes at room temperature. The 
slides were then washed well under water and then placed in a Phosphate Buffered Saline 
(PBS) bath. 
CD3 mAb (Dako, code A0452) was used in a dilution of I :50 and CD20 (Dako, Clone L26, 
code M0755) was used in a dilution of I :70. Dilutions were done with Bovine Serum 
Albumin. Slides were incubated in primary antibody for 4 minutes and 30 seconds at low 
temperature in a microwave oven. This is equivalent to 37°C. Thereafter slides were 
allowed to stand at room temperature for IO minutes. 
Slides were washed well in 3 changes of PBS and thereafter placed in a PBS Bath. The 
slides were then incubated in Biotinylated Link (Dako LSAB2 system) for 3 minutes 
and 30 seconds on low temperature in the microwave oven. Slides were again washed 
thrice in PBS and placed in a PBS bath. 
The slides were then incubated in substrate-chromogen solution (DAB, Dako 
Chromogen substrate buffer) for between 3 to 5 minutes. Thereafter the slides were 
washed well with tap water. The nuclei were then stained in Mayer's Haemotoxylin for 
I minute and 30 seconds. Slides were again washed well in water. Blue nuclei in 
ammoniated water. Slides were again washed well in water. Slides were then 
dehydrated, cleared and mounted. 
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A similar protocol was performed for the CD68 mAb (Dalrn, clone Kpi, code M0814) 
but the dilution was 1 :200 using BSA and the stand time after incubation in the 
rmcrowave oven was 1 minute. LCA (CD45) [Dako, clone 2B 11 + PD7 /26, code 
M0701) was used in a dilution of 1 :60 effected using PBS and the stand time was the 
same as for CD68. Slides were prepared as above for CD4 (Novocastia Laboratories, 
Newcastle upon Tyne, UK; clone IF6, code NCL-CD4-IF6), and CD8 (Novocastia 
Laboratories, Newcastle upon Tyne, UK; clone 4Bl 1, code NCL-CD8-4Bl 1) except 
following deparrafinization, the slides were incubated in 0.5% H202/methanol for 10 
minutes at room temperature. The slides were then placed in Antigen Retrieval Solution 
(lmM EDTA) for IO minutes at 85°C in the microwave oven. The slides were then 
cooled to room temperature for about 5 minutes. The slides were then washed well in tap 
water and placed in a PBS bath. Slides were then incubated in normal serum for 20 
minutes at room temperature. The slides were then placed in the primary antibody 
( dilution 1 :30) for 4 minutes and 30 seconds at low temperature in the microwave oven. 
The slides were then allowed to stand for 50 minutes at room temperature. Slides were 
thereafter washed in PBS and then incubated with biotinylated link for 3 minutes and 30 
seconds at low temperature in the microwave oven. Thereafter, the slides were allowed 
to stand at room temperature for 5 minutes. Slides were thereafter washed well in PBS. 
The slides were then incubated for 3 minutes 30 seconds at low temperature in the 
microwave oven in Streptavidin-HRP. The slides were then allowed to stand at room 
temperature for 5 minutes. The slides were again washed well in PBS and then 
incubated in Substrate-Chromogen Solution (DAB-Dako Chromogen/ Substrate Buffer) 
for between 3 to 5 minutes at room temperature. The slides were then washed well under 
tap water. The nuclei were stained in Mayer's Haematoxylin for 90 seconds. The slides 
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were again washed well under tap water. Blue nuclei in ammoniated water. The slides 
were again washed well under tap water. These cells were dehydrated, cleared and 
mounted. 
Cell surface marker counts 
Cell surface markers were counted in a higher power field (HPF) over 10 areas on the slide 
and the average result was taken. This was then done on 5 occasions for each slide and the 
average of this was taken as the final result. An experienced histopathologist, blinded to the 
clinical background of the submitted ganglia, evaluated all slides on all 5 occasions. 
Ethical approval was obtained from the Ethics Committee of the Nelson R Mandela 
Medical School, University of Natal. 
Statistical analysis was carried out using SPSS 9.0 for windows (BMDP statistical 
software, Los Angeles, CA). Data was entered directly onto SPSS. Results were expressed 
as medians and range. The statistical significance of the differences between the median 




4.1 SAMPLE DEMOGRAPIDCS 
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Between May 1992 to September 200 I, a total of 498 patients presented for upper limb 
sympathectomy. A total of 939 operations were undertaken. Palmar hyperhidrosis was 
by far the commonest indication for upper limb sympathectomy. The indications for 
sympathectomy, the numbers of patients presenting and operations undertaken for 
various conditions are indicated in Table 6 and Figure I 0. 
TABLE 6: FREQUENCY(%} OF SYMPATHECTOMIES UNDERTAKEN: 1992-2001 
l'\umhcr of Patients('¼,) :\umhcr of Operations('¼,) 
Palmar Hyperhidrosis 448 (89.9) 884 (94.1) 
Chronic Regional Pain Syndrome 42 (8.5) 43 (4.6) 
Raynaud's Disease 5 (1.0) 9 (1.0) 
Peripheral Vascular Disease 3 (0.6) 3 (0.3) 
TOTAL 498 939 





□ Palmer Hyperhyd rosis ■ CRPS El Raynaud 's ■ PVD
Figure 10: Patients presenting/or sympathectomy- indications 
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4.1.1 PALMAR HYPERHIDROSIS 
Between May 1992 to September 200 I, a total of 448 patients presenting with palmar 
hyperhidrosis (Plate 10) were considered suitable for thoracoscopic sympathectomy. 
Table 7 summarizes the experience between 1992 and 2001 (Appendix 1 ). 
TABLE 7: FREQUENCY OF THORACOSCOPIC SYMPATHECTOMIES FOR PALMAR 
HYP ERHIDROSJS 
YEAR PA TIE:\iTS OPF.RATIO:\ 
1992 17 34 
1993 39 78 
1994 42 83 
1995 61 121 
1996 56 109 
1997 59 116 
1998 68 134 
1999 57 113 
2000 31 61 
2001 18 35 
.__T_O_T_AL __._ __ 4_48 _ __.__ ___ 8_84 __ __, Plate JO: Pa/mar hyperhidrosis - typical presentalion
Associated axillary hyperhidrosis was noted in 226 patients (50.4%); associated plantar 
hyperhidrosis was encountered in 358 (79.9%). When present, axillary and plantar 
hyperhidrosis were always subordinate to palmar hyperhidrosis as the presenting 
problem. In all but 2 patients, the palmar hyperhidrosis was bilateral. In these 2 
patients presenting with unilateral hyperhidrosis, both patients had undergone 
thoracoscopic sympathectomy previously. One patient had recurrent palmar 
hyperhidrosis following a period of anhidrosis; the other patient had persistent palmar 
hyperhidrosis following an apparent successful thoracoscopic sympathectomy. One 
patient presented with persistent bilateral palmar hyperhidrosis also following an 
apparently successful procedure. 
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There were 249 males and I 99 females. The mean age at presentation was 19 .2 years 
(range 13-52 years). The means Visual Linear Analogue Scale Score for palmar 
hyperhidrosis on presentation was 9.1 (range: 8.7-10). 
Thoracoscopic sympathectomy was successfully undertaken in 448 patients (884 
procedures). In 6 patients, thoracoscopic sympathectomy was performed successfully, 
unilaterally; of these, 2 patients had either recurrent palmar hyperhidrosis (n=2) or 
persistent hyperhidrosis (n=4). In the other 6 patients successfully undergoing unilateral 
thoracoscopic sympathectomy, dense pleural adhesions precluded the attainment of an 
adequate lung collapse to facilitate safe thoracoscopy. This prompted the abandonment 
of the procedure. Thus, a total of 884 ( out of a possible n=890) procedures were 
successfully undertaken. 
In all patients in whom thoracoscopic sympathectomy was successfully accomplished 
(n=884) the clinical outcome was excellent. In the vast majority of patients (n=882), 
complete palmar anhidrosis was reported immediately following the procedure and at 
the one week review; three patients reported unilateral persistence of palmar 
hyperhidrosis that disappeared within a fortnight of the procedure. The overall success 
rate was 99.7%. Review at three months by personal and telephonic interview was 
possible in 395 patients (89%). The successful effect of sympathectomy at the one 
week review was noted to have persisted. However, in 2 patients, recurrent sympathetic 
activity (rSA) developed after 6 months; the details of these patients and their outcome 
to further management are detailed in Chapter 4.2.4. 
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Compensatory Hyperhidrosis 
Compensatory hyperhidrosis developed in 56 patients (12.6%); this was usually evident 
at the three month review. This sweating was unpredictable and manifested in 
circumstances similar to those predisposing to palmar hyperhidrosis. Invariably the 
front and back of the chest, trunk and thighs were affected. All 56 patients were 
severely distressed by this side effect, notwithstanding the pre-operative cautioning 
about this. Twenty-two patients (4.9%) were so distressed by this compensatory 
hyperhidrosis that they regretted the procedure, even though the palms were now dry. 
In the remaining 34 patients the compensatory hyperhidrosis was moderate; these 
patients accepted this side-effect and given the successful outcome of the palmar 
hyperhidrosis, were satisfied with the outcome. 
Gustatory Sweating 
Gustatory sweating developed in 2 patients; this effect was noted to develop 3 months 
following sympathectomy. Whilst the symptoms regressed spontaneously in one patient 
over the ensuing 9 months, in the 2
nd patient with this affliction the symptoms persisted. 
Anaesthetic effects during thoracoscopic sympathectomy 
A sudden bradycardia (28 beats per minute and 18 beats per minute, respectively) 
developed in 2 patients. Both patients were fit, young (<24 years old) and with no 
history of cardiac disease. No anaesthetic reason could be found for this. In both 
patients, the procedure was undertaken initially on the left side, contrary to the policy of 
always undertaking right sympathectomy initially. Further manipulation of the 
sympathetic chain was stopped. In both patients, no pharmacological agents apart from 
Atropine were administered to regain sinus rhythm which returned within 2 and 3 
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minutes, respectively. The procedure was thereafter continued uneventfully. On 
transection of the sympathetic chain, no changes were noted with respect to pulse, blood 
pressure, respiratory rate or oxygen saturation. The post-operative recovery in both 
patients was uneventful. 
Complications (Table 8) 
1. Haemothorax : One patient developed a haemothorax; this was confirmed on
day one post-surgery with the patient complaining of right sided discomfort
and dyspnoea. Intercostal chest drainage had to be instituted over the ensuing
two days.
11. Pneumothorax : Pneumothorax presenting with persistent dyspnoea
immediately following surgery was noted in one patient. With the insertion
of an intercostal chest drain, this improved within 24 hours. Surgical
emphysema developed in 7 patients. This was always confined to the lateral
chest wall, adjacent to and between the port sites. In 4 patients, an
underlying apical pneumothorax less than 2cm from the thoracic apex was
noted on chest radiography. Since there was no associated respiratory
embarrassment, these patients were managed conservatively.
111. Homer's Syndrome : A Homer's Syndrome developed unilaterally (right
side) in one patient. This patient developed meiosis, ptosis and rhinitis. The
surgical procedure was reported to be uncomplicated; the 2nd thoracic
ganglion was readily recognized. Neither excessive traction nor diathermy
was applied to the sympathetic chain. The Homer's Syndrome was noted on
day one post-surgery. Over the ensuing months, the signs gradually
improved so that corrective surgery was not necessary.
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1v. Hospital Stay : The majority of patients (435 patients; 97.9%) were 
discharged within 24 hours of admission. Nine patients had a longer hospital 
stay, either requiring intercostal chest drainage (2 patients) or the 
observation of surgical emphysema (7 patients). The two patients requiring 
intercostal chest drainage each stayed in hospital for two and three days, 
respectively; those patients with surgical emphysema stayed in hospital for at 
least two days after chest radiography had excluded the progression of a 
pneumothorax. 
v. Return to work : All patients who were discharged within 24 hours of the
procedure were able to return to work or study within 5 days of admission.
Two hundred and forty nine patients (56.2%) were able to return to activity
within 3 days. Those patients requiring intercostal drainage or observation
of surgical emphysema returned to activity at a mean period of 12 days
(range: 7-16 days).
TABLE 8: COMPLICATIONS FOLLOWING THORACOSCOPIC SYMPATHECTOMY FOR 
PALMAR HYPERHIDROSJS 
CO,\IPLIC:\ TION P.\TI E:\TS '¼, OF PROCEl>l RES 
(n=-U8) ( n=88-t) 
Haemothorax 1 0.1 
Pneumothorax 
Requiring drain I 0.1 
No drain 4 0.5 
Homer's Syndrome I 0.1 
Surgical emphysema 7 0.8 
Atelectasis 0 0 
Compensatory hyperhidrosis 56 12.6 
Gustatory sweating 2 0.2 
Persistent sympathetic activity 3 0.3 
Recurrent sympathetic activity 3 0.3 
4.1.2 CHRONIC REGIONAL PAIN SYNDROME 
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A total of 42 patients underwent upper limb sympathectomy. The median duration of 
symptoms was 9.5 (range 4 - 200) weeks at the time of presentation for surgery. There 
were 27 males; the median age was 32 (range 17 - 64) years. The median duration of 
symptoms in patients in Group I (n = 24; symptoms < 3 months) was 6.5 (range 4 - 11) 
weeks. The median duration of symptoms in patients in Group 2 (n = 18; symptoms > 3 
months) was 26.5 (range 14 - 200) weeks (Plate 11) (Appendix 2 (i), 2 (ii)). 
Plate 11 : Late CRPS (> 12 months) - radiological effects. Note the marked 
osteoporosis affecting the left hand 
TABLE 9: RESULTS OF SYMPATHECTOMY FOR CHORNJC REGIONAL PAIN 
SYNDROME 
Group I ('1/.,)ln = 2-JI Group II (%)In = 181 
Excellent 17 (80.9) 3 (23.5) 
Good 7 (19.0) 5 (29.4) 
Satisfactory 0 3 (I 1.8) 
Satisfactory clinical outcome 24 (100) 11 (64.7) 





Surgery (Table 9) 
Sympathectomy was successfully performed in all patients referred for the procedure. 
Thoracoscopic sympathectomy was attempted in all patients. This was successful in 30 
patients. In 12 patients, sympathectomy had to be performed by the open route. In the 
latter group, the thoracoscopic approach was abandoned either because of dense 
adhesions involving the lung apex or pleural thickening totally obliterating an adequate 
view of the proximal sympathetic chain. 
The higher rate of open sympathectomy in Group 2 patients correlated with the larger 
number of SGB administered to this group compared to the patients in Group I. Patients 
in group I had a median of I (range I - 2) blocks and patients in group2 had a median of 
3.5 (range I - 5) blocks administered. 
Predictive value of SGB 
Of the 42 patients referred for surgery, only 25 patients had appreciable pain relief from 
SGB that confirmed the presence of sympathetic mediated pain. In the remaining 17 
patients there was no response to SGB. 
f n the 25 patients who had relief from SGB, the outcome following sympathectomy was 
noted to be poor in 5 patients; In the 17 patients with a poor response to SGB, the 
outcome was noted to be excellent in 6 patients. 
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Pain response to sympathectomy 
The overall improvement in all 42 patients from a median preoperative score of 9.0 
(range 7 - I 0) to a median postoperative score of 2.0 (range 0 - 9.4) was noted to be 






GROUP I GROUP2 OVERALL 
• Pre-operative
El Post-operative 
Figure I I : Mean outcome to sympathectomy in Group I, Group II and Overall 
The clinical improvement in VLAS in Group I patients was a decline from a median 
preoperative score of 9 (range 7.5 - I 0) to a median postoperative score of 1.65 (range 0 
- 4.2) (Figure 12). Due to the minimal impact of pharmacotherapy and progressive












Figure 12 : Outcome to Sympatliectomy in Gr<Jtlp I 
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In patients in Group 2, the clinical improvement was a decline from a median 
preoperative score of 9.1 (range 7 - I 0) to a median postoperative score of 4.2 (range 














Figure 13 : Outcome to Sympathectomy in Group II 
The outcome in Group I versus Group 2 was noted to be significantly better in the 
fonner group (p<0.003, Mann-Whitney U test). 
The poorest results were in 7 patients from Group 2 who had been symptomatic for 
between 29 to 192 weeks. 
The beneficial effect noted on day IO following sympathectomy persisted during the 
median follow-up period of 40.6 (2 - 73) months. Three patients were lost to follow-up. 
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Surgical outcome 
All patients who had thoracoscopic sympathectomy were discharged within 24 hours of 
admission. There were no complications following the procedure (Plates 12 a, b ) . 
Plate 12 (a) Pre-operative 
presentation of CRPS (Group I patient, 
history of 8 weeks) - note the arm 
support and bandaging applied by 
• 
Plate 12 (b): Effect within 24 hours oj 
thoracoscopic sympathectomy with 
disappearance of pain and return of hand 
.function 
In contrast, the average inpatient stay following open sympathectomy was 2.5 days. 
Complications following open sympathectomy included a Homer's Syndrome in I 
patient and wound haematoma in 2 patients. 
In all patients the submitted ganglia confirmed the histological presence of neuronal 
ganglionic tissue. 
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4.1.3 RA YNAUD'S DISEASE 
Thoracoscopic sympathectomy was undertaken bilaterally in 4 patients and unilaterally 
in one patient, all with associated finger-tip gangrene. All patients had little response to 
conservative medical therapy. All 5 patients had obtained relief of pain; in three 
patients, bilaterally, there was healing of the gangrenous tips noted within 6 months of 
the procedure (Plate 13 a, b ). Two patients were lost to follow-up; however, in both 
these patients there was evidence of clinical improvement within four weeks of surgery. 
Plate 13 (a) : Raynaud's disease with 
finger-tip gangrene 
Plate J 3(b) : Six months following sympathectomy; 
healing of finger-tip gangrene noted 
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4.1.4 PERIPHERAL VASCULAR DISEASE 
Unilateral thoracoscopic sympathectomy was undertaken in three patients with un-re­
constructable upper limb peripheral vascular disease; two of these patients had 
previously undergone bypass surgery for lower limb peripheral vascular disease. All 
three patients presented with rest pain; one patient required digit amputation. Following 
sympathectomy two patients experienced satisfactory pain relief that persisted up to 
three months following the procedure. The third patient did not obtain any benefit from 
sympathectomy. All patients were lost to longer term follow-up. 
4.2 ISSUES IN TECHNIQUE 
4.2.1 OPEN VERSUS THORACOSCOPIC SYMPATHECTOMY 
Between December 1994 and March 1995, 20 patients who underwent thoracoscopic 
sympathectomy were evaluated (Group I). There were 15 females. The mean age of 
Group I was 19.2 years (range: I 3-28). Group II (open sympathectomy) comprised 20 
patients; 12 were females. The mean age of Group II was 19.4 years (range : 12-32). 
This group of patients had their surgical procedures performed during the period August 
1992 to July 1993. Forty procedures were performed in each group. The mean 
operating time for Group I patients was 19 (range : 11-30) minutes. In Group II patients, 
the mean operating time was 87.3 (range : 42-120) minutes. 
TABLE JO: RESULTS: OPEN VS THORACOSCOPIC SYMPATHECTOMY 
y (da s 
Opioid usage 
No. of patients 
Doses 










All patients had a successful outcome immediately following surgery that was 
maintained at the one month follow- up review. All histological evaluation confirmed 
the presence of neural ganglion tissue. The only complication encountered in each 
group was a pneumothorax; this was evident in I patient in Group I and 4 patients in 
Group IL This was not statistically significant. Opioid usage was evaluated and only 5 
patients in Group I required opioids following surgery as opposed to all the patients in 
Group 11. The number of doses required to sustain pain relief was 3 times greater than 
that of Group II. Both achieved statistical significance. The hospital stay in Group I 
was significantly shorter with all but 2 patients being discharged within 24 hours ( 1-3 
days). In Group II the average hospital stay was 2.6 days (2-5 days); this also achieved 
statistical significance. 
All patients in Group I were able to resume their duties by the end of the first week 
following surgery (mean : 5 days; range : 3-7 days). The mean return to work in Group 
II was 10 days (range : 7-18 days) with at least 25% only being able to resume normal 
duties in the third week following surgery. This was statistically significant. 
An evaluation of the cost implications of the two approaches demonstrated a significant 
saving with the patient undergoing thoracoscopic sympathectomy (Table 11 ). A net 
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saving of R 4859.40 (R5262.40 if no assistant surgeon is used) is possible for a patient 
undergoing thoracoscopic sympathectomy. 
TABLE 11: COST ANALYSIS (IN RANDS): OPEN VERSUS THORACOSCOPJC 
SYMPATHECTOMY 
OPE:\ THOR..\COS('OPIC 
Theatre charge* 3238.40 
Theatre consumables 800.00 
Hospital stay• 2160.00 
Anaesthetic fee 1200.00 
Surgeon's fee 1340.00 
Assistant's fee 446.00 
TOTAL R 9184.40 
* Standard rate 1s R35.20 per minute
♦ R720 per day for inpatient; R437 for day case admission








R 3722.00 • 
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4.2.2 ANESTHETIC CONSIDERATIONS SINGLE LUMEN ENDO-
TRACHEAL INTUBATION VE3RSUS DOUBLE LUMEN 
ENDO BRONCHIAL INTUBATION FOR THORACOSCOPIC 
SYMPATHECTOMY 
Twenty patients were prospectively evaluated. Group I (double lumen endobronchial, 
n= I0) had a mean age of 18 (15-28) years, weight of 54 (39-71) kg and comprised 4 
females. Group II (single lumen endotracheal, n= I 0) patients had a mean age of 17.5 
(16-30) years, weight of 52 (38-68) kg and there were 5 females. There was no 
statistical difference between the two groups with respect to age, weight and gender 
distribution. 
Desaturation was only encountered in Group I and there were five episodes recorded 
that was statistically significant (p< 0.002). In addition, more supplementary opioids 
were required by patients in Group I; this was also statistically significant (6 years I; p< 
0.03). Pain scores using a visual analogue scale were similar at 2 and 6 hours following 
the procedure. Retro-sternal discomfort was common and present in both groups (60%) 
(Appendix 3). 
No complications were encountered in both groups. 
All patients were discharged within 24 hours. 
A successful surgical outcome was achieved in both groups. 
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sympathectomy. Complications were essentially minor. There was no incidence of a 
Homer's Syndrome or gustatory sweating. One patient developed a haemothorax that 
warranted intercostal tube drainage and a hospital stay of three days. A second patient 
developed surgical emphysema along the right chest wall; chest radiography revealed a 
small pneumothorax that was managed conservatively over 2 days. The remaining 53 
were discharged within 24 hours. 
There was an excellent outcome in the immediate post-operative period in all 55
patients with palmar hyperhidrosis; the mean (SD) post-operative score was 0.55 
(0.46). This was statistically significant (p = < 0.0001 ). An excellent outcome was also 
noted in 26 patients (81 %) with axillary hyperhidrosis and in 26 patients (53%) with 
plantar hyperhidrosis. 
A satisfactory outcome was volunteered by 3 patients with axillary hyperhidrosis and by 
20 patients with plantar hyperhidrosis. There was a poor outcome in 3 patients with 
axillary hyperhidrosis and 3 patients with plantar hyperhidrosis. 
The mean overall (SD) improvement in axillary hyperhidrosis from 7 .26 (2.16) to3. I 4 
(2.33) was noted to be significant (p = < 0.00 I); likewise, the mean improvement in 
plantar hyperhidrosis from 7.32 (2.27) to 3.08 (2.05) was noted to be significant (p = < 
0.001) (Table 13 and 14). 
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TABLE 13 : OUTCOME TO LIMITED GANGLIONECTOMY: MEAN (SD) POST 
OPERATIVE SCORES 
Excellent n ('¼,) Satisfactor� n (%) Poor n ('1/.,) \lcan(SD) 
Palmar 55(100) - - 0.55 (0.46) 
Axillary 26(81.2) 3(9.4) 3(9.4) 3.14 (2.33) 
Plantar 26(53) 20(40.8) 3(6.2) 3.08 (2.05) 
TABLE 14: OUTCOME TO LIMITED GANGLIONECTOMY: MEAN (SD) PRE­
OPERATIVE VERSUS POST-OPERATIVE SCORES 
9.29 (0.68) 0.55 (0.46 
7.26 (2.16) 3.14 (2.33) 
7.32 (2.27) 3.08 (2.05) 
All patients were extremely gratified with the cosmetic outcome of the procedure. 
Compensatory hyperhidrosis was by far the most severe side effect and was noted in 7 
patients ( 13%) with a mean LAS score of 7.5 (2.1 ). This sweating was unpredictable 
and invariably along the trunks, back and thighs. It usually presented approximately 
three to six weeks after the procedure. All 7 patients were severely distressed by this 
side- effect; 3 patients regretted having undergone the operation even though the palms 
were now dry. Amongst these 7 patients there were 3 patients with axillary 
hyperhidrosis and 2 patients with plantar hyperhidrosis; there was no change in the 
sweating patterns in these areas. In 4 patients the compensatory hyperhidrosis was 
moderate ( mean score 4.5); all 4 patients accepted this side-effect and, given the 
successful outcome of the palmar hyperhidrosis, were satisfied with the outcome. 
There was a l 00% follow-up at the six months with patients either seen personally or 
telephonically interviewed. At the end of the study (March 1998) there were 41 patients 
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followed up for > 9 months; in all these patients the effects of the sympathectomy -
both positive and negative - proved to be enduring. 
4.2.4 OUTCOME TO THORACOSCOPIC SYMPATHECTOMY: 
MECHANISMS FOR FAILURE 
A total of 448 patients with palmar hyperhidrosis were considered for thoracoscopic 
sympathectomy : a total of 884 procedures were undertaken. In 12 patients the 
procedure was undertaken unilaterally. In 6 of these patients, unilateral procedures were 
performed owing to the presence of dense pleural adhesions that precluded an adequate 
thoracoscopy. The other 6 patients had unilateral failures (n=4) and recurrent 
sympathetic activity (n=2). 
Progress and outcome in those patients who had not presented for review at I week 
following surgery was established by telephonic contact with patients or the referral 
doctor. The outcome at I week in all patients was known. However, follow-up at 3 
months and subsequently was less rewarding with 89% presenting for review or being 
contactable at one year following the procedure. Follow-up in our practice, which 
largely subserves a working class population, is notoriously poor; we do, however, have 
an effective self-referral system. 
Persistent Sympathetic Activity (pSA) 
At the I week follow-up visit, there was a 99. 7% successful outcome ( <3) to the 
procedure with complete satisfaction noted on linear analogue scale. In 2 patients, 
unilaterally, the palmar hyperhidrosis was noted to be persistent. Histological evaluation 
114 
confirmed the clinical suspicion that a sympathectomy had not been successfully 
undertaken. 
Two other patients, who had undergone sympathectomy by other surgeons, were 
referred with pSA noted within I week of the procedure. The excised tissue, presumed 
to be sympathetic neural tissue, was not submitted for histological evaluation by the 
attendant surgeon. In all 4 patients with pSA, the surgeons had reported little technical 
difficulty in undertaking the procedure. 
Recu"ent Sympathetic Activity (rSA) 
This was encountered in 2 patients. This included a patient previously reported 
[Singh, 1998]. fn these patients, progressive and unilateral recurrence of hyperhidrosis 
was noted some 30 months after a successful bilateral thoracoscopic sympathectomy. At 
presentation, the affected limb was as hyperhidrotic as the original state. 
Management 
All 6 patients (4 pSA and 2 rSA) were managed by re-thoracoscopy. Creation of the 
pneumothorax was surprisingly easy, there being few significant adhesions. In 3 of the 4 
patients with pSA it was apparent that the original surgical endeavour was misdirected. 
Scarring was noted medial to the 2nd and 3rd rib necks. A 2nd thoracic ganglionectomy 
was performed and histology confirmed the presence of sympathetic ganglion cells. 
In the 4th patient, a dense pleural reaction was noted extending from the region of the 
stellate ganglion to the 3
rd 




intercostal nerve could be convincingly identified. The procedure was
abandoned. 
In the first patient with rSA, a contemporaneous video recording of the re-thoracoscopic 
procedure was made. Scarring was evident along the site of the previous 
sympathectomy. Dissection from the undissected sympathetic chain distally to the 
superior aspect of the 2nd rib revealed a cord-like structure connecting to the stellate 
ganglion (Plate 14). 
Plate 14 : Regenerated sympathetic chain (+ ) noted at re-thoracoscopy 
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Histology of this excised segment revealed haphazardly arranged myelinated and 
unmyelinated nerve fibers in scar tissue. Axons were noted but no sympathetic ganglia -
findings consistent with sympathetic regeneration (Plate 15). 
Plate 15: Photomicrograph (magnification x 390) illustrating regenerated nerve fibers 
(asterisk) in scar tissue (arrowed) in patient with recurrent sympathetic activity 
In the second patient with rSA dense scarring was noted along the area of the previously 
excised 2
nd 
thoracic ganglion; a regenerated sympathetic chain, as described in the first 
patient with rSA, was not seen. The scar tissue was extensively cauterized; no biopsy 
could be taken. At 3 months following re-thoracoscopy both patients with rSA showed 
no signs of recurrent sweating The outcome in the 5 patients subjected to re­
thoracoscopic sympathectomy was satisfactory with a mean LAS of 2 noted at the six 
month follow-up evaluation. To date, this favourable outcome [ mean 20.3 (3-60 
months)] has persisted. 
4.3 ANA TOMI CAL CONSIDERATIONS 
4.3.1 SAMPLE DEMOGRAPHICS 
117 
Twenty one cadavers were dissected to define the incidence and location of alternate 
neural pathways and the morphology of the stellate ganglion. In one cadaver the 
dissection process was abandoned totally because of chronic lung disease, scarring the 
thoracic outlet. Thus a total of 41 sides were dissected and were available for 
evaluation. 
4.3.1.1 ALTERNATE NEURAL PATHWAYS 





thoracic ventral rami. In one cadaver, two alternate neural pathways were
noted bilaterally; one cadaver had two neural pathways noted unilaterally. 
A spectrum of alternate neural pathways were demonstrated. These were categorised as 
either Type A, Type B or Type C using the intrathoracic ramus (ITR or the nerve of 
Kuntz) between the 2nd intercostal nerve and the ventral ram us of the l st thoracic nerve
as a basis on both right and left sides (Ramsaroop et al., 2001) (Appendix 4). 
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TYPE A: This group displayed demonstrable 
sympathetic connections to either stellate, T2 ganglia 
or the intergnglionic portion of the sympathetic chain. 
This was noted in 46.3% (n=
19
/41) (Figure 14, Plate






thoracic ventral ram us 
ITR Intrathoracic ramus 
T2ICN 2nd intercostal nerve 
R2 2nd rib 
Plate 16: Right supero-lateral view demonstrating intrathoracic ramus with macroscopic 
sympathetic connection (J'ype A) 
ICG 
Type B : This group is the classic intrathoracic 
ram us between the I st and 2n<1 thoracic ventral










ventral ram i 
Inferior cervical ganglion 
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st, 2nd thoracic ganglia
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rami (J'ype BJ 
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TYPE C: This group displayed macroscopic 
sympathetic connections to either the Tl intercostal 
nerve or its lateral cutaneous branch. This type was 
noted in 17.1 % (n=
7






R2 I st 
T2ICN 
ITR 









lateral cutaneous branch of
intercostal nerve 
lntrathoracic ramus 
Plate 18 : Left superior oblique view illustrating communication between stel/ate 
ganglion and split intrathoracic ramus to lateral cutaneous nerve (Type C) 
Proximity of alternate neural pathways to the sympathetic chain (Appendix 4) 
• Mean distance was I 0.15mm on the right, range 3.0 - 30.0mm
• Mean distance was 7. I 8mm on the left, range 2.3 - 12.3mm
• Overall mean distance was 7.66mm, range 2.3 - 30.0mm
Location of rd thoracic ganglion and incidence of rd ganglion fusion 
In the 41 sides analyzed, the 2
nd 
thoracic ganglion was consistently located in the 2
nd 
intercostal space in 37 dissections (90,2%), in 4 dissections (9.8%) the T2 ganglion was 
noted to be as follows:-
• fused T l  and T2 ganglia lying over the neck of the 2nd rib (2.4%) (Plate 19)
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• enlongated, flattened T2 ganglion fused to Tl ganglion and extending to upper
border of 3 rd rib (2.4%)
• Fused directly to the stellate ganglion (4.8%) (Plate 20)
Plate 19: Right superior oblique view Plate 20: Left superior oblique view 
demonstrating.fused Tl and T2 ganglia demonstrating.fused stellate and T2 ganglia 
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n = 4(9.8%) 
T2 ICN 
Key ••• Type A : ITR between SG, T2 and interganglionic segment
■ ■ ■ ■ Type B: Classic ITR between Tl and T2 ventral ramus 
Type C : ITR between Tl ICN or /en 





4.3.2 STELLA TE GANGLION BLOCK : AN ANATOMICAL RE-APPRAISAL 
The sympathetic blockade was undertaken bilaterally in 20 fresh cadavers. The 
procedure was abandoned on one side because of extensive cervical adenopathy.; a total 
of 19 blocks were evaluated. 
1n all 19 blocks, the Toludine Blue Solution consistently tracked posteriorly; there was 
neither intra-thoracic spillage nor extravasation along the anterior pleura. Proximal 
spread up to the transverse process of the C7 vertebra was noted in all 19 blocks; this 
effectively blocked the proximal aspect of the inferior cervical/stellate ganglion. The 
distal spread extended up to the lower border of the neck of the 3
rd 
rib (n=3), the lower
border of the neck of the 4
th 
rib (n= I 5) and as far as the neck of the 7'
h 
rib (n= 1 ). The
medial spread was consistently greater than the lateral spread; in all cases the medial 
spread extended to the medial aspect of the vertebral bodies. The lateral spread in all 19 
cases "blocked" the lower roots of the brachial plexus; although alternate neural 
pathways (Nerve of Kuntz) were not dissected, the lateral spread of the Toludine Blue 
Solution was consistently noted to be beyond the usual location of the Nerve of Kuntz 
(Plate 21). 
Plate 21 : Ste/late Ganglion Block using Toludine Blue. Note 
extravasation of dye in the region of the lower trunk of the 
brachia/ plexus ( ..... ) and the caudal extent of the 
sympathetic chain 
SA Subclavian Artery 
SG Stellate Ganglion 




T2G 2nd thoracic ganglion 
4.4 PATHOLOGICAL CON SID ERA TIO NS 
Control ganglia 
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ln all the control ganglia evaluated no cell surface markers were noted (Appendix 5). 
Primary Hyperhidrosis ganglia 
All markers that were evaluated were present. This was statistically significant for CD3, 
CD20, CD4, and CDS. Markers for acute inflammatory cells such as CD68, and LA 
were present but were not statistically significant (Table 15). The inflammatory 
response induced a consistent fibrotic reaction in all ganglia. 
TABLE 15: PRIMARY HYPERHIDROSIS: TEST STATISTICS' 
('1)3 CD20 CD-' CD8 ('1)68 LC.\ FIBROSIS 
Mann-Whitney U .000 2.500 5.000 .000 10.000 .000 .000 
Wilcoxon W 15.000 17.500 
-3.075 -2.776
Asymp. Sig .002 .006 
(2-tailed) 
Exact Sig .0013 .0043 
[2*( I-tailed)] 





b. grouping variable : ganglion source
25.000 15.000 15.000 
-1.945 -3.068 -3.606
.052 .002 .000 
.1123 .0013 .001 a 
CRPS ganglia : surface markers evaluated were present. In these ganglia both the 
lymphocyte markers, CD3, CD20, CD4 and CDS as well as the macrophage markers 
were present in statistically significant amounts. Additionally, the accompanying 
fibrosis was also statistically significant in the ganglia excised from the patients with 
CRPS. 
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TABLE 16 :CHRONIC REGIONAL PAIN SYNDROME: TEST STATISTJCS1 
CD3 CD20 
Mann-Whitney U .000 .000 
Wilcoxon W 15.000 15.000 
z -3.072 -3.100
Asymp. Sig (2- .002 .002 
tailed) 
Exact Sig [2*(1- .001 a .0013 
tailed)] 







CD8 CD68 LC:\ FIBROSIS 
.000 2.500 .000 7.500 
15.000 17 .500 15.000 22.500 
-3.072 -2.792 -3.068 -2.327
.002 .005 .002 0.020 
.0013 .0043 .0013 .0423 
b. grouping variable : ganglion source
Plate 22 : Lymphocylic infiltration of 
sympathetic ganglion with destruction of 
neurons and associated cytoplasmic 
condensation (arrow) 
{Haemotoxylin & Eosin x 180] 
Plate 24 : Lymphocyte common antigen 
demonstration of lymphoid aggregates 
[x 120] 
Plate 23: Lymphocytic infiltration of 
sympathetic ganglion with destruction of 
neurons : Note fibrosis (arrow) and cell 
destruction (asterisk) 
[Haemotoxylin & Eosin x 180] 
Plate 25 : CD3 antigen immuno-positivity 
confirming T-lymphocyte subtype [x240] 
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Plate 26 : CD8 antigen immuno-positivity in 
lymphoid aggregate [x480 J 
Plate 2 7: Sparse CD4 antigen immuno-positivity 
in lymphoid aggregate [x280 J 
Plate 28 : Scattered CD20 immuno-positive B 
lympocyte in lymphoid aggregate 
CHAPTERS 
DISCUSSION 
5.1 CLINICAL PERSPECTIVES 
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Current clinical experience underscores the view that sympathectomy is a relevant 
surgical option with clearly defined indications. Primary hyperhidrosis is by the most 
popular indication for sympathectomy; CRPS, in the era of minimal access surgery, has 
increasingly gained popularity over traditional conservative therapy. Advances in 
pharmacotherapy and the availability and refinements in vascular techniques have 
relegated the role of sympathectomy in vasculopathies and occlusive vascular diseases. 
5.1.1 PALMAR HYPERHIDROSIS 
Since Kotzarefrs (1920) somewhat fortuitous treatment of palmar hyperhidrosis by 
sympathectomy (stellatectomy), surgery has proved to be the most effective and 
enduring treatment of this condition. Notwithstanding this, various forms of 
conservative treatment have consistently evolved; this intimates a lingering 
apprehension about surgery, fuelled probably by the technical demands and 
complications of open sympathectomy. That no universally safe and easily reproducible 
open surgical technique is available is reflected by the range of open techniques 
described. Presently, the wide availability, safety, and reproducibility of the 
thoracoscopic approach negates the trepidation of surgical risk. The early results of 
thoracoscopic sympathectomy for upper limb sympathectomy been confirmed in large 
world wide series (Drott, 1993; Gothberg et al., 1994; Kux, 1978; Lin, 1990). 
Furthermore, Malone (I 986) demonstrated that the technique is easily learnt. When 
considering surgical management for the treatment of hyperhidrosis, careful patient 
selection is essential. This entails thorough history taking and clinical evaluation. The 
clinical picture of primary hyperhidrosis is clear cut, forming a distinct clinical entity. 
The complaint is invariably of long duration with no change in pattern or influence on 
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general health. Special investigations are unnecessary, the only tests being done are 
those necessary to qualify the patient for a general anaesthetic. In this series a pre­
operative chest radiograph was not routinely performed; if there was a history of 
chronic lung disease or pulmonary trauma a chest radiograph was done. 
Despite the success of thoracoscopic sympathectomy the search for an appropriate 
conservative treatment continues, prompted by the occasional unpleasant and 
unpredictable effect of sympathectomy. Compensatory hyperhidrosis (Chapter 5.2.3) is 
the foremost of these unpleasant effects and is arguably the major reason for the search 
for conservative treatment. To date no conservative treatment has been shown to effect 
the enduring treatment of hyperhidrosis. The injection of Botulinum toxin , the most 
recently described conservative treatment, is yet to be proved as an effective, economic, 
and enduring alternative. 
Gustatory phenomenon , originally described by Guttmann ( 1921 ), developed in one 
patient. This phenomenon has been described to occur in up to 5% of patients 
undergoing sympathectomy (Moron and Brady, 1991; Kux, 1978). It has been suggested 
that gustatory sweating represents an expression of aberrant regeneration or collateral 
sprouting of preganglionic fibers making abnormal synapses in the superior cervical 
ganglion (Kurchin et al., 1977a). The low incidence of this effect in this series endorses 
the suggestion that it may be obviated by confining the sympathectomy to the 2
nd 
thoracic ganglion. 
In this series a Homer's syndrome (with ptosis, meiosis and rhinitis) developed in one 
patient; this complication gradually improved over the ensuing six months, not 
warranting corrective surgery. This complication developed during the early phase of 
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our experience with thoracoscopic sympathectomy when cautery was applied onto the 
sympathetic chain prior to its transection. Unipolar cautery applied to the sympathetic 
chain has the potential to extend proximally (and distally) and thereby lead to unwanted 
coagulative necrosis. In general, the incidence of Homer's syndrome is related to the 
approach used; for cervical sympathectomy the reported incidence ranges from zero 
(Bogokowsky et al., 1983 ) to 40% (Adar et al., 1977). Homer's syndrome was not 
observed in 2 series that used the transaxillary approach (Ellis 1975; Sternberg et al., 
1982), in several series that used the endoscopic route (Kux, 1978; Malone et al., 1982; 
Byrne et al., 1990) and in the largest in the literature that used the dorsal midline 
approach (Shih and Wang , 1978). The thoracoscopic approach affords the easy 
recognition of the stellate ganglion (by its characteristic overlying yellow fat pad) so 
that its injury is avoided. In those rare instances (<I%) of 1st and 2
n
d thoracic ganglion 
fusion it is suggested that the sympathectomy be confined to below the lower border of 
the 2
nd 
rib; at this level the innervations to the 1st thoracic ganglion and inferior cervical 
ganglion (to eyelid) are intact. 
Phantom sweating ie the subjective feeling of impending sweating in the palms without 
actual sweating has been reported in a high percentage of patients (Hashmonai et al., 
1992 ; Adar et al.,1977; Kurchin et al., 1977b). Many series, including this, do not 
mention this effect. It is conceivable that detailed questioning of the patient may 
probably elicit this effect. 
Transient palmar sweating appearing I to 7 days after successful sympathectomy (that 
was followed by complete anhidrosis) is disconcerting to the patient and the surgeon. 
This occurred in three patients in this series and has also been reported by others (Adar 
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et al., 1977; Greenhalgh et al., 1971; Keaveny, 1977). The reason for this phenomenon 
is unclear; it has been suggested that it may represent a transient discharge of the 
neurotransmitter substance at the nerve ending resulting from post-ganglionic 
degeneration. If the surgeon is confronted by this phenomenon after a technically 
successful sympathectomy, the patient should be reassured about the long-term effect. 
In contrast to transient hyperhidrosis, recurrence of hyperhidrosis in the long-term may 
be due to nerve regeneration. The incidence ofrecurrent hyperhidrosis ranges between I 
to 5%, occurring between 2 to 48 months following sympathectomy (Hashmonai et al., 
1992). In this series relapse of hyperhidrosis - as opposed to persistent sympathetic 
function - occurred in 2 of 884 limbs that were noted to anhidrotic following 
sympathectomy. 
Post sympathectomy rhinitis, has been reported to occur in 3.5 to 10% of patients 
(Hashmonai et al., 1992; Herbst et al., 1994); this side-effect was not volunteered by 
any patients in this study. In the report by Hashmonai et al. ( 1994) and Herbst et al. 
( 1994 ), TI /f2 - T4 and T 1-T4 components of the sympathetic chain were resected. It 
has been speculated that post-sympathectic rhinitis follows the diminished sympathetic 
but increased parasympathetic stimulation of nasal mucosa leading to nasal obstruction 
because of mucosa! oedema (Whittet and Fisher, 1988). 
No long term respiratory complaints were volunteered by any patients in this series ; 
Herbst et al. (1994) and Hashmonai et al. (1992) also did not report respiratory 
problems following sympathectomy. However, Adar et al., (1977) and Adar (1994) 
reported the persistence of respiratory complaints beyond the post-operative period in 
patients returning to physical activity. This was substantiated by Molho et al. ( 1980) 
131 
who demonstrated a change in pulmonary function following sympathectomy. For three 
to six months after surgery, pneumo-constriction and a small increase in airway 
resistance was demonstrated; subsequently the pulmonary function normalized. Adar et 
al. ( I 977) also reported in his series of I 00 patients the re-exacerbation of childhood 
bronchial asthma (in 2 patients) and the cessation of asthma attacks (in I patient). The 
basis for the improvement of asthma following sympathectomy is not known. 
Most of the hyperhidrosis series deal with the adult population; in this series the mean 
age at surgery was I 9.2 years (range 13-52 years), although most had been affected 
since early childhood. Similarly in Sternberg's series (1982) the mean age operated 
upon was 22,5 years; IO to I 5 years of conservative treatment elapsed before surgery 
was performed. Shih and Wang (1978) in his series of 457 patients reported that 9 I% 
had symptoms dating from childhood but surgery was only performed between the age 
21 to 25 years. The situation is similar in many other series (Gruszkiewicz et al., I 986; 
Adar et al., 1977; Gjerris and Olsen, I 975; Gothberg et al., 1994 ). Apprehension to 
outcome to open sympathectomy and the belief in conservative therapy by the attendant 
physician are the reasons for the belated referral of children for sympathectomy. 
However, there have been reports of successful sympathectomy in children. Rode et al. 
(1986) reported a good outcome in his series of 14 transaxillary sympathectomies 
undertaken in children with an average age of 9 years. O'Donoghue et al. ( 1980) 
reported on 4 children (aged between 6-13 years, symptoms commencing at 2 years) 
subjected to supraclavicular sympathectomy; outcome was good, although one child 
developed a transient Homer's syndrome . Mares et al. (I 994) in his series of 67 
patients (mean age 14 years, range 5 .5 to 17 years), reported that there was a 
successful outcome to transaxillary sympathectomy in all but 2 patients. In the light of 
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the reported successful outcome to open sympathectomy in children, should 
thoracoscopic sympathectomy be offered more widely in this population group? The 
effects on pulmonary physiology following insufllation during thoracoscopy in children 
are not fully appreciated. Furthermore, crucial in the selection of patients is the degree 
of debility and the extent of the hyperhidrosis i.e. regional versus generalized. It is a 
moot point whether a child less than 14 years could be capable of quantifying these 
issues. An unanswered question is whether hyperhidrosis spontaneously regresses; if 
this happens, sympathectomy in a sub-set of patients may be an unnecessary procedure. 
For these reasons it is suggested that sympathectomy be deferred until adolescence 
when the scholastic and social restraints posed by hyperhidrosis become quantifiable. 
The development of cardiac arrhythmias during thoracoscopic sympathectomy is an 
uncommon, potentially lethal side-effect rarely described. Lin et al. (1994) who 
undertook thoracoscopic sympathectomy from the left side initially, reported 2 cases of 
cardiac arrest preceded by arrhythmias. In this series, 2 patients who developed severe 
bradycardia had the sympathectomy initially undertaken on the left side, contrary to our 
standard practice; both patients reverted to sinus rhythm spontaneously on stopping 
further manipulation of the sympathetic chain. The mechanisms responsible for 
arrhythmias during sympathectomy are not known. This effect was not reported during 
the era of open sympathectomy when cautery was rarely applied on the sympathetic 
chain. The minimal amount of current necessary for inducing ventricular fibrillation is 
lower for the left stellate ganglion than for the right stellate ganglion. Thus, less 
stimulation to the left stellate ganglion is needed to produce an arrhythmia compared to 
the right stellate ganglion (Armour et al., 1972; Hagemann et al., 1973, Schwartz, 
1973). The left sympathetic chain and vagus nerve innervate the atrio-ventricular node; 
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the right sympathetic chain and vagus nerve innervate the sino-atrial node, the principal 
pacemaker. When the sympathectomy commences on the right side, the sino-atrial node 
is able to adapt to the changes prompted by the sympathetic manipulation (and 
accommodates further manipulations on the left sympathetic chain). By contrast, when 
the left sympathetic chain is manipulated initially, the atrio-ventricular node is unable 
to handle manipulations and traction on the sympathetic chain and becomes out of sync 
with the sino-atrial node, leading to arrhythmias. In addition to starting on the right side 
there should be minimal manipulation and traction on the sympathetic chain; on freeing 
the overlying pleura, the sympathetic should be transected initially between the TI-T2 
ganglion before proceeding to further manipulations. 
Haemothorax developed in one patient; this patient had pleural adhesions, the freeing of 
which was thought to cause the haemothorax. Bleeding at thoracoscopic 
sympathectomy is usually minor, self limiting and usually follows injury to the 
intercostal veins; the superior intercostal vein may be located anterior or posterior to the 
sympathetic chain (on the right side) may be a source of troublesome bleeding. If the 
dissection is adjacent to and confined to the sympathetic chain, injury to the underlying 
intercostal artery could be avoided. 
Pneumothorax following thoracoscopic sympathectomy is usually the result of the 
failure to fully evacuate the pleural space by suction and application of positive end 
expiratory pressure; the herniation of lung up to the intercostal muscles following the 
latter maneuver should always be sought out for. Lung injury (at the time of Veress 
needle or trocar placement) is uncommon and is reflected by the rapidity of the 
resolution of the pneumothorax (within 12 to 24 hours in this series). The need to 
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routinely undertake a post-operative chest radiograph is a moot point; a residual 
pneumothorax probably exists in large proportion of patients but is not clinically 
significant. 
In the minimal access era, sympathectomy for hyperhidrosis has been consistently 
described as a relatively minor procedure well received by patients and associated with 
excellent results and few complications. The Achilles heel of this procedure remains 
compensatory hyperhidrosis. It is this effect that courts objection to surgical 
intervention for what is a benign functional disorder. Indiscriminate surgery for all 
patients presenting with hyperhidrosis should be discouraged. Careful patient selection 
is crucial with patients being fully informed of the spectrum of possible side effects. 
5.1.2 CHRONIC REGIONAL PAIN SYNDROME 
Even though various theories have been proposed (Doupe et al., 1944; Livingstone, 
1943; Melzack and Wall, 1968) for the pathophysiology of CRPS, this condition 
remains poorly understood; it is hardly surprising that there is not a uniform approach to 
therapy. Functional restoration of the affected limb can only be established by relief of 
pain. This encourages movement, prevents contractures, maintains limb function, 
reduces vascular stasis and prevents osteoporosis. The analgesic modalities available 
include pharmacological agents, regional anaesthesia or neuromodulation (Raj and 
Wilder, 1995). The sequence of application of these modalities varies from center to 
center, depending on the personal experience and the expertise of the attendant 
physician. The preferred therapy has little scientific basis (Ochoa, 1995). There is, 
however, unanimity that CRPS may progress from an acute, to a dystrophic and then to 
an atrophic stage (Drucker et al., 1959). Each clinical stage may last from several weeks 
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to months. The acute phase may be considered as being reversible and resolution is 
possible with medical therapy. A good result may also be anticipated when the analgesia 
provided by regional sympathetic or stellate ganglion blockade extends beyond the 
duration of the block itself. Whilst SGB might prove useful as a therapeutic modality, it 
was shown to be a poor predictor of outcome to surgical sympathectomy in this series. 
The dystrophic phase usually has a poor response to stellate or regional blockade. 
Spontaneous resolution is uncommon. The atrophic stage represents the final and 
unforgiving phase of CRPS that is usually unresponsive to therapy (Mockus et al., 
1987). This temporal progression of CRPS may have therapeutic implications. In 
choosing the appropriate therapeutic algorithm it is imperative that it is time contingent. 
Early recognition during the acute phase stage is crucial as it may readily afford a 
favourable outcome following either drug therapy or sympathectomy. The mainstay of 
an early diagnosis is clinical awareness. Laboratory, radiological, histological and 
neurophysiological studies have little value in this regard (Schott, 1995). The failure to 
promptly recognise and appropriately treat CRPS may result in a complicated clinical 
course with irreversible changes, as well as a missed opportunity for relief by 
sympatholytics or sympathectomy. 
The range of pharmocotherapeutic options advocated includes non-steroidal anti-
inflammatory agents, corticosteroids, biphosphonates, calcitonin, anti-depressants, anti-
convulsants, opioids and, sympatholytic drugs (Raj and Wilder, 1995). Amongst the 
latter are oral agents (phenoxybenzamine) and transdermal agents (clonidine) (Byas­
Smith et al., 1995). These agents are prescribed in combination and may have 
disconcerting side effects and underscore the failure of a suitable pharmacological 
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option. In concert with medical treatment, physiotherapy and occupational therapy are 
crucial in expediting functional restoration. Given the complexity of the condition and 
its management, it is advisable that a multidisciplinary team affiliated to a pain clinic 
manages these patients. This affords access to pharmacologists, anaesthetists, 
physiotherapists, physicians and surgeons, each of whom may have a role to play. 
Compensation neurosis is an under-appreciated factor in these patients; the role of a 
psychologist, occupational therapist and a welfare agency early in the management may 
be of salutary benefit (Raj and Wilder, 1995; Raj et al., 1990). 
SGB is undertaken in our practice when, at the end of 6 weeks, medical treatment 
proves to be ineffectual. SGB may be both diagnostic and therapeutic. It has been 
suggested that if performed accurately, sympathetic blockade may define the so-called 
Sympathetic Mediated Pain (SMP), thereby justifying the role of sympathectomy. 
Furthermore, if undertaken in the early or acute phase, the procedure may prove to be 
therapeutic in itself (Mokus et al., 1987; Abu Rahma et al., 1994). However, the 
drawbacks to SGB are manifold; the procedure is operator dependant and its universal 
accuracy unknown. Furthermore, the stellate ganglion is distant from the 2nd thoracic 
ganglion that is now considered pivotal in effecting upper limb sympathetic 
denervation. Also, alternate neural pathways to the brachia! plexus bypass the stellate 
ganglion and may not be blocked by a standard SGB. Thus, SBG may under-estimate 
the true incidence of SMP and thereby deny patients a potentially beneficial outcome 
from sympathectomy. In the present series, a beneficial outcome was noted in 20 of25 
patients identified by sympathetic blockade as having sympathetic mediated pain and in 
15 of 17 patients with a poor response. Thus, contrary to the experience of others 
(Mockus et al., 1987; Abu Rahma et al., 1994) the response to sympathectomy did not 
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correlate with the response to SGB. Open sympathectomy was required in 2 of 24 
patients (8.4%) in group I patients and was required in IO of 18 patients (55.5%) in 
group 2 patients. Since there was no antecedent history of pulmonary infection or chest 
trauma, these adhesions and pleural thickening obscuring the sympathetic chain were 
considered to be a consequence of SGB. 
Three months from the onset of symptoms was the arbitrary period chosen to 
distinguish early from late onset CRPS as by that stage standard therapy becomes 
largely ineffectual. Clinical assessment of response to therapy by a consistent medical 
team is important. Persistence of a conservative approach does not guarantee 
spontaneous resolution of symptoms and this has to be balanced against the prospect of 
progress to the dystrophic stage that is disastrous for most patients, particularly manual 
labourers. 
Spurling ( 1930) originally described sympathectomy as an effective treatment for CRPS 
when he successfully treated a patient (then described as having causalgia) by 
performing a stellate ganglionectomy. Since then, the value of sympathectomy, 
particularly when undertaken timeously, has been endorsed by others (Mockus et al., 
1987; Abu Rahma et al., 1994; Thompson, 1979). However the role of sympathectomy 
has been a controversial issue (Ochoa, 1995; Schott, 1995; Schott, 1998). Our study 
demonstrates that all patients referred timeously (within 3 months) for sympathectomy, 
have an excellent or good result. When sympathectomy is undertaken beyond this stage, 
a favourable outcome is not guaranteed and only 8 of 18 patients ( 44.4%) had a good or 
excellent outcome. Overall, sympathectomy was noted to have a good or excellent 
outcome in 32 (76.2%) of our patients. The results in this series and the range of 
available therapies suggest that a placebo-controlled trial may not be feasible or indeed 
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ethical. The role of sympathectomy in current practice is enhanced by the ease and 
safety of the thoracoscopic approach (Byrne et al., 1990; Hsu et al., 1994; Singh et al., 
1996). 
In this study, thoracoscopic sympathectomy has been shown to be a safe option with a 
better outcome than in those patients undergoing open surgery. Results in the latter 
category of patients were adversely influenced by the longer duration of symptoms. The 
greater number of SGB undertaken in this group may have contributed to apical 
thickening and adhesions that precluded thoracoscopic sympathectomy and thereby the 
benefit of a minimally invasive procedure. Early clinical recognition without persistent 
SGB affords the opportunity of successfully accomplishing thoracoscopic 
sympathectomy, an option that may be invaluable in the management of CRPS. 
An understanding to the mechanisms of the sympathetic pathway is useful to the 
understanding of the anatomical basis that makes sympathectomy effective, particularly 
for the treatment of CRPS. Figure 15 (Pick, 1970) is the standard depiction of 
autonomic reflex pathway. [n general the autonomic nervous system does not include 
nerve components which conduct impulses into the central nervous system. The 
afferent neurons which conduct impulses from visceral organs to the spinal cord and the 
brain stem are visceral afferent components of the spinal and cranial nerves. The cell 
bodies of these neurones , like those of the somatic afferent neurones, are located in the 
ganglia associated with the sensory roots of the respective nerves. 
Both visceral and somatic afferent nerve fibers make reflex connections with pre­
ganglionic neurons in the spinal cord and the brain stem. They are, therefore, 
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functionally related to the autonomic nerves , but are not anatomic components of them. 
The simplest autonomic reflex arc consists of an afferent conductor (either visceral or 
somatic), a connecting mechanism located to the central nervous system and an efferent 
conducting chain made up of a pre-ganglionic and a ganglionic neuron. It is the 
interruption of the reflex arc at the ganglionic level that makes sympathectomy an 
effective option for conditions such as CRPS. The interruption of the reflex arc along 
the afferent pathway is impractical; in contrast, a ganglionectomy has no deleterious 
effect on somatic nervous function. Figure 16 provides the anatomical rationale for a 
ganglionectomy However, this arrangement has not been scientifically verified. The 
histological demonstration of sympathetic collateral nerve sproutings in the dorsal root 
ganglion and the presence of inflammatory cells in the sympathetic ganglia excised 
from patients with CRPS, suggests that the afferent pathway may extend, in the first 
instance, to the nearest ganglion i.e. sympathetic ganglion. The ulnar and median nerves 
are the principal source of sympathetic neurones among the peripheral nerves. The 
pathway is then to the dorsal root ganglion. Interruption of the pathway at the level of 
the 2nd thoracic ganglion therefore provides an afferent and efferent blockade. 
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The effectiveness of the 2
nd 
thoracic ganglionectomy implies that the upper limb
sympathetic outflow is via this ganglion. The middle and stellate ( inferior cervical and 
l st thoracic ganglion ) do not have pre-ganglionic contributions; thus, the persistence of 
middle cervical and stellate ganglionic function following 2
nd 
thoracic ganglionectomy
suggests that the pre-ganglionic contributions to the 2
nd 
thoracic ganglion (the highest 
level of pre-ganglionic spinal outflow) must ascend to the middle and stellate ganglia. 
This would explain the avoidance of a Homer's Syndrome. It also underscores the 
anatomical significance of the 2nd thoracic ganglion for upper limb sympathetic supply.
An extrapolation of this view is that the spinal sympathetic segments are not 
synonymous with ganglionic levels - the highest spinal segment (Tl) issuing pre­




5.1.3 RA YNAUD'S DISEASE 
The low incidence of sympathectomy undertaken in this series for vascular disease is 
representative of current surgical opinion. This follows the unpredictable and invariably 
disappointing outcome following open sympathectomy (Bimstingl, 1967; Landry et al., 
1996); the ease and safety of thoracoscopic sympathectomy may prompt a re-think on 
this issue (Baker et al., 1994 ; Milewski et al., 1985.). Presently the guidelines are 
unclear since the value of thoracoscopic sympathectomy has largely come in the form of 
case reports and uncontrolled studies (Claes et al., 1994 ; Baker et al., 1994 ). 
Furthermore, channel blocking agents may be of value in some patients with 
Raynaud's disease, a condition which has shown the tendency to resolve spontaneously 
on occasions (Gordan et al., 1994 ). 
Raynaud's disease infrequently gives rise to serious complications. Although patients 
may symptomatically improve in the short term there is a tendency for the condition to 
recur in the long-term (Montorsi et al., 1980 ; Johnstone et al., 1965). Gifford et al., 
( 1958) concluded that no definite advantage could be attributed to sympathectomy over 
medical treatment. Providing that sympathectomy can be undertaken with minimal 
morbidity and mortality it is a reasonable treatment option for the severe manifestations 
of the condition such as digital gangrene as demonstrated in the five patients treated in 
this study. A relative indication is the persistence of symptoms notwithstanding optimal 
medical treatment. 
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5.1.4 PERIPHERAL VASCULAR DISEASE 
In a small number of patients with severe upper limb ischaemia reconstructive vascular 
surgery will not be feasible. In this category of vascular patients the ease and safety of 
thorascopic sympathectomy may be a reasonable option to improve rest pain and defer 
or even avoid amputation. The role of sympathectomy in these patients is largely based 
on the management of lower limb non-reconstructible vascular disease ; the role of 
sympathectomy for upper limb vascular disease is therefore extrapolated from that 
experience. In general, the outcome to sympathectomy is difficult to interpret because of 
poor patient selection and definition and the absence of prospective, randomized 
evaluation. Furthermore, as in this experience, the long term outcome is not stated. 
Thus, Repelaar van Oriel ( 1988) reported that at 6 months 14% of patients with rest pain 
and 45% with gangrene required major amputation. Gordan et al. (1994) and Barnes 
( 1994) suggested that there was circumstantial evidence that sympathectomy may be 
effective in those patient with rest pain who stop smoking. Johnson ( 1998), in reviewing 
the outcome to lumbar sympathectomy in 29 patients with focal necrosis with a long 
term follow-up in l O patients, suggested this approach may be useful in a sub-set of 
patients (ABI > 0.03, with transcutaneous oxygen tensions less than 30mmHg that 
increase more than 20mmHg with limb dependency). 
Notwithstanding the absence of controlled, randomized trials to validate its role and in 
the absence of alternative therapy, thoracoscopic sympathetectomy may have an 
increasingly important role to play in the management of this difficult and uncommon 
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problem; in this review was shown to be useful (in the short-term) in two of the three 
patients in whom it was undertaken. 
5.2 ISSUES IN TECHNIQUE 
5.2.1 OPEN VERSUS THORACOSCOPIC SYMPATHECTOMY 
The thoracoscopic approach has been convincingly shown to be superior to the standard 
supraclavicular approach in terms of technical requirements and cost saving to the 
patient. Although patient evaluation of these procedures was not undertaken it is 
apparent from the opioid usage, hospital stay and the cost benefit that the thoracoscopic 
approach will be considered to be superior. The prospect of tiny scars compared to the 
much larger supraclavicular scars of the open procedure will undoubtedly also make the 
thoracoscopic approach more favourable. Given the longstanding satisfactory 
experience with thoracoscopic sympathectomy for palmar hyperhidrosis, it would be 
difficult to undertake a prospective randomized study comparing this approach with the 
open approach. This study was prompted by the comparative study of the short term 
results of open supraclavicular sympathectomy and thoracoscopic sympathectomy of 
the 2nd to 4th thoracic ganglia in two randomly selected groups of 12 patients with 
palmar hyperhidrosis reported by Hashmonai et al., (1994); in this study though dry 
hands were achieved in all patients, patients in the thoracscopic group had a longer 
anaesthetic time and were less satisfied one week after surgery. Hashmonai ( 1994) 
concluded that the supraclavicular sympathectomy did not take longer, was no more 
difficult than thoracoscopic sympathectomy and might be associated with less morbidity 
and greater subject satisfaction. These results, reported in 1994, were probably 
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reflective of the early experience with thoracoscopic sympathectomy. In 1996, the same 
group reported 106 thoracoscopic sympathectomies in 53 patients with palmar 
hyperhidrosis; all limbs were dry at the end of the procedure and at a mean follow-up 
of 19.5 months 88.5% of the patients had expressed subjective satisfaction prompting 
the authors to conclude that thoracoscopic sympathectomy was preferred to open 
sympathectomy in the management of palmar hyperhidrosis (Kopelman et al., 1996). 
Support for the thoracoscopic approach (over the open trans-axillary approach) has also 
been provided by Yilmaz et al. (1996). While both procedures were equally effective, 
there was less post-operative pain, shorter hospital stay and more rapid recovery 
following thoracoscopic sympathectomy. 
The longer operating time for supraclavicular open sympathectomy in this study (mean: 
92 minutes; range : 42-130 minutes) is reflective of the technical challenge sometimes 
presented by this approach. f n our practice, the open technique is undertaken by an 
experienced surgeon, assisted by a surgeon of comparable experience. By contrast, 
thoracoscopic sympathectomy may be undertaken safely and quickly (in our experience 
mean operating time : 19 minutes; range : I 1-30 minutes) by surgeons equipped with 
basic minimal access surgical skills. Our experience suggests that the technique may be 
undertaken without an assistant surgeon. The solitary surgeon undertakes the 
procedures using a two-handed technique (one hand camera, one hand for surgery). The 
latter approach has a cost saving implication. 
Whilst no surgical procedure is free from complications, the relative ease ofundertaking 
sympathectomy safely via the thoracoscopic route firmly establishes this as the 
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approach of choice for upper limb sympathectomy. Basic minimal access techniques 
and a sound appreciation of the thoracoscopic anatomy of the sympathetic chain are 
necessary caveats. 
5.2.2 ANAESTHETIC CONSIDERATIONS : SINGLE LUMEN ENDO-
TRACHEAL INTUBATION VERSUS DOUBLE LUMEN 
ENDOBRONCHIAL INTUBATION FOR THORACOSCOPIC 
SYMPATHECTOMY 
Most published articles stress the importance of lung isolation with a double-lumen 
endobronchial tube (DLEBT), paralysis and controlled one lung ventilation for 
thoracoscopic sympathectomy (Banker et al., 1993; Miller et al., 1992). 
The value of single-lumen endotracheal (SLET) intubation for thoracoscopic 
sympathectomy has been demonstrated by Lee ( 1994 ). SLET was shown to be safe, 
economic and did not compromise the thoracoscopic approach (Marshall and Marshall, 
1980). Nothwithstanding these advantages, a comparison of SLET with DLEBT 
intubation anesthetic technique (with respect to effects on Sa02, hypoxis and pain) has 
not been previously undertaken. This study, in addition to confirming the study of Lee 
et al., (1994) has demonstrated that SLET is associated with less post-operative opioid 
requirement. Retro-sternal chest pain was the major reason for the administration of 
opioids and the prolongation of the hospital stay. The SLET technique was shown to be 
a simpler technique that obviated the need for the more expensive and more difficult to 
place DLEBT. Unlike the technique described by Lee (1994), following the partial 
collapse of the lung caused by disconnecting the SLET tube from the anaesthetic circuit, 
the pneumothorax is sustained by the insufflation of carbon dioxide. A pneumothorax 
no more than 5cm (from the apex of the thorax) is all that is required for the procedure. 
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A larger collapse of the lung (>70%) may cause the protective effect of hypoxic 
pulmonary vasoconstriction to be abolished; partial lung collapse to the degree 
described with or without carbon dioxide insuffiation does not decrease the hypoxic 
pulmonary vasoconstriction. Blood is therefore directed to better ventilated areas, 
thereby safely maintaining SaOi levels. Total lung collapse is likely to follow DLEBT, 
predisposing to the loss of the protective effects of hypoxic pulmonary vasoconstriction 
(Marshall and Marshall, 1980). 
When applying carbon dioxide insuffiation this should not be rapid; rapid carbon 
dioxide insufflation may lead to tension pneumothorax, displacement of the 
mediastinum and possibly haemodynamic instability. During insufflation accidental 
lung puncture (by Veress needle or trocar) may result in sudden steep increase in end 
tidal carbon dioxide concentration which is evident by a classic wave form on the 
capnograph. Irrespective of the technique used, insufflation of no more than 0.8 litres 
of carbon dioxide is usually sufficient for a safe procedure. The advantage of carbon 
dioxide insuffiation is the fairly rapid development of the pneumothorax; with the 
opening of the inserted cannula to atmospheric pressure, the lung may take up to fifteen 
minutes to collapse (Grichnik et al., 1993; Robinson et al., 1994). To sustain the partial 
lung collapse the anesthetist should ensure that positive end expiratory pressure is not 
applied because this will prevent lung deflation. Notwithstanding these concerns, the 
overall safety of SLET for a procedure that is short (<20 minutes) in patients who are 
usually young and fit, lends this procedure to be taken as a same day case. Although 
not evaluated in this study subsequent experience suggests that SLET allows for 
thoracoscopic sympathectomy to be undertaken as a same day case. 
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The feasibility of undertaking thoracoscopic syrnpathectomy using a SLET technique 
represents a transformation in anaesthetic practice. From the initial practice of DLEBT 
with carbon dioxide insuffiation (Jedeiken et al., 1992) this was modified to the use of 
DLEBT without carbon dioxide insuffiation (Robinson et al., 1994). The use of SLET 
with insuffiation represents what should be standard practice in the anaesthesia for 
thoracoscopic syrnpathectomy. The major advantages of SLET is elimination of the 
complications associated with DLEBT, notwithstanding the improved design of double 
lumen tubes. Furthermore, 38-83% of DLEBTs are found to be malpositioned when 
evaluated with fiber-optic bronchoscopy. Thus, it has been suggested that positioning 
of the double lumen tubes should always be confirmed by bronchoscopy (Hurford and 
Alfille, 1993). This may have further technical and cost implications with the possible 
prolongation of the anaesthetic time. The SLET technique does not require the use of a 
bronchoscope and the intubation is therefore quicker and simpler. The advantages of 
SLET are listed in Table 17. 
TABLE 17: ADVANTAGES OF SINGLE LUMEN INTUBATION 
I. Avoids problems ofDLEBT insertion
• Malposition
• Less traumatic to airway than DLEBT
• Expensive DLEBT avoided
2. A voids problems associated with the IPPV* of one lung ventilation
• Potential rupture of the subpleural blebs
• Potential loss of ability to ventilate with bilateral air leaks
3. Possibly better V /Q matching with spontaneous ventilation
4. Possibly less shunt to collapsed lung with spontaneous ventilation
* = Intermittent Positive Pressure Ventilation 
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The SLET technique may be unsuitable in patients who have an absolute indication for 
DLEBT, for example, when there is the potential for spillage of infected sputum or if 
conversion to an open thoracotomy is contemplated. These are however, uncommon 
clinical scenarios since patients presenting with thoracoscopic sympathectomy are 
invariably fit and usually without the history of lung disease. ln the latter situation the 
more appropriate approach would be an open sympathectomy via the supraclavicular 
approach. This study has shown that the SLET technique with insufflation is associated 
with fewer episodes of desaturation and less need for opioid analgesia compared with 
DLEBT. Furthermore, hypotensive episodes were not recorded and the surgical 
exposure not compromised by the SLET technique. 
5.2.3 LIMITED GANGLIONECTOMY : A PROSPECTIVE EVALUATION 
Primary hyperhidrosis, particularly of the palms, causes much psychosocial trauma and 
sometimes physical discomfort; on occasions this condition may compromise an 
individuals vocation. It is therefore not surprising that the palmar component of 
primary hyperhidrosis is what drives the patient to seek treatment. By contrast axillary 
hyperhidrosis, even though it occurred in just under 60% of our patients, was rarely 
troublesome to the extent that specific treatment was requested. Likewise plantar 
hyperhidrosis - evident in nearly 90% of our patients - was largely tolerable, even 
though longstanding plantar hyperhidrosis predisposes to blistering, infections, 
bromhidrosis and rotting of shoes and socks (Moran and Brady, 1991 ). 
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Surgical sympathectomy, by various approaches, has long been acknowledged as 
offering the most effective and enduring treatment of hyperhidrosis. 
Minimal Access Surgery, using the thoracoscopic approach, has gone a long way to 
diminishing the morbidity associated with open syrnpathectomy (Byrne et al., 1990; 
Kux, 1978; Singh et al., 1996; Edmonson et al., 1991 ). Notwithstanding this, there are 
two problems associated with sympathectomy undertaken for hyperhidrosis that persists 
during the thoracoscopic era. These relate to the problem of compensatory 
hyperhidrosis and the appropriate management of axillary hyperhidrosis. We suggest 
that these issues are related to the extent of the syrnpathectomy undertaken for upper 
limb hyperhidrosis. 
Compensatory hyperhidrosis is recognized as an unpredictable but potentially 
devastating effect of thoracic syrnpathectomy. The reported incidence of compensatory 
hyperhidrosis ranges from 22-81 % (O' Riordain et al., 1993; Hsu et al., 1994 ). This 
wide range probably reflects the varying extent of the sympathectomy undertaken for 
upper limb hyperhidrosis. In addition most series fail to quantify the degree or severity 
of the compensatory hyperhidrosis. 
The mechanisms responsible for compensatory hyperhidrosis are unclear. Whereas the 
original hyperhidrotic state may be induced by emotions, amongst other factors, 
compensatory hyperhidrosis tends to be largely a heat regulated phenomenon. 
Following upper limb sympathectomy nearly 40% of the total sweat gland function is 
lost; it is therefore not surprising that the residual truncal sweat glands show unusually 
increased activity, thereby producing compensatory hyperhidrosis. Thus, the greater the 
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number of sweat glands excluded from thermoregulatory control, the greater the chance 
of compensatory hyperhidrosis. However, other factors may yet be involved because 
compensatory hyperhidrosis may occur even in an air-conditioned environment (Shelley 
and Florence, 1 960; Andrews and Rennie, 1997). 
The surgical technique of clipping the sympathetic chain and removing these clips on 
the development of compensatory hyperhidrosis is an interesting option that merits 
further evaluation. The preliminary results reported by Lin (1998) suggests that this 
approach may prove to be invaluable in the management of this difficult problem. 
Notwithstanding this, reducing the extent of the sympathetic ganglionectomy has been 
associated with a lower incidence of compensatory hyperhidrosis. An incidence of 
compensatory hyperhidrosis of up to 64% has been reported when the ganglionectomy 
is extended up to the 5th or 6th thoracic ganglion. By contrast, limiting the extent of the
ganglionectomy to the 2
nd thoracic ganglion has been associated with a reduction in 
compensatory hyperhidrosis to between 22 - 24%. Hederman (1994) has reported a 
24% incidence with electrocautery of the 2nd thoracic ganglion. O'Riordain (1993) has 
reported a 22% incidence of compensatory hyperhidrosis following precise excision 
from below the stellate ganglion to above the 3rd ganglion, effectively removing the 2nd 
ganglion and the adjacent interganglionic segment. The anatomical basis for a 
successful upper limb sympathectomy with a 2nd thoracic ganglionectomy was 
described by Hyndman and Wolkin, but clearly was not widely appreciated (Hyndman 
and Wolkin, 1942). 
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In this series the overall compensatory hyperhidrosis rate is 20% (11 patients); if the 4 
patients assessed to have moderate, tolerable compensatory hyperhidrosis are excluded 
that rate of severe compensatory hyperhidrosis is 12.6% (7 patients). 
Assessment of compensatory hyperhidrosis is based on subjectivity, rather than on 
objective sweat production analysis. It is suggested that compensatory hyperhidrosis 
rates may be significantly reduced by a meticulous dissection and resection of only the 
2nd thoracic ganglion. Diathermy application on the sympathetic chain should be 
avoided as this may cause a coagulative necrosis proximal and distal to the 2nd thoracic 
ganglion, thereby effectively extending the extent of the ganglionectomy. For similar 
reasons traction should not be applied on the chain. These technical considerations are 
probably the basis for the absence of facial anhidrosis and gustatory sweating in this 
series. 
Accurate localization of the 2
nd 
thoracic ganglion is crucial and is afforded by dissection 
of the pleura off the chain and a thorough appreciation of the anatomy of the thoracic 
sympathetic chain. However, compensatory hyperhidrosis remains largely 
unpredictable; when severe this side-effect surplants the presenting palmar 
hyperhidrosis. In this series 3 of the 7 patients with severe compensatory hyperhidrosis 
regretted undergoing the procedure (even though their palms were now anhydrotic). A 
variety of non-surgical measures such as topical agents (aluminium chloride, tanning 
agents, glutaraldehyde), iontophoresis (electric coagulation of the eccrine sweat glands) 
and systemic anticholinergic agents have been used, invariably, without much success. 
For these reasons it behoves the attendant surgeon to fully counsel the patient about this 
potential side-effect (Andrews and Rennie, 1997). 
153 
Because axillary hyperhidrosis often occurs concomitantly with palmar hyperhidrosis, 
the traditional approach has been to perform an extended sympathectomy (up to the 5
th
- 6th thoracic ganglion) in an endeavour to effect axillary anhidrosis. The anatomical
basis for this approach is unclear. The potentially devastating effects of an extended 
sympathectomy have been mentioned; furthermore it has been reported that extensive 
ganglionectomy does not guarantee a successful outcome for axillary hyperhidrosis 
(Bretteville, 1973). Clearly a balanced approach is necessary. We suggest that 
extensive sympathectomy should not be undertaken for concomitant axillary 
hyperhidrosis, particularly as axillary hyperhidrosis is rarely a presenting factor. 
Rather, we recommend a limited 2nd thoracic ganglionectomy be offered. This was 
associated with an 80% success rate for axillary hyperhidrosis and a disabling 
compensatory hyperhidrosis rate of 12.6% in our series. In those patients troubled with 
persistent axillary hyperhidrosis excision of the axillary sweat glands is probably the 
best option. To date none of our patients have qualified for this procedure which entails 
excision of an ellipse of skin with careful undermining above and below to remove the 
deeper layer containing the sweat glands. Siting of the incision is important to avoid an 
unsatisfactory scar that may restrict arm movement following excision (Hurley and 
Shelley, 1966). 
Plantar hyperhidrosis occurred in 49 patients (89%) but was never a prime complaint; 
the anatomical basis for the successful treatment of plantar hyperhidrosis by 2
nd 
thoracic
ganglionic (in over 80% of the patients) is unclear. The successful treatment of plantar 
hyperhidrosis following thoracic ganglionectomy should be regarded as a bonus and, as 
such, should not be guaranteed to the patient. 
154 
Our experience with this procedure suggests that for primary hyperhidrosis 
thoracoscopic sympathectomy maybe performed on a day care basis and that a limited 
2
nd 
thoracic ganglionectomy is adequate to treat palmar hyperhidrosis. Furthermore, 
this approach may cure axillary hyperhidrosis and more importantly, decrease the 
incidence of debilitating compensatory hyperhidrosis. 
5.2.4 OUTCOME OF THORACOSCOPY FOR PALMAR HYPERHIDROSIS: 
MECHANISMS FOR FAILURE 
The persistence and recurrence of the sympathetic function following a seemingly 
successful sympathectomy are often reflective of surgical and anatomical 
misinterpretation of the sympathetic chain, as well as the ability of the sympathetic 
chain to regenerate. By contrast, rSA or pSA following successful sympathectomy for 
vasculopathies, particularly Raynaud's phenomenon, is reflective of the unpredictable 
responses of these conditions to surgery rather than to the factors cited (Haxton, 1947). 
The role of alternate neural pathways [ANPs], specifically the nerve of Kuntz, an 
inconstant and variable intrathoracic ramus between the 2 nd thoracic intercostal nerve 
and the T l  root was long considered an important cause of sympathetic reactivity. This 
was especially emphasized during the era when stellate ganglionectomy was the 
standard surgical procedure for upper limb sympathectomy (Figure 6). In current 
surgical practice, wherein the 2nd thoracic ganglionectomy is standard practice, the 
significance of ANPs is dubious. The 2
nd 
thoracic ganglionectomy effectively interrupts 
the sympathetic outflow to the upper limb proximal to these ANPs thereby eliminating 




Figure 17: T2 ganglionectomy interrupts sympathetic outflow to the brachia! 
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For most surgeons thoracoscopic sympathectomy is a novel approach. It compels us to 
consider the probability of misinterpretation of the anatomy as an important cause of 
persistent sympathetic function. Furthermore, the teaching of the surgical anatomy of 
the sympathetic chain and its variations is under-emphasized during standard surgical 
training. In 3 patients with pSA, it was apparent that the location of the sympathetic 
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chain was not appreciated at the primary procedure; it is conceivable that this also 
occurred in the 4
th 
patient. Fibrosis consequent to this intervention precluded a safe re­





nerves with their spinal ganglia and surrounding tissue has been suggested as a useful 
option to be undertaken at open surgery (van Rhede van der Kloot and Jorning, 1990). 
The authors are not comfortable with undertaking this option thoracoscopically. 
Plate 29 demonstrates the potential of the fascia overlying the tendon of longus colli 
muscle (TLC) being misinterpreted as the sympathetic chain. The TLC lies medial to 
the sympathetic chain and is a much broader structure. However, with inappropriate 







Superior intercostal artery 
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2nd intercostal nerve 
Plate 29 : Thoracoscopic view of right proximal sympathetic chain; note TLC 
mimicking the sympathetic chain 
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Sympathetic regeneration accounting for rSA has long been a controversial issue; whilst 
some authors found no evidence of regeneration at re-operation, others (Telford, 1935; 
Jepson, 1951) attributed this phenomenon to rSA (Mattasi et al., 1981; Haxton 1970). 
However, reports incriminating nerve regeneration have often not been accompanied by 
the histological evidence of nerve regeneration. 
Regenerating nerve fibers establish contact between the divided ends by thin strands 
that may grow to the caliber of the sympathetic chain. Regeneration is only effective 
when the connecting neural fibers are correctly aligned. Return of sympathetic activity 
depends on the extent of the regenerating process and the proportion of sympathetic 
fibers successfully re-establishing a functional pathway. Conceivably, a greater number 
of sympathetic re-connections do occur but, because of inappropriate functional 
connections, returned sympathetic activity is subclinical. The rarity of this phenomenon 
underscores the difficulty of re-establishing functional sympathetic re-connections 
(Singh et al., 1998). 
Nerve regeneration may be suspected clinically by the gradual return, over months to 
years, of sympathetic activity to assume the pre-sympathectomy state. This is in contrast 
to the presence of intact ANPs wherein the surgery does not affect sympathetic activity 
(Singh et al., 200 I). 
Failure of effective sympathectomy is uncommon and rSA is even rarer. From the afore­
mentioned findings, it is apparent that pSA is invariably a technical misadventure. 
Circumvention of this pitfall necessitates appreciation of the surgical anatomy of the 2
nd 
thoracic ganglion which is located in the 2
nd 
intercostal space somewhat distal to the 
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corresponding intercostal nerve and adjacent to the superior border of the 3
rd 
rib. 
However, this ganglion has been reported to be located anterior to the 3
rd 
rib in 15% of 
cases (Chiou and Liao, 1996). It is incumbent upon the surgeon to be familiar with the 
landmarks that assist with its identification. The 2
nd 
intercostal nerve, located medial to 
the 2
nd 
rib's posterior angle, is an under-appreciated landmark that directs to the T2 
ganglion. Similarly, the superior intercostal artery (a branch of the costocervical trunk 
of the subclavian artery), runs an infero-Iateral course parallel to the sympathetic chain 
at an average distance of IO mm from the sympathetic chain. This artery ends as the 2nd 
intercostal artery and has been suggested to be a useful landmark (Chiou and Liao, 
1996). 
Electrophysiological stimulation to confirm the location (and appropriate ganglion 
level) of the sympathetic chain has been suggested; this expensive, time-consuming and 
complicated manoeuvre has, unsurprisingly, not gained wide acceptance in surgical 
practice (Lindquist et al., 1989). 
The results presented in this study accurately reflect the outcome to sympathectomy I 
week following the operation; at that visit instances of early failure would have been 
evident. Less clear is the true incidence of late recurrence since the long-term outcome 
could not be evaluated in all patients. Given the potential of the sympathetic chain to 
regenerate, it is a moot point whether the described case in this series is truly reflective 
of the phenomenon. 
Today, the great numbers of thoracoscopic sympathectomies undertaken have re­
defined the role of ANPs. Our experience has also demonstrated the need to be 
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appreciative of the anatomy of the sympathetic chain. Furthermore, instances of rSA 
and pSA may be safely and readily treated by the thoracoscopic route (Singh et al., 
1996). 
5.3 ANATOMICAL CONSIDERATIONS 
5.3.1 ALTERNATE NEURAL PATHWAYS 
The incidence and array of alternate neural pathways associated with the 200 thoracic 
ganglion should alert the surgeon to the clinical significance of these. Historically, 
alternate neural pathways were considered responsible for an unsuccessful 
sympathectomy. Since Kuntz's original description (Kuntz, 1927), the role of alternate 
pathways has cast a questioning shadow on the technique of sympathectomy. However, 
in current practice employing an isolated 2
00 
thoracic ganglionectomy, this is not the 
case. An isolated 2nd thoracic ganglionectomy- without addressing alternate neural 
pathways- has an almost I 00% successful outcome in effecting upper limb 
sympathectomy. What are the reasons for this? 
i. When stellate ganglionectomy was the standard practice, sympathetic outflow
&om the 2
00 
thoracic ganglion was unaffected; thus fibres issuing &om the 2
nd
thoracic ganglion- including the alternate neural pathways- may potentially
afford an alternate pathway via the T2 ganglion and the alternate neural pathway
to the Tl root (Figure 6).
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thoracic ganglionectomy to, as in current practice, a
limited T2 ganglionectomy, the clinical significance of alternate neural pathways
gradually dissipated. This would suggest, from extrapolation of clinical
outcome, that the T2 ganglion is pivotal to upper limb sympathetic innervation.
T2 ganglionectomy effects sympathetic denervation at level before the alternate
neural pathways become clinically relevant (Figure 17).
111. Is it conceivable that during the performance of a T2 ganglionectomy, alternate
neural pathways are inadvertently removed? ln the technique of T2
ganglionectomy described, the surgical dissection is confined to the T2 ganglion,
the interganglionic segment and the T2 rami communicantes. Notwithstanding
this precise technique-aided by ample illumination and magnification- it is
conceivable that alternate neural pathways may be avulsed during this
procedure.
In the cadaveric dissections undertaken, the alternate neural pathways, when 
encountered, were noted to be located at a mean distance of 7.66 (range 2.3-30.0) mm 
lateral to the sympathetic chain along the inferior border of the 2nd rib. Given the 7-fold 
optical magnification afforded by thoracoscopy, it is surprising that alternate neural 
pathways are not readily encountered when the dissection is confined to the T2 
ganglion. It is a moot point whether these alternate neural pathways are located far 
laterally, out of the magnified operating field. However, when looked for, alternate 
neural pathways will be noted (Plate 30). 
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Plate 30 : Left thoracoscopic sympathectomy : transpleural view of alternate neural pathway 







If alternate neural pathways need to be defined, our technique is to commence 
dissection medial to the sympathetic chain in the region of the 2nd intercostal space 
(rather than over the 2nd rib) (Plate 24). 
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Plate 31: Left thoracoscopic sympathectomy: alternate neural pathway (Nerve of 




What is the significance of alternate neural pathways in current surgical practice? Our 
current understanding suggests that the superior spinal outflow (by white rami 
communicantes) is to the stellate ganglion. The persistence of the middle and superior 
cervical ganglion function (given that there is no white rami to these) suggests that the 
white rami to the stellate ganglion must ascend to the middle and superior cervical 
ganglia. The avoidance of a Homer's effect and a facial anhidrosis by undertaking a T2 
ganglionectomy further emphasizes the role of the T2 ganglion (and its white ramus) in 
effecting upper limb sympathetic function. Extirpation of the T2 ganglion would 
interrupt the sympathetic outflow proximal to the stellate ganglion and the brachia) 
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plexus; outflow to the T2 root would also be interrupted as would the alternate neural 
pathways that issue from it. 
Thus, whilst the alternate neural pathways have long held interest as an important cause 
of an unsuccessful sympathectomy, in the context of the current practice of a 2
nd 
thoracic ganglionectomy they hold no surgical significance. Certainly, as demonstrated 
during the era of stellate ganglionectomy, these alternate neural pathways were 
significant. Following stellate ganglionectomy, they afforded a pathway from the intact 
2nd thoracic ganglion to the T2 root and, when present, via alternate neural pathways to 
the Tl  root (and thereby to the brachia) plexus). 
In the era of 2
nd 
thoracic ganglionectomy, it is not surprising that surgeons rarely 
appreciate alternate neural pathways. It has been noted that these are rarely encountered 
when the sympathetic chain is dissected thoracoscopically and that the clinical outcome 
(following 2nd thoracic ganglionectomy) is excellent. Furthermore, many surgeons 
prefer to cauterize the sympathetic chain, thereby having an even smaller opportunity to 
visualize alternate neural pathways. 
Further definitions of the sympathetic chain and its variations add to the body 
knowledge of the sympathetic nervous system. The anatomy of the sympathetic 
nervous system has long been unchallenged. Anatomical detail in many current texts 
have been largely unchallenged and unchanged over the past century. With the 
increasing numbers of sympathectomies been undertaken- largely afforded by its ease 
when undertaken by the minimally invasive route- a wider clinical appreciation of this 
operation may further evolve. Thus, a greater understanding of the anatomical vagaries 
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will prove invaluable in further refining established surgical techniques and approaches. 
A case in point is the role of the Stellate Ganglion Block (SGB) in predicting the 
response to sympathectomy in patients with CRPS involving the upper limb. The 
development of a Homer's Syndrome following SGB has long been considered to also 
reflect a sympathetic blockade of the ipsilateral upper limb; improvement of the CRPS 
following SGB, in current practice; suggests that the pain is "sympathetic maintained" 
qualifying the patient for a sympathectomy. In the light of our present understanding of 
sympathetic pathways to the upper limb, correlated by clinical experience with a 2nd 
thoracic ganglionectomy, it is apparent that SGB may not consistently provide an upper 
limb sympathetic blockade. To effect an accurate sympathetic blockade of the upper 
limb, it is necessary to block the tid thoracic ganglion. Thus a SGB, in patients with 
CRPS, may not truly reflect those patients who would benefit from a sympathectomy. It 
is conceivable, however, that injectate may infiltrate down (from the region of the SGB) 
to the 2nd thoracic ganglion, thereby accounting for a proportion of patients who wou Id 
qualify for sympathectomy. It is therefore appropriate to challenge the technique and 
status of the SGB vis-a-vis its role in the management of CRPS given the anatomical 
considerations outlined. 
Notwithstanding the peripheral role of alternate neural pathways in upper limb 
sympathectomy, the original descriptions of these by Albert Kuntz (in 1927) will long 
continue to engender anatomical interest. The spectrum of alternate neural pathways 
following Kuntz's description of an intrathoracic ramus between the Tl  and T2 root has 
been demonstrated in this study. This corroborates the study by Jit and Mukerjee 
( 1960). Whilst the so-called nerve of Kuntz may be evident as an isolated entity, it may 




thoracic ganglion and to the interganglionic segment) and laterally (to the Tl 
intercostal nerve or the lateral cutaneous nerve of the axilla). This array in distribution 
has prompted a categorization of these alternate neural pathways (to Types A, Band C). 
Type B was noted to be more prevalent (incidence of 51.4%). Whilst Type C was least 
prevalent, it is possibly the most interesting. The communications to the lateral nerve of 
the axilla have not been previously described. This communication may be of clinical 
significance in primary hyperhidrosis accounting, when present, for axillary 
hyperhidrosis. ln a cohort of 55 patients with palmar hyperhidrosis, associated axillary 
hyperhidrosis was noted in 32 patients (58%). Following a T2 ganglionectomy 29 
patients (90%) had a satisfactory (n=3, 9.3%) or excellent (n=26, 81%)outcome. The 
basis for the beneficial effect on axillary hyperhidrosis following sympathectomy for 
palmar hyperhidrosis has long been unclear; in the light of the demonstration of an 
alternate pathway to the lateral cutaneous nerve of the axilla (Type C), this effect may 
be attributed to an unappreciated anatomical factor. 
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5.3.2 STELLA TE GANGLION BLOCK : AN ANA TOMI CAL RE-APPRAISAL 
The anatomical basis for a sympathetic blockade of the upper limb has been an under­
appreciated issue relative to the importance of the block in the management of CRPS. 
Universally, the anterior paratracheal approach is probably the most popular technique. 
Palpation of Chassiagnac's tubercle (at the level of the 6th cervical transverse process 
and cricoid cartilage) is pivotal; however, the site of anaesthetic injection varies 
according to the practice with some injecting at the level of the 6th cervical vertebra and 
others at the 7th cervical vertebra. The effects of injecting at these sites has been 
mentioned (Guntamukkala and Hardy, 1991; Hogan et al., 1992). Further studies by 
Malmqvist et al., (1992) have been shown that blockade at the level of the 6th cervical 
vertebra produced more successful sympathetic blockade to the head and neck rather 
than to the upper extremities. Sympathetic blockade at the level of the 7th cervical 
vertebra, in contrast, produces successful sympathetic blockade of the upper extremity. 
Conversely, it has been suggested that a sympathetic block at the level of the 2nd or 3 rd
thoracic vertebrae should be used to effect upper limb sympathetic blockade 
(Wilkinson, 1984 and 1995; Elias, 2000a,b). Notwithstanding these recommendations, 
this study demonstrates that when the needle is directed in an infero-medial direction 
towards the antero-lateral aspect of the 7th cervical vertebral body, the thoracic chain, 
extending from the stellate ganglion to at least the 4th thoracic ganglion, is consistently 
blocked. The infero-medial technique with the injectate delivered at the level of the th 
cervical vertebra directs the solution towards a posterior route, thereby ensuring a block 
of the stellate and the proximal sympathetic chain. 
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The stellate ganglia and proximal sympathetic chain are separated from the posterior 
osseous structures by loose areolar tissue. This facilitates the spread of the injectate 
when deposited near the ganglia (Raj, 1996). This also explains the spread of the 
injectate to adjacent structures such as the brachia! plexus, resulting in a false-positive 
response to the block. The spread of a local anaesthetic agent to the brachia! plexus 
produces a somatic block (rather than sympathetic block), contributing to a negative 
diagnostic test. Another possibility for this phenomenon is the blockade of post­
ganglionic sympathetic fibers along the vertebral and subclavian arteries (and their 
branches) since these structures are positioned more anterior to the stellate ganglion and 
is in the path of the injectate. It has also been suggested that a false positive reaction 
may be due to the systemic absorption of the local anaesthetic (Hogan, 1992). This 
explains why a large volume of injectate can misdirect the purpose of the injection 
(Elias, 2000a,b ). For this reason, it has been suggested that a small volume of injectate 
could localize the spread and provide additional information about the sympathetic 
pathway. In current practice volumes between I 0-20mls are used (Elias, 2000a,b ). The 
quantity of an inappropriate "small" volume is unknown; a I ml solution has been 
suggested for diagnostic or prognostic purposes (Elias, 2000a, b). It is apparent that a 
large volume may confuse the outcome and prognosis of the block. However, in the 
context of pain relief necessary for physical therapy or rehabilitation or to improve 
circulation a large volume of local anaesthetic may be useful solely for therapeutic 
purposes. 
This anatomical study has demonstrated that whilst the stellate ganglia and proximal 
sympathetic chain are consistently blocked, roots of the lower trunk of the brachia! 
plexus are also blocked when I Om ls injectate is delivered. The issue of a false positive 
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response and a negative diagnostic test may therefore require the use of discriminatory 
tests to evaluate the block. 
To test the efficacy of the sympathetic blockade to the upper limb several methods have 
been used. This may be necessary since the presence of a Homer's Syndrome does not 
necessarily indicate a complete interruption of the sympathetic outflow to the upper 
extremity, a situation predisposed when the inferior cervical ganglion is separate from 
the Tl ganglion. Clinical examination, which includes dilatations of the veins in the 
upper extremity, is inconclusive. A successful sympathetic blockade shows 5 criteria 
viz. 
1. Homer's Syndrome within 300 seconds
11. I O to 30°C temperature increase 
111. An increase in blood flow by 50% or more from the pre-block state
1v. Abolition of skin resistant response on the radial and ulnar side following the
block
v. Increase in skin resistant response amounting to 13% or more of the pre­
block value on the radial and ulnar side (Malmqvist et al., 1992)
In practical terms, the Homer's Syndrome apart, the aforementioned are rarely applied 
consistently to diagnose a successful block. Like other methods used to predict a 
complete sympathetic block (eg. pulse amplitude changes, micro-neurography and 
sweat testing) these tests may be difficult to quantify, require elaborate equipment and 
experience and may be cumbersome, time-consuming and not well accepted by patients. 
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Of these tests mentioned, temperature measurement is probably the most practical 
technique to assess completeness of the sympathectomy. 
In our practice, a blind paratracheal technique is used; the failure to instill the inject ate 
at a consistent point (i.e at C6 vs C7 level) most probably contributes to a varied 
extravasations and thereby an unpredictable outcome. 
The difficulty of procuring an isolated sympathetic block using a "blind' technique has 
prompted the use of various localizing techniques. These include use of Magnetic 
Resonance Imaging (MRI), Computerised Tomography (CT) scan and fluoroscopy. 
Often these modalities are not available. Furthermore, the effectiveness of these 
modalities, whilst attractive, await objective demonstration of their value. In the light of 
the effectiveness and safety of therapeutic sympathectomy and the problem of 
sympathetic blockade, the need to accurately localize sympathetic outflow in patients 
present with clinical features of CRPS is a moot point. Furthermore, persistent 
sympathetic blockade (particularly with large volumes of local anaesthetic) may 
provoke fibrosis along the surgically significant component of the sympathetic chain. 
This, as described, may render subsequent surgery hazardous; indeed thoracoscopic 
sympathectomy may not become possible because of the development of adhesions. 
This anatomical study has demonstrated that the infero-medial injection of I 0ml of 
Toludine Blue Solution will consistently block the stellate ganglion and the proximal 
sympathetic chain. The clinical applicability of this approach awaits clarification. The 
pitfalls of this technique aside, we suggest that this technique be reserved for therapeutic 
purposes particularly when sympathectomy is not contemplated. 
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5.4 PATHOLOGICAL CONSIDERATIONS 
5.4.1 PRIMARY HYPERHIDROSIS 
To date, primary hyperhidrosis has been attributed to an exaggerated physiological 
response. The credibility for this inference has been the inability to identify pathological 
alterations in either structure or function of the sweat glands. Furthermore, there are no 
additional pathological changes associated with this condition. 
In contradiction to this, clinical observations do allude to factors other than physiologic 
over-expression for manifestation of the symptoms. These include: 
• There is a strong familial association suggesting a genetic predisposition. This is
unlikely to be X-linked as sexes are affected equally. This observation has been made 
by most units that have an interest in the condition (Adar, 1977; Mares, 1994). 
• Surgical management of palmar hyperhidrosis, whilst it is effective and enduring, is
attended by an unpredictable response with respect to sweating in other areas. It may 
result in resolution of the not uncommonly associated plantar and axillary hyperhidrosis 
or, may even result in truncal hyperhidrosis that in itself may prove disabling to the 
patient. This latter symptom is more predictable with the more extensive 
ganglionectomies (Shelley, 1960). 
• Routine staining of the ganglia done to confirm surgical excision has revealed the
presence of an inflammatory infiltrate. This has not been described previously. 
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These factors favoured the hypothesis of an autoimmune disease with the target 
structure being the sympathetic ganglia and the excessive sweating a manifestation of 
the disease in the sympathetic ganglia rather than a disorder of the sweat glands. 
Substantiating this hypothesis requires the demonstration of 
• Genetic susceptibility
• Immune response directed at self-antigens peculiar to the sympathetic
ganglia
• Alterations in sympathetic outflow as a result of this disease process
Identification of genetic susceptibility 
It is well established that autoimmune conditions occur in genetically vulnerable 
individuals. Various MHC (Major Histocompatibility Complex) alleles of both class I 
and class II origin have been identified that have been unequivocally linked with 
autoimmune disorders (Theofilopoulos, 1995). 
While this has not been investigated in these patients, the evidence for genetic 
susceptibility can be inferred from the strong familial association. It is not uncommon to 
find a parent and offspring as well as siblings being equally debilitated by the condition. 
In closed communities it is fairly common to find this condition affecting members 
across families. 
Others have noted this observation ( Adar, l 977; Mares, I 994). 
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Immunological response 
In an organ-specific autoimmune disease, the immune response is directed to a target 
antigen unique to that single organ or gland, so that the manifestations of the disease 
process are largely limited to that organ. The target organs may be subject to direct 
cellular damage by humoral or cell-mediated mechanisms; alternatively, the function of 
a target organ may be stimulated or blocked by autoantibodies. 
Identifying the defect underlying human autoimmune diseases has been difficult; 
information has largely been gleaned by characterizing the immune defect in the various 
animal models. All the animal models have implicated the CD4 T cell as the primary 
mediator of autoimmune disease (Haskins, 1990; Liblau, 1990). 
Given the difficulty in determining the target antigen, we used cell surface markers to 
phenotype the inflammatory cells that infiltrated the ganglia. We attempted to determine 
whether there were significant CD4 T cells in the inflammatory infiltrate as well as to 
attempt to determine whether the subsequent response was humoral or cell mediated. 
The presence of a significant CD4 population of T cells in the lymphocytic infiltrate 
supported this autoimmune hypothesis. Additional cell surface markers showed a 
significant infiltrate of CDS cells as well as CD20 cells, markers for cytotoxic T cells 
and mature B cells respectively. Overall, the cell counts showed a much higher 
proportion of cytotoxic T cells rather than B cells favouring a predominantly cell 
mediated response (Liblau, 1995). Although acute inflammatory cell markers were 
identified, the counts were not found to be significant. 
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fn addition to the above cellular elements, all ganglia that were evaluated consistently 
demonstrated the presence of fibrosis that was statistically significant. A well 
established hallmark of auto-immune disease is the replacement of the target structure 
with connective tissue, lending further credibility to the pathogenesis being auto­
immune in origin. 
Sympathetic outflow disturbances 
The sympathetic outflow disturbance has been well described; sympathetic denervation 
of the palms results in the abolition of the disorder. This may be attended with 
resolution of symptoms affecting other areas such as the plantar surfaces and axillae 
suggesting that the diminution in the target antigens may abrogate disease. In contrast, a 
significant percentage of patients develop truncal hyperhidrosis. This suggests that other 
(or unexicised) sympathetic ganglia are affected. 
A significant chronic inflammatory infiltrate comprising CD4 T cells, CDS T cells and 
mature B cells in sympathetic ganglia coupled with the clinical observation ofa familial 
tendency favours the hypothesis of an autoimmune component for the disorder of 
primary hyperhidrosis. The disorder manifests at various stages in childhood in keeping 
with an autoimmune disease precipitated by either an infection or an immune reaction to 
microbial products that share homology with self-antigens as has been described for 
Heat Shock Protein 60 in tuberculosis (Jones, 1993). The consistent presence of fibrosis 
in the ganglia corresponds with the connective tissue replacement prevalent in 
autoimmune disease. 
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Further investigations needed to substantiate this hypothesis would include 
identification of MHC alleles that predispose to the condition, cytokine markers in the 
CD4 cells favouring a Th 1 type response and, identifying a target antigen peculiar or 
significantly expressed by the sympathetic ganglion. 
5.4.2 CHRONIC REGIONAL PAIN SYNDROME 
Interruption of the pain cycle early in the course of the disease in CRPS is crucial to 
affect a satisfactory outcome. Failure to do so can result in a significant morbidity that 
even includes limb loss. 
The difficulty in providing effective therapy for CRPS stems from an inability to 
reconcile all of the changes that occur in the disease process with a unified 
pathophysiological process. Subsequently, treatment has been directed at symptomatic 
relief and these have been directed at terminal factors such as nerve membrane 
stabilizing drugs or symptomatic agents such as analgesics. 
There is ample evidence of pathological changes that perpetuate the disease process. 
The precipitant to the response is usually trauma to peripheral nerves that may be either 
innocuous or overt. Perpetuation and progression of pain is invariable; to date, the 
reasons for this remain elusive. 
Our recourse to early sympathectomy, rather than perseverance with medical therapy, 
has demonstrated that these patients always have a satisfactory clinical outcome. While 
the relationship of sympathetic innervation and its importance in the pain pathogenesis 
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remains controversial, a more pivotal role was hypothesized when routine histological 
examination to confirm the excised sympathetic ganglion also revealed an inflammatory 
infiltrate. This prompted the hypothesis that the peripheral injury prompted an 
inflammatory response that recognized self-antigens that are normally sequestered from 
the immune system and this resulted in the perpetuation of the pain response. 
It is well recognized that self-reactive T cells can persist in the circulation especially to 
self-antigens that they are not exposed to during development and subsequent thymic 
maturation (Kronenberg, 1991). These self-reactive T cells are anergic either due to a 
low expression of the self-antigen or the self-antigens are sequestered from the immune 
system by location. They can become clonally expanded either due to exposure to cross­
reacting antigens from microbes or microbial products (Jones, 1993) or, consequent to 
trauma, these normally protected self-antigens are exposed to these immuno-competent 
cells stimulating a response. Additionally, trauma would induce changes that may see 
the expression of or increase in MHC expression making them vulnerable to the 
immune system (Feldmann, 1993). 
Against this background, an autoimmune hypothesis is proposed to explain the 
pathophysiological changes that occur in CRPS. 
Exposure of self-antigens 
Neural tissue and their products are largely sequestered from the immune system and 
self-antigens are not normally present on the surface. Trauma results in the disruption of 
these structures making these antigens available for expression by antigen presenting 
cells. Additionally, stimulation of the local tissues by the inflammatory response can 
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result in the upregulation of both class I and class II MHC molecules, an effect mediated 
by IFN y, on the injured tissues rendering them more susceptible to injury as a response 
by the immune system. 
Credibility for this would be that CRPS is always preceded by trauma to the peripheral 
nerves and less commonly by nerve infections such as Herpes Zoster. This renders the 
possibility of self-antigens to become exposed from the nerve fibres. A second 
possibility is that this stimulates the neural cells in the ganglion to upregulate the 
receptors and hence the localization of the response to the affected sympathetic ganglia. 
Of note, this effect occurs in selective patients. Whether this is due to genetic 
susceptibility remains unclear as the nature of the triggering event is unlikely to provide 
a sample population to substantiate this. 
Demonstration of progressive inflammation 
Cells in the sympathetic ganglia demonstrate a significant infiltrate of CD4 and CD8 
positive cells. The high percentage of CD8 cells favours a Th I type response being 
mediated by the CD4 cells present (Haskins, 1990; Liblau, 1995). This is widely 
accepted as the dis-equilibrium favouring the progression of an autoimmune process. 
There are also significant levels of mature B cells as evidenced by CD20 staining and 
macrophages as demonstrated by the staining for the CD68 marker. This lends 
credibility to the hypothesis of sequestered self-antigen exposure as well as up­
regulation in the ganglion cells of MHC molecules (Theofilopoulos, 1995). This is 
currently being investigated. 
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fn addition to these fmdings, fibrosis is invariable in these ganglia. It is well recognized 
that autoimmune diseases that are organ specific results in a progressive connective 
tissue replacement of the targeted tissue. These changes must be viewed in the light that 
these ganglia are remote from the primary traumatic insult. 
The focal nature of the ganglion involvement would suggest that the original injury 
triggers the expression of MHC alleles not normally expressed by these cells 
circumventing a global sympathetic ganglia involvement. 
Altered function and therapeutic effects 
Functional impairment attests to the original insult but the accompanying aberrant 
sympathetic activity accompanying the injury cannot be explained by the primary insu It. 
These changes are usually progressive and the significance of the sympathetic system 
has been long documented given the historical terms for the disease such as Reflex 
Sympathetic Dystrophy. Additionally, sympathetic blockade is not enduring and ranges 
from no effect to an effect that lasts longer that the duration of the anaesthetic agent 
used. This would favour that the sympathetic component perpetuates the disease process 
and this is consolidated by the predictable response from the performance of early 
sympathectomy in these patients. 
These effects would also explain the alterations in the dorsal root ganglia as cytokines 
are known to cross into the central nervous system and would influence the alterations 
such as increased sprouting that has been reported to occur in the dorsal root ganglia in 
CRPS. 
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The sympathetic mediated effects accompanying CRPS are most likely due to the 
inflammation of the sympathetic ganglia. This may play a pivotal role in the disease 
process that results in perpetuation and progression of the disease. An autoimmune 
mechanism as result of sympathetic nerve disruption is an attractive hypothesis given 
the inflammatory infiltrate recognized in these ganglia. The fibrosis lends credibility to 
this hypothesis. Furthermore, that this does not occur in all patients suggest genetic 
vulnerability supporting our hypothesis. 
Further investigations that would support this hypothesis would be the demonstration of the 




6.1 CLINICAL CONSIDERATIONS 
The primacy of thoracoscopic sympathectomy (with respect to safety, cost, and ease) is 
endorsed in this study, establishing this technique as arguably the brightest strand in the 
tapestry of minimal access surgery. 
The commonest indication for upper limb sympathectomy is palmar hyperhidrosis; 
presently, the heightened public awareness of the safe and effective treatment for palmar 
hyperhidrosis has led to ever increasing numbers of this procedure being undertaken 
(Appendix 5). 
A limited 2nd thoracic ganglionectomy is always successful for palmar hyperhidrosis; 
associated axillary and plantar hyperhidrosis may also be successfully treated in up to 
81 % and 53% respectively by limited ganglionectomy. 
In patients with CRPS sympathectomy is effective when undertaken within 3 months of 
onset of symptoms. There is a poor outcome when sympathectomy is undertaken 
belatedly. The stellate ganglion block was noted to be non-predictive in defining patients 
who would benefit from sympathectomy. 
With respect to anaesthetic technique, a single-lumen endo-tracheal tube was noted to be 
safe, effective and associated with less post-operative discomfort when compared to the 
double-lumen endo-bronchial tube. 
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6.2 ANATOMICAL CONSIDERATIONS 
Alternate neural pathways (ANP) to the upper limb were noted in 90% of cadaveric 
dissections; 3 types of ANP were defined. The commonest variation was Type A, noted 
in 46.3%. Type B, the original nerve of Kuntz, was noted in 26.8 %. Type C was noted in 
17.1 %. 
When correlated to clinical outcome to an isolated 2nd ganglionectomy these ANPs are 
not considered to be of surgical significance. 
When a modified anterior approach to the stellate ganglion block is undertaken, the 
clinically significant 2nd thoracic ganglion is consistently blocked. This may have clinical 
significance, notwithstanding the often-associated blockade of the lower trunk of the 
brachia! plexus. 
6.3 PATHOLOGICAL CONSIDERATIONS 
There is strong evidence for an autoimmune hypothesis in both primary hyperhidrosis as 
well as CRPS. The mechanisms responsible for the development of the symptoms in 
these conditions appear to be different. 
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APPENDIX 
APPENDIX 1 
SYMPATHECTOMY (1992-2001): INDICATIONS 
Palmer h� pcrhidrosis CRPS Ra� naud's 
208 
PVD 
Year Patients Operation Patients Operation Patients Operation Patients Operation 
1992 17 34 - - - -
1993 39 78 2 2 1 2 
1994 42 83 3 4 1 2 
1995 61 121# 2 2 - -
1996 56 109 .. # 3 3 - -
1997 59 116· # 3 3 - -
1998 68 134•# 5 5 2 4 
1999 57 113. 8 8 1 1 
2000 31 61 • 9 9 - -
2001 18 35• 7 7 - -
448 884 42 43 5 9 
Key: 
• procedure abandoned (lung adhesions- failure to collapse lung)
# undertaken unilaterally for persistent sympathetic activity 
..A. undertaken unilaterally for recurrent sympathetic activity 
SY:\'IPATHECTOi\1Y lfNDER TAKEN 1992-2001 
Patients Operation 
Palmer Hyperhidrosis 448 884 
CRPS 42 43 
Raynaud's 5 9 
Peripheral Vascular Disease 3 3 












Thoracoscopic sympathectomy was successfully undertaken on 884 occasions ( out of a 
possible total of 890); in 6 cases because of lung adhesions, a pneumothorax could not 
be attained and a procedure was abandoned. Unsuccessful outcome to sympathectomy 
(in the 890 procedures) was as follows: 
i) at 3 months 2 had pSA; i.e. 880/882 = 99.77%
ii) at I year 4 had pSA, 2 had rSA; i.e. 877/882 = 99.43%
CAUSES OF UNSUCCESSFUL SYMPATHECTOMY 
a) Failure to attain collapse (n=6)
b) Persistent sympathectomy activity (n=4); No anatomical reason noted at re­
thoracoscopy
c) Recurrent sympathectomy activity (n=2): Regenerated sympathectic chain (n= l); 














APPENDIX 2 (i) 
CHRONIC REGIONAL PAIN SYNDROME : GROUP I 



















































































1.50 1 TS 10.0 4.2 
1.00 1 TS 9.2 l.O
1.75 1 TS 8.6 0.5 
1.25 1 TS 8.4 2.1 
1.50 1 TS 9.0 1.0 
1.00 1 TS 7.8 0.6 
2.25 1 TS 10.0 3.8 
1.75 I TS 8.1 0 
1.50 1 TS 8.9 1.9 
1.50 I TS 9.2 1.0 
2.75 2 TS 8.9 3.0 
2.00 I TS 8.5 0.2 
1.50 I TS 9.6 0.4 
1.50 I TS 10.0 0 
2.00 I TS 9.4 1.0 
2.50 I TS 9.6 1.5 
2.00 I TS/OS 9.6 1.0 
2.50 I TS/OS 9.7 2.0 
1.50 I TS 9.0 1.0 
2.50 I TS 9.5 1.5 
2.00 1 TS 9.0 1.0 
2.50 I TS 8.0 4.0 
2.00 I TS 7.5 3.5 
1.70 I TS 9.0 2.0 
symptoms evident for< 
3
/ 12 
Number of stellate ganglion blocks performed 
TS - Thoracoscopic sympathectomy 
TS/OS - Thoracoscopic converted to open sympathectomy 
OS - Open sympathectomy 



























































































APPENDIX 2 (ii) 
GROUP II : GRPS 
PRE- POST-
DURATION SGB ROLTE OPERATIVE OPERATIVE DIFFERENCE 
5.00 1 TS 7.0 3 
4.00 3 TS 9.8 4.6 
4.25 4 OS 8.8 3.8 
8.00 4 OS 10.0 9.2 
3.50 3 TS 9.2 0.2 
4.50 3 OS 8.7 3.1 
7.25 4 OS 9.9 8.9 
3.75 3 TS 8.1 1.2 
12.25 5 TS 9.7 7.9 
5.25 2 OS 9.7 0.8 
9.00 4 OS 10.0 9.4 
12.00 I TS 8.0 3 
13.00 4 TS 9.6 9 
84.00 I TS 8.6 3 
48.00 4 TS 8.0 6 
24.00 I OS 8.0 6 
36.00 2 TS 9.0 I 
19.00 I TS 10.0 4.5 
24.00 I TS 7.5 I 
symptoms evident for< 
3
/ 1 2 
Number of stellate ganglion blocks performed 
TS - Thoracoscopic sympathectomy 
TS/OS - Thoracoscopic converted to open sympathectomy 
OS - Open sympathectomy 























LIMITED GANGLIONECTOMY: PRE-vs POST- OPERATNE SCORING ON 
VLAS 
�-----\_\._I _I_ \_R_,_ \_ \_l_ll_l _l'_II _________ Pl_\,_l _\l_{_\ \ _l_l _ll_ l'_I_I ___ 
�������� 
7 I 6 9 1.9 7.1 10 I 9 
8 1.2 6.8 8.8 2.6 6.2 8.6 1.5 7.1 
9 1.3 7.7 9.4 3.6 5.8 9.5 1.9 7.6 
10 I 9 10 2 8 7.9 2.3 5.6 
7.5 2 5.5 7.8 2.8 5 9.9 2 7.9 
7.9 1.2 6.7 10 2.4 7.6 9.4 2.2 7.2 
8.6 I. I 7.5 8.5 2.6 5.9 8.9 3 5.9 
9.3 0.9 8.4 9.5 3.7 5.8 10 2.1 7.9 
9.9 0.4 9.5 9.7 2.1 7.6 9.7 1.4 8.3 
10 0.6 9.4 9 1.9 7.1 9.4 1.8 7.6 
9.8 0.2 9.6 9.3 1.4 7.9 8.6 0.8 7.8 
9.6 0 9.6 8.5 1.3 7.2 8.9 0.9 8 
8.9 0.7 8.2 8.2 1.9 6.3 9.7 2.1 7.6 
10 0 10 9.6 2 7.6 7.7 2.6 5.1 
10 0.4 9.6 9.3 1.6 7.7 9.8 2.6 7.2 
9.9 0.2 9.7 7.3 2.9 4.4 9.2 2.1 7.1 
8.9 I 7.9 7.5 1.3 6.2 8.9 0.1 8.8 
9.6 0.6 9 8.6 2.4 6.2 7.9 I. I 6.8 
9.5 0.9 8.6 4.7 3.7 I 8.7 0.5 8.2 
9.4 0.7 8.7 5.5 2.6 2.9 10 0 10 
10 I 9 6 2 4 9.9 2 7.9 
8.9 2 6.9 6.8 2.2 4.6 7.9 0 7.9 
7.8 0.9 6.9 6.4 I. 7 4.7 9.5 0.4 9.1 
9 0.3 8.7 4.9 1.8 3.1 8.7 0.1 8.6 
9.7 0.5 9.2 4.6 0.9 3.7 3.3 2 1.3 
10 0.2 9.8 5.6 I 4.6 9.2 2.1 7.1 
9.6 O.J 9.3 6.7 5.6 I.I 8.5 4 4.5 
9.5 0.6 8.9 4.8 5 -0.2 6.5 3.1 3.4 
9.3 0.8 8.5 5.9 6.3 -0.4 6.3 5.4 0.9 
9.2 0.7 8.5 5.8 8.1 -2.3 5.4 4.6 0.8 
9.1 0.9 8.2 2.3 9.8 -7.5 5.7 5.7 0 
9.6 0.2 9.4 2.4 9.5 -7.1 5.4 4.2 1.2 
9.9 0.3 9.6 6.3 3.2 3.1 
9.7 0 9.7 5.3 4.3 I 
9.3 0.4 8.9 5.8 4.8 I 
9.5 0.1 9.4 6.8 3.6 3.2 
9.2 0.4 8.8 5.7 4.1 1.6 
9.5 0.2 9.3 5.9 5 0.9 
9.8 0.5 9.3 6.7 7.6 -0.9
9 0.5 8.5 5.8 4.7 I. I 
9.1 0.3 8.8 5.9 4.3 1.6 
9.3 0.1 9.2 6.3 4 2.3 
9.6 0 9.6 6.9 4.2 2.7 
9.6 0 9.6 2.5 4 -1.5
9.8 0 9.8 2.9 5 -2.1
10 0.7 9.3 2.5 5 -2.5
10 0.3 9.7 3.9 6.5 -2.6 
8.9 0.1 8.8 3.8 7.3 -3.5
7.9 0.2 7.7 2.9 8 -5.1
9 0.1 8.9 
9.6 0.1 9.5 
9.7 0.4 9.3 
9.2 0.2 9 
9.4 0.6 8.8 




NERVE OF KUNTZ: DISTANCE (mm) FROM SYMPATHETIC 
INTERGANGLIONIC SEGMENT (BETWEEN STELLATE AND T2 GANGLIA) 
TYPE A (n= 17) TYPF: B (n=J I) TYPE C (n=7) 
Right (11=SJ Left (11=//J Right (11=4) l.eft (11=7) Right (11-3) l.e./1 (11=4) 
2.7 4.6 6.0 12.3 8.0 12.0 
3.0 5.0 15.3 6.0 1.0 9.0 
2.4 8.0 4.0 10.0 9.0 4.5 
8.7 10.5 4.5 9.0 I 1.0 
6.0 7.5 7.0 
30.0 2.5 5.0 
3.7 3.5 4.8 
9.0 8.0 
6.0 
5.4 
7.5 
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